Home Cart Sign in  
Chemical Structure| 4342-03-4 Chemical Structure| 4342-03-4

Structure of Dacarbazine
CAS No.: 4342-03-4

Chemical Structure| 4342-03-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dacarbazine is an antineoplastic agent with significant activity against melanomas, by acting as an alkylating agent and inhibiting DNA synthesis as a purine analog

Synonyms: Imidazole Carboxamide; NCI C04717; Detimedac

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dacarbazine

CAS No. :4342-03-4
Formula : C6H10N6O
M.W : 182.18
SMILES Code : O=C(C1=C(/N=N/N(C)C)N=CN1)N
Synonyms :
Imidazole Carboxamide; NCI C04717; Detimedac
MDL No. :MFCD00057167
InChI Key :FDKXTQMXEQVLRF-ZHACJKMWSA-N
Pubchem ID :135398738

Safety of Dacarbazine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H351
Precautionary Statements:P501-P202-P201-P264-P280-P308+P313-P337+P313-P305+P351+P338-P302+P352-P332+P313-P362-P405

Related Pathways of Dacarbazine

DNA

Isoform Comparison

Biological Activity

Description
Dacarbazine is an antineoplastic alkylating agent used broadly in oncology, particularly effective due to its ability to inhibit both T and B lymphocyte responses, with IC50 values of 50 μg/mL and 10 μg/mL respectively. It is primarily used in the treatment and research of metastatic malignant melanoma[1].[2].[3].[4].[5].

In Vitro:

Cell Line
Concentration Treated Time Description References
MNT-1 cells 6.25-500 μg/mL 24, 48, 72 hours To evaluate the effect of DTIC on cell viability. MNT-1 cells were less responsive to DTIC. After 24 h exposure, only the highest concentration (500 μg/mL) significantly reduced cell viability to 87%. After 48 h exposure, 100 μg/mL concentration reduced cell viability by ~80%. PMC8998307
A375 cells 6.25-500 μg/mL 24, 48, 72 hours To evaluate the effect of DTIC on cell viability. DTIC showed a concentration- and time-dependent antiproliferative effect on A375 cells. After 24 h exposure, cell viability was below 85% at concentrations ≥100 μg/mL. After 48 and 72 h exposure, all tested concentrations significantly reduced cell viability. PMC8998307
SK-MEL-28 309.55 ± 5.73 µM (IC50) 72 hours Evaluate the cytotoxicity of DTIC to SK-MEL-28 cells, showing an IC50 of 309.55 ± 5.73 µM. PMC10077623
A375 15.40 ± 1.39 µM (IC50) 72 hours Evaluate the cytotoxicity of DTIC to A375 cells, showing an IC50 of 15.40 ± 1.39 µM. PMC10077623

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03646123 Hodgkin Lymphoma Phase 4 Recruiting March 2023 United States, New Jersey ... More >> New Jersey Hematology Oncology Associates, LLC Recruiting Brick, New Jersey, United States, 08724 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Regional Cancer Care Associates - Freehold Recruiting Freehold, New Jersey, United States, 07728 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Regional Cancer Care Associates - Howell Recruiting Howell, New Jersey, United States, 07731 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Regional Cancer Care Associates - Mount Holly Recruiting Mount Holly, New Jersey, United States, 08060 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Regional Cancer Care Associates - Central Jersey Recruiting Somerville, New Jersey, United States, 08876 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Regional Cancer Care Associates - Sparta Recruiting Sparta, New Jersey, United States, 07871 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          United States, New York Clinical Research Alliance - Morton Coleman, MD Recruiting Lake Success, New York, United States, 11042 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          CareMount Medical Group Recruiting Mount Kisco, New York, United States, 10549-3412 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          Clinical Research Alliance - Abraham Mittelman, MD, LLC Recruiting Purchase, New York, United States, 10577 Contact: Colleen Kats    516-488-2918    ckats@researchcra.com    Principal Investigator: Morton Coleman          United States, Ohio Case Western Reserve University / University Hospitals Cleveland Medical Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Judah Friedman    440-286-5050    judah.friedman@uhhospitals.org    Principal Investigator: Judah Friedman Less <<
NCT02684708 Classical Hodgkin Lymphoma Phase 3 Recruiting September 2021 Germany ... More >> Justus Liebig University of Giessen Recruiting Giessen, Germany, 35392 Contact: Dieter Koerholz, MD       dieter.koerholz@paediat.med.uni-giessen.de    Contact: Christine Mauz-Koerholz, MD       christine.mauz-koerholz@paediat.med.uni-giessen.de Less <<
NCT01716806 Hodgkin Disease Phase 2 Recruiting July 2021 -
NCT00992030 Hodgkin Lymphoma Phase 3 Active, not recruiting December 2019 United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Italy Ospedali Riuniti Umberto I Ancona, Italy, 60020 Ospedali Riuniti Bergamo, Italy, 24100 Policlinico S. Orsola Malpighi Bologna, Italy, 40138 Ospedale Roberto Binaghi Cagliari, Italy, 09126 Azienda Ospedaliera Vittorio Emanuele Ferrarotto Catania, Italy, 95124 Fondazione IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 Azienda Ospedaliero Universitaria S. Luigi Gonzaga Orbassano, Italy, 10043 Gianpietro Semenzato Padova, Italy, 35128 Ospedali Riuniti Villa Sofia Cervello Palermo, Italy, 90146 Ospedale San Carlo Potenza, Italy, 85100 Less <<
NCT00654732 Classic Hodgkin Lymphoma ... More >> Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 Less << Phase 2 Completed - United States, Florida ... More >> University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00615160 Melanoma Phase 1 Phase 2 Suspended(Substance was withdr... More >>awn from further development.) Less << - Germany ... More >> Dpt. of Dermatology, University of Essen Essen, Germany, D-45122 Dpt. of Dermatology, University of Frankfurt Frankfurt/Main, Germany, D-60590 Dpt. of Dermatology; UK-SH Campus Kiel, Germany Kiel, Germany, D-24105 Dpt. of Dermatology, University of Cologne Koeln, Germany, D-50937 Less <<
NCT02298257 HIV Infection ... More >> HIV-associated Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma Less << Phase 2 Active, not recruiting December 2019 France ... More >> APHP - Hôpital Antoine Béclère Clamart, France, 92140 CHU de Nice Nice, France, 06202 APHP - Hôpital Saint Antoine Paris Cedex 12, France, 75571 Hopital St Louis Paris, France, 75475 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU de Toulouse Toulouse, France Less <<
NCT02292979 Hodgkin Lymphoma Phase 2 Active, not recruiting August 2022 -
NCT01712490 Hodgkin Lymphoma Phase 3 Active, not recruiting March 1, 2020 -
NCT03527628 Classical Hodgkin Lymphoma ... More >> Hodgkin Lymphoma (Category) Hodgkin Disease Hodgkin Lymphoma Less << Phase 2 Recruiting January 15, 2022 Saudi Arabia ... More >> King Abdulaziz Medical City, Ministry of National Guard Recruiting Riyadh, Saudi Arabia, 22390 Contact: Ayman Hejazi, MD    +966 8011111 ext 53388    hejazia@ngha.med.sa Less <<
NCT00722865 Hodgkin Lymphoma Phase 2 Terminated(slow enrollment) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02505269 Hodgkin Lymphoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01712490 - Active, not recruiting - -
NCT03070392 Uveal Melanoma Phase 2 Recruiting March 2023 -
NCT00327600 Malignant Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> Investigational Site 009 Los Angeles, California, United States, 90033 Investigational Site 002 Santa Monica, California, United States, 90404 United States, Colorado University of CO Anschutz Cancer Pavilion Aurora, Colorado, United States, 80010 United States, Florida US Oncology Orlando, Cancer Centers of FL Ocoee, Florida, United States, 34761 United States, New York US Oncology Albany, New York Oncology Albany, New York, United States, 12208 United States, Ohio US Oncology Kettering Kettering, Ohio, United States, 45409 United States, South Carolina US Oncology Greenville, Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29615 United States, Texas US Oncology, Tyler Cancer Center Tyler, Texas, United States, 75702 United States, Utah Investigational Site 012 Salt Lake City, Utah, United States, 84112 United States, Virginia US Oncology, Virginia Oncology Assoc Norfolk, Virginia, United States, 23502 United States, Washington US Oncology Spokane, Cancer Care Northwest Spokane, Washington, United States, 99218 Less <<
NCT02994498 Advanced Melanoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00179608 Malignant Melanoma Phase 1 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00722865 - Terminated(slow enrollment) - -
NCT01771107 AIDS-Related Hodgkin Lymphoma ... More >> Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage IIA Hodgkin Lymphoma Ann Arbor Stage IIB Hodgkin Lymphoma Ann Arbor Stage III Hodgkin Lymphoma Ann Arbor Stage IIIA Hodgkin Lymphoma Ann Arbor Stage IIIB Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IVA Hodgkin Lymphoma Ann Arbor Stage IVB Hodgkin Lymphoma Classic Hodgkin Lymphoma HIV Infection Less << Phase 1 Phase 2 Recruiting December 12, 2019 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          UCLA Center for Clinical AIDS Research and Education Recruiting Los Angeles, California, United States, 90035 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Scott D. Christensen    916-734-3771    schristensen@ucdavis.edu    Principal Investigator: Scott D. Christensen          United States, Florida University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Illinois John H Stroger Jr Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Louisiana Louisiana State University Health Science Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Massachusetts Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Beth Israel Deaconess Medical Center Active, not recruiting Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Washington University - Jewish Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, New York Montefiore Medical Center-Einstein Campus Recruiting Bronx, New York, United States, 10461 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Pennsylvania Pennsylvania Oncology Hematology Associates Recruiting Philadelphia, Pennsylvania, United States, 19106 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Washington Virginia Mason Medical Center Recruiting Seattle, Washington, United States, 98101 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          France Centre Hospitalier Universitaire (CHU) de Toulouse Recruiting Cedex, France, 31059 Contact: Pierre Delobel    33-5-6177-7508    delobel.p@chu-toulouse.fr    Principal Investigator: Pierre Delobel          Hopital Antoine Beclere Recruiting Clamart, France, 92140 Contact: Francois Boue    33-1-4537-4409    francois.boue@abc.aphp.fr    Principal Investigator: Francois Boue          Henri Mondor University-Hospital Center Recruiting Creteil, France, 94000 Contact: Corinne Haioun    33-1-49-81-20-51    corinne.haioun@hmn.aphp.fr    Principal Investigator: Corinne Haioun          Hopital l'Archet-CHU de Nice Recruiting Nice, France, 06202 Contact: Nicolas Mounier    334-9203-5841    mounier.n@chu-nice.fr    Principal Investigator: Nicolas Mounier          Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Eric Oksenhendler    33-1-4249-9811    eric.oksenhendler@sls.aphp.fr    Principal Investigator: Eric Oksenhendler          Hospital Saint-Antoine Recruiting Paris, France, 75012 Contact: Paul Coppo    33-1-4928-2616    paul.coppo@sat.aphp.fr    Principal Investigator: Paul Coppo          Centre Hospitalier Lyon-Sud Recruiting Pierre Benite, France, 69310 Contact: Gilles Salles    33-(0)-4-78-86-43-02    gilles.salles@chu-lyon.fr    Principal Investigator: Gilles Salles          Chu Purpan Recruiting Toulouse, France, 31059 Contact: Paul G. Rubinstein    (312) 864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein Less <<
NCT00498979 Stage IV Melanoma Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT02288897 Cutaneous Melanoma Phase 3 Active, not recruiting April 2019 -
NCT01534078 Hodgkin Lymphoma Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hosptial Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01009177 Melanoma Phase 2 Completed - Australia ... More >> Barwon Health - The Geelong Hospital Geelong, Australia, VIC 3220 Sydney Haematology and Oncology Unit Hornsby, Australia, NSW Cabrini Hopsital - Oncology Department Malvern, Australia, VIC 2144 New Castle Melanoma Unit New Castle, Australia, NSW Mount Medical Centre Perth, Australia, WA Redcliffe Hospital - Dept Oncology & Palliative Care Redcliffe, Australia, QLD 4020 Mater Adult Hospital South Brisbane, Australia, QLD 4001 Pacific Private Clinic Southport, Australia, QLD 4215 Royal North Shore Hospital St Leonards, Australia, NSW Sydney Cancer Centre, Royal Prince Alfred Hospital Sydney, Australia, NSW Westmead Hospital - Department of Oncology Westmead, Australia, NSW 2145 Southern Medical Day Care Centre Wollongong, Australia, NSW Less <<
NCT00559026 Melanoma Phase 1 Completed - Italy ... More >> University Hospital Tor Vergata Rome, Italy, 00133 Regina Elena Cancer Institute Rome, Italy, 00153 Less <<
NCT01534078 - Completed - -
NCT00849875 Melanoma Phase 2 Terminated(Early end of trial ... More >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) Less << - Belgium ... More >> GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Brussel, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1180 GSK Investigational Site Liège, Belgium, 4000 GSK Investigational Site Roeselare, Belgium, 8800 GSK Investigational Site Yvoir, Belgium, 5530 France GSK Investigational Site Caen, France, 14033 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris, France, 75018 GSK Investigational Site Reims, France, 51092 GSK Investigational Site Villejuif, France, 94805 Less <<
NCT01476410 Adult Lymphocyte Depletion Hod... More >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Stage II Adult Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma Less << Phase 2 Active, not recruiting May 2020 United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 United States, Illinois NorthwesternU Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7835 United States, New York Memorial Sloan- Kettering Cancer Center New York, New York, United States, 10065 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00849875 - Terminated(Early end of trial ... More >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) Less << - -
NCT01376713 Stage III Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Completed - Austria ... More >> Rudolfstiftung Vienna, Austria, 1030 Medical University of Vienna Vienna, Austria, 1090 Less <<
NCT00395070 Metastatic Melanoma Phase 3 Completed - -
NCT00006200 Melanoma Phase 2 Unknown - United States, New York ... More >> Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00072124 Melanoma (Skin) Phase 3 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00087776 Malignant Melanoma Not Applicable Completed - United States, Pennsylvania ... More >> Luitpold Pharmaceuticals, Inc. Norristown, Pennsylvania, United States, 19403 Less <<
NCT01280565 Metastatic Melanoma Phase 3 Recruiting December 2020 France ... More >> Hôpital Sainte Marguerite Recruiting Marseille, France, 13274 Contact: Jean-Jacques GROB, MD, PhD Less <<
NCT00991250 Malignant Melanoma Phase 2 Unknown September 2011 Sweden ... More >> Lunds Universitetssjukhus Recruiting Lund, Skåne, Sweden, 22185 Contact: Christian Ingvar, MD    +46 (0)46-17 10 00    christian.ingvar@skane.se    Principal Investigator: Christian Ingvar, MD          Södersjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 11883 Contact: Peter Gillgren, MD    +46 (0)8-616 23 84    peter.gillgren@sodersjukhuset.se    Principal Investigator: Peter Gillgren, MD          Karolinska Sjukhuset Recruiting Stockholm, Stockholms Län, Sweden, 17176 Contact: Johan Hansson, MD    +46 (0)8-5177 36 40    johan.hansson@karolinska.se    Principal Investigator: Johan Hansson, MD          Norrlands Universitetssjukhus Recruiting Umeå, Västerbottens Län, Sweden, 90185 Contact: Peter Naredi, MD    +46 (0)90- 785 00 00    peter.naredi@surgery.umu.se    Principal Investigator: Peter Naredi, MD          Sahlgrenska Universitetssjukhuset Not yet recruiting Göteborg, Västra Götalands Län, Sweden, 41685 Contact: Jan E Mattsson, MD    +46 (0)31-342 84 58    jan.e.mattsson@vgregion.se    Principal Investigator: Jan E Mattsson, MD Less <<
NCT01721746 Unresectable or Metastatic Mel... More >>anoma Less << Phase 3 Active, not recruiting March 6, 2019 -
NCT00003647 Stage IV Melanoma ... More >> Stage III Melanoma Recurrent Melanoma Less << Phase 3 Completed - -
NCT01100528 Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Iris Melanoma Recurrent Intraocular Melanoma Less << Phase 2 Active, not recruiting January 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01721746 - Active, not recruiting - -
NCT01100528 - Active, not recruiting - -
NCT01692678 Advanced or Metastatic Liposar... More >>coma or Leiomyosarcoma Less << Phase 3 Completed - China ... More >> Beijing, China Shanghai, China Less <<
NCT03016819 Alveolar Soft Part Sarcoma ... More >> Leiomyosarcoma Synovial Sarcoma Soft-Tissue Sarcoma Less << Phase 3 Recruiting August 2021 United States, California ... More >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90404 Contact: Alice Study Coordinator       APolyakov@mednet.ucla.edu    Principal Investigator: Bartosz Chmielowski, MD, PhD          Stanford Medicine Cancer Institute Recruiting Stanford, California, United States, 94305 Contact: Feriel Study Coordinator       Ferielbu@stanford.edu    United States, Florida University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Lizbeth Study Coordinator       lizbeth.bornote@med.miami.edu    Contact: Michelle Study Coordinator       mliendo@med.miami.edu    Principal Investigator: Breelyn Wilky, MD          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Paige Study Coordinator       crawforp@med.umich.edu    Principal Investigator: Rashmi Chugh, MD          United States, Missouri Washington University St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Sarah Study Coordinator       s.chandler@wustl.edu    United States, Pennsylvania Thomas Jefferson Hospital - Sidney Kimmel Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Sarah Study Coordinator       Sarah.shaw@jefferson.edu    United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37203 Contact: Eligibility Office    800-811-8480       Principal Investigator: Vicki L Keedy, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Viju Study Coordinator       viju@mdanderson.org    Principal Investigator: Neeta Somaiah, MD          Italy Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Chiara Study Coordinator       chiara.negrelli@istitutotumori.mi.it    Principal Investigator: Silvia Stacchiotti, MD Less <<
NCT00797472 Hodgkin's Disease Phase 2 Unknown April 2014 United States, New Jersey ... More >> Raritan Bay Medical Center Not yet recruiting Englishtown, New Jersey, United States, 07726 Contact: Prem A Nandiwada, M.D.    908-941-5480    rgreywal@americanscitech.com    Contact: Ratna Grewal, M.D.    908-941-5480    rgreywal@americanscitech.com Less <<
NCT00066196 Melanoma Mali... More >>gnant Metastatic Melanoma Less << Phase 2 Completed - -
NCT01542255 Metastatic Melanoma Phase 2 Terminated(Low accrual not all... More >>owing to support statistical endpoints) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00542893 Advanced Melanoma Phase 1 Completed - -
NCT01542255 - Terminated(Low accrual not all... More >>owing to support statistical endpoints) Less << - -
NCT03342300 Progression-free Survival ... More >> Overall Survival Toxicity Less << Phase 2 Phase 3 Recruiting December 30, 2019 China ... More >> Peking University People's Hospital Recruiting Beijing, China, 100044 Contact: Tingting Ren, Ph.D.    +86-13810095026    tumorcenter@163.com    Principal Investigator: Wei Guo, M.D. and Ph.D. Less <<
NCT00308607 Metastatic Melanoma Phase 2 Completed - Finland ... More >> Kuopio University Hospital Kuopio, Finland, FIN-70211 Oulu University Hospital Oulu, Finland, FIN-90029 Tampere University Hospital Tampere, Finland, FIN-33521 Less <<
NCT01359956 Malignant Melanoma ... More >> Recurrent Melanoma Less << Phase 3 Completed - -
NCT00110994 Cancer Melano... More >>ma Less << Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, Colorado Aurora, Colorado, United States, 80045 United States, Florida Lakeland, Florida, United States, 33805 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02115-6084 Boston, Massachusetts, United States, 02215 United States, Missouri St. Louis, Missouri, United States, 63110-1093 United States, Nebraska Omaha, Nebraska, United States, 68114 United States, North Carolina Charlotte, North Carolina, United States, 28203 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hilton Head Island, South Carolina, United States, 29926-2739 United States, Tennessee Nashville, Tennessee, United States, 37232-6307 United States, Texas San Antonio, Texas, United States, 78229 Less <<
NCT00070343 Melanoma (Skin) Not Applicable Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-6996 Less <<
NCT00110994 - Completed - -
NCT00796991 Advanced Melanoma Phase 1 Completed - United States, California ... More >> The Angeles Clinic & Research Inst. Los Angeles, California, United States, 90025 United States, Florida H Lee Moffit Cancer Cnt And Res Inst Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Blumenthal Cancer Center, Carolinas Medical Center Charlotte, North Carolina, United States, 28204 Less <<
NCT01614301 Advanced Melanoma Phase 1 Phase 2 Unknown May 2016 Germany ... More >> University of Regensburg Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Albrecht Reichle, Professor    +499419440    albrecht.reichle@UKR.de    Sub-Investigator: Martin Vogelhuber, MD          Sub-Investigator: Stephanie Mayer, MD          Sub-Investigator: Christina Hart, MD          Sub-Investigator: Matthias Grube, MD          Sub-Investigator: Susanne Gantner, MD Less <<
NCT00016263 Melanoma (Skin) Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, New Jersey Genta Incorporated Berkeley Heights, New Jersey, United States, 07922 Less <<
NCT01705392 Metastatic Malignant Melanoma ... More >> Unresectable Malignant Melanoma Less << Phase 2 Terminated(Lack of financing o... More >>f the study drug. Not sufficient financial support.) Less << - Norway ... More >> Haukeland University Hospital Bergen, Norway, 5021 Less <<
NCT01404936 Lymphoma Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00796991 - Completed - -
NCT00813449 Advanced Melanoma ... More >> Untreated Patients Less << Phase 2 Unknown August 2010 China, Beijing ... More >> Beijing tumor hospital Recruiting Beijing, Beijing, China, 100036 Contact: Jun Guo, professor    8610-88121122    guoj307@126.com    Contact: liang ch Cui, doctor    8610-88121122       Principal Investigator: Jun Guo, professor Less <<
NCT01404936 - Completed - -
NCT01974752 Metastatic Uv... More >>eal Melanoma Less << Phase 3 Completed - -
NCT00911443 Malignant Melanoma Phase 2 Completed - -
NCT03233347 Ann Arbor Stage I Hodgkin Lymp... More >>homa Ann Arbor Stage IA Hodgkin Lymphoma Ann Arbor Stage IB Hodgkin Lymphoma Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage IIA Hodgkin Lymphoma Ann Arbor Stage IIB Hodgkin Lymphoma Less << Phase 2 Recruiting August 7, 2024 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Elizabeth Budde, MD    626-256-4673    ebudde@coh.org    Principal Investigator: Elizabeth E. Budde          United States, Georgia Emory University Hospital/Winship Cancer Institute Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Amanda A. Hutchison-Rzepka    404-778-2386    ahutch7@emory.edu    Principal Investigator: Jonathon B. Cohen          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referrals Office    855-776-0015       Principal Investigator: Stephen M. Ansell          United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Peggy Heires    402-559-4596    peggy.heires@unmc.edu    Principal Investigator: Philip J. Bierman          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara Yannotti, BSN    551-996-5168    Kara.Yannotti@HackensackMeridian.org    Principal Investigator: Tatyana A. Feldman          United States, North Carolina Carolinas Medical Center/Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28203 Contact: Donna Acampora    980-442-2319    Donna.Acampora@carolinashealthcare.org    Principal Investigator: Steven I. Park          United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Terease Waite    267-324-8497    Terese.Waite@uphs.upenn.edu    Principal Investigator: Jakub Svoboda          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nafis Deen    832-750-1643    NMDeen@mdanderson.org    Principal Investigator: Hun Lee          United States, Utah Huntsman Cancer Institute/University of Utah Withdrawn Salt Lake City, Utah, United States, 84112 United States, Washington University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Heather Rasmussen    206-606-7140    hrasmuss@seattlecca.org    Principal Investigator: Stephen D. Smith Less <<
NCT00911443 - Completed - -
NCT01974752 - Completed - -
NCT00936221 - Completed - -
NCT02076646 Metastatic Melanoma Stage IV Phase 1 Phase 2 Unknown June 2017 Germany ... More >> University Hospital Tuebingen, Germany Italy Azienda Ospedaliera Universitaria Senese Siena, Italy Less <<
NCT01327885 Soft Tissue Sarcoma Phase 3 Completed - -
NCT00246012 Melanoma Phase 1 Phase 2 Completed - -
NCT00936221 Melanoma Phase 2 Completed - -
NCT01327885 - Completed - -
NCT01845675 Advanced Well-differentiated P... More >>ancreatic Neuroendocrine Tumor Less << Phase 2 Completed - China ... More >> Division of Medical Oncology, Peking Union Medical College Hospital Beijing, China, 100730 Less <<
NCT00257205 Melanoma Phase 3 Completed - -
NCT00246012 - Completed - -
NCT00794235 Melanoma Stage III or IV ... More >> No Prior Chemotherapy Less << Phase 2 Completed - Switzerland ... More >> Department of Dermatology, University Hospital Zurich Zurich, Switzerland, 8091 Less <<
NCT00412581 Melanoma Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01006980 Malignant Melanoma Phase 3 Completed - -
NCT02979522 Hodgkin Disease Phase 1 Phase 2 Recruiting October 29, 2021 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 United States, Ohio Cincinnati Childrens Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Brazil Hospital Sao Rafael S/A Recruiting Salvador, Bahia, Brazil, 41253-190 INCA - Instituto Nacional de Cancer Recruiting Rio de Janeiro, Rio Do Janeiro, Brazil, 20230-230 Hospital de Clinicas de Porto Alegre Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Hospital de Cancer de Barretos - Fundacao Pio XII Recruiting Barretos, Sao Paulo, Brazil, 14784-400 Jardim das Americas Recruiting Parana, Brazil, 81520-060 GRAACC - Grupo de Apoio ao Adolescente e a Crianca com Cancer Recruiting Sao Paulo, Brazil, 04023-062 ICr - Instituto da Crianca - HCFMUSP Recruiting Sao Paulo, Brazil, 05403-000 Hospital Santa Marcelina Recruiting Sao Paulo, Brazil, 08270-070 Hong Kong The Chinese University of Hong Kong Recruiting Shatin, Hong Kong, 00000 Italy Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi Recruiting Bologna, Italy, 40138 Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer Recruiting Firenze, Italy, 50139 Fondazione IRCCS Policlinico San Matteo Recruiting Pavia, Italy, 27100 Ospedale Pediatrico Bambino Gesu,UOC Onco-ematologia Recruiting Roma, Italy, 165 Azienda Ospedaliera Citta della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Japan NHO Nagoya Medical Center Recruiting Nagoya-shi, Aichi-Ken, Japan, 460-0001 Kyushu University Hospital Recruiting Fukuoka-shi, Fukuoka-Ken, Japan, 812-8582 Hokuyukai Sapporo Hokuyu Hospital Recruiting Sapporo-shi, Hokkaido, Japan, 003-0006 St. Marianna University School of Medicine Hospital Recruiting Kawasaki-shi, Kanagawa-Ken, Japan, 216-8511 Singapore National University Cancer Institute Singapore Recruiting Singapore, Singapore, 119228 Taiwan Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Less <<
NCT01006980 - Completed - -
NCT00324155 Melanoma Phase 3 Completed - -
NCT03331341 Classical Hodgkin Lymphoma Phase 2 Not yet recruiting June 15, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal          Principal Investigator: Ajay K. Gopal Less <<
NCT00324155 - Completed - -
NCT01721772 Melanoma Phase 3 Active, not recruiting February 23, 2019 -
NCT00516802 Melanoma Neoplasms Phase 1 Completed - United States, Pennsylvania ... More >> Research Site Pittsburgh, Pennsylvania, United States United Kingdom Research Site London, United Kingdom Research Site Manchester, United Kingdom Research Site Oxford, United Kingdom Less <<
NCT00533702 Metastatic Malignant Melanoma Phase 2 Completed - United States, Alabama ... More >> ImClone Investigational Site Decatur, Alabama, United States, 35601 United States, Arizona ImClone Investigational Site Scottsdale, Arizona, United States, 85258 ImClone Investigational Site Scottsdale, Arizona, United States, 85260 United States, California ImClone Investigational Site Fresno, California, United States, 93720 ImClone Investigational Site San Francisco, California, United States, 94109 United States, Colorado ImClone Investigational Site Aurora, Colorado, United States, 80045 United States, Florida ImClone Investigational Site Jacksonville, Florida, United States, 32256 ImClone Investigational Site Orlando, Florida, United States, 32806 United States, Mississippi ImClone Investigational Site Oxford, Mississippi, United States, 38655 United States, Montana ImClone Investigational Site Missoula, Montana, United States, 59806 United States, New York ImClone Investigational Site Buffalo, New York, United States, 14263 ImClone Investigational Site New York City, New York, United States, 10016 ImClone Investigational Site New York, New York, United States, 10021 United States, Pennsylvania ImClone Investigational Site Willow Grove, Pennsylvania, United States, 19090 United States, Texas ImClone Investigational Site Dallas, Texas, United States, 75230 ImClone Investigational Site Houston, Texas, United States, 77030 United States, Washington ImClone Investigational Site Seattle, Washington, United States, 98109 Less <<
NCT01721772 - Active, not recruiting - -
NCT00533702 - Completed - -
NCT00496223 Melanoma Phase 1 Phase 2 Terminated(toxicities required... More >> dose reduction compromising effectiveness and PI left Moffitt) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00091572 Melanoma Phase 3 Completed - -
NCT00091572 - Completed - -
NCT00130442 Melanoma Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Centre Tuscon, Arizona, United States, 85724 United States, Colorado University of Colorado Health Science Centre Denver, Colorado, United States, 80010-0510 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6307 Australia, New South Wales Sydney Cancer Centre, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Westmead Institute for Cancer Research Sydney, New South Wales, Australia, 2145 Australia, Queensland Wesley Research Institute Auchenflower, Queensland, Australia, 4066 Townsville Cancer Centre Townsville, Queensland, Australia, 4814 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia The Queen Elizabeth Hospital Woodville, South Australia, Australia, 5011 Australia, Victoria Border Medical Oncology Wodonga, Victoria, Australia, 3690 Australia, Western Australia Royal Perth Hospital Perth, Western Australia, Australia, 6001 Sir Charles Gairdner Hospital Perth, Western Australia, Australia, 6009 Less <<
NCT00553618 Metastatic Melanoma Phase 2 Active, not recruiting August 2022 United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 Less <<
NCT03095079 Melanoma Phase 2 Recruiting October 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Chuanliang Cui, MD    +86 13691489319 Less <<
NCT01227889 Cancer Phase 3 Completed - -
NCT01343277 Advanced Liposarcoma or Leiomy... More >>osarcoma Less << Phase 3 Completed - -
NCT01835145 Recurrent Uveal Melanoma ... More >> Stage III Uveal Melanoma AJCC v7 Stage IIIA Uveal Melanoma AJCC v7 Stage IIIB Uveal Melanoma AJCC v7 Stage IIIC Uveal Melanoma AJCC v7 Stage IV Uveal Melanoma AJCC v7 Less << Phase 2 Completed - -
NCT01551459 Metastatic Uveal Melanoma Phase 2 Unknown November 2016 United Kingdom ... More >> Clatterbridge Centre for Oncology NHS Foundation Trust Wirral, United Kingdom, CH63 4JY Less <<
NCT01227889 - Completed - -
NCT02545075 Melanoma Phase 3 Active, not recruiting November 5, 2019 China, Jiangsu ... More >> Local Institution Nanjing, Jiangsu, China, 210000 China, Jilin Local Institution Changchun, Jilin, China, 130021 China, Shanxi Local Institution Xi'an, Shanxi, China, 710038 China, Tianjin Local Institution Tianjing, Tianjin, China, 300060 China, Zhejiang Local Institution Hanghzou, Zhejiang, China China Local Institution Beijing, China, 100142 Local Institution Kunming, China Local Institution Shanghai, China, 200032 Less <<
NCT01152788 Melanoma Phase 2 Completed - United States, California ... More >> The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Northeast Cancer Center Health Sciences Sudbury, Ontario, Canada, P3E 5J1 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT01343277 - Completed - -
NCT01763164 Metastatic or Unresectable Cut... More >>aneous Melanoma Less << Phase 3 Active, not recruiting July 31, 2019 -
NCT01152788 - Completed - -
NCT02190838 Melanoma Phase 2 Unknown December 2017 Russian Federation ... More >> N.N. Petrov Research Institute of Oncology Ambulatory Chemotherapy Department Recruiting St. Petersburg, Russian Federation, 197758 Contact: Elena V. Tkachenko, MD    +78124399575    elenatkachen@yandex.ru    Principal Investigator: Elena V. Tkachenko, MD          N.N. Petrov Research Institute of Oncology Chemotherapy and Innovative Technologies Department Recruiting St. Petersburg, Russian Federation, 197758 Contact: Aleksei V. Novik, MD, PhD    +78124399505    anovik@list.ru    Principal Investigator: Svetlana A. Protsenko, MD, PhD, DSc          N.N. Petrov Research Institute of Oncology Clinical Diagnostic Department Recruiting St.Petersburg, Russian Federation, 191124 Contact: Tatiana Y. Semiglazova, MD, PhD, DSc       tsemiglazova@mail.ru    Principal Investigator: Tatiana V Semiglazova, MD, PhD, DSc Less <<
NCT00354523 Solid Tumor T... More >>hyroid Cancer Less << Phase 1 Phase 2 Terminated(Study closed follow... More >>ing Phase I portion, insufficient activity to continue to Phase II.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00580320 Melanoma Soft... More >> Tissue Sarcoma Parathyroid Carcinoma Small Cell Carcinoma of the Lung Carcinoid Tumors Less << Phase 1 Completed - United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Virginia Massey Cancer Center/Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT00492297 Melanoma Phase 2 Completed - France ... More >> Bordeaux, France, 33000 Lyon Cedex, France, 39373 Toulouse, France, 31052 Villejuif, France, 94805 United Kingdom Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Southampton, Hampshire, United Kingdom, SO16 6YD Northwood, Middlesex, United Kingdom, HA6 2RN Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, NW3 2QG London, United Kingdom, SE1 7EH London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX Less <<
NCT01681212 - Completed - -
NCT01055522 Metastatic Melanoma Phase 2 Terminated - Austria ... More >> Universitätsklinik Graz Graz, Austria Germany Charité- Universitätsmedizin Berlin Berlin, Germany Universitätsklinikum Schleswig-Holstein-Campus Kiel Kiel, Germany University Hospital Tuebingen, Germany, 72076 Italy University Hospital Pisa Pisa, Tuscany, Italy, 56126 A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy) Ancona, Italy European Institute of Oncology Milan, Italy, 20141 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Fondazione Giovanni Pascale Di Napoli Napoli, Italy Azienda Ospedaliera Universitaria Senese Siena, Italy Switzerland Universitäts Spital Zürich Zürich, Switzerland Less <<
NCT00492297 - Completed - -
NCT01164007 - Completed - -
NCT00864253 Malignant Melanoma Phase 3 Completed - -
NCT01681212 Melanoma Phase 2 Completed - Japan ... More >> Local Institution Fukuoka-shi, Fukuoka, Japan, 8128582 Local Institution Kumamoto-shi, Kumamoto, Japan, 8608556 Local Institution Matsumoto-shi, Nagano, Japan, 3908621 Local Institution Sunto-gun, Shizuoka, Japan, 4118777 Local Institution Chuo-ku, Tokyo, Japan, 1040045 Local Institution Chuo-shi, Yamanashi, Japan, 4093898 Less <<
NCT00802880 Sarcoma PHASE2 COMPLETED 2025-01-15 Washington University School o... More >>f Medicine, St. Louis, Missouri, 63110, United States Less <<
NCT01164007 Malignant Melanoma Phase 2 Completed - Italy ... More >> Istituto Europeo Di Oncologia Milano, Lombardia, Italy, 20141 Less <<
NCT00837148 Sarcoma Synov... More >>ial Sarcoma Leiomyosarcoma Malignant Peripheral Nerve Sheath Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03279601 Neuroendocrine Tumors Phase 2 Recruiting September 1, 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Shen Lin, Professor    010-88196561    Linshenpku@163.com    Principal Investigator: Shen Lin, professor Less <<
NCT01693068 - Completed - -
NCT00802880 Sarcoma PHASE2 COMPLETED 2025-01-15 Washington University School o... More >>f Medicine, St. Louis, Missouri, 63110, United States Less <<
NCT01693068 N-Ras Mutated Locally Advanced... More >> or Metastasis Malignant Cutaneous Melanoma Less << Phase 2 Completed - -
NCT00864253 - Completed - -
NCT00518895 Melanoma Phase 3 Completed - -
NCT03023124 Solitary Fibrous Tumors Phase 2 Recruiting March 2024 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milano, MI, Italy, 20133 Contact: Silvia Stacchiotti, MD       silvia.stacchiotti@istitutotumori.mi.it    Principal Investigator: Silvia Stacchiotti, MD          Policlinico Universitario Campus Biomedico Not yet recruiting Roma, RM, Italy, 00128 Contact: Bruno Vincenzi, MD    +3902225411123    b.vincenzi@unicampus.it    Principal Investigator: Bruno Vincenzi, MD          Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo - Recruiting Candiolo, Italy, 10060 Ospedale Giaccone Not yet recruiting Palermo, Italy Contact: Giuseppe Badalamenti, MD Less <<
NCT01692691 Melanoma Metastatic Phase 2 Terminated(PI decision) - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT01692691 - Terminated(PI decision) - -
NCT00837148 - Completed - -
NCT01133977 Stage IV Melanoma Phase 1 Phase 2 Completed - United States, Maryland ... More >> Hagerstown, Maryland, United States United States, New York Albany, New York, United States United States, South Carolina Greenville, South Carolina, United States United States, Texas Dallas, Texas, United States United States, Virginia Norfolk, Virginia, United States Germany Berlin, Germany, 10249 Berlin, Germany, 12351 Berlin, Germany, 13585 Heidelberg, Germany, 69120 Muenchen, Germany, 81675 Italy Bari, Italy, 70126 Milan, Italy, 20133 Milian, Italy, 20141 Napoli, Italy, 80131 Siena, Italy, 53100 Spain Barcelona, Spain Madrid, Spain, 28033 Madrid, Spain, 28034 Madrid, Spain, 28050 Valenica, Spain, 46014 United Kingdom Dorset, United Kingdom Glasgow, United Kingdom Manchester, United Kingdom Middlesex, United Kingdom Oxford, United Kingdom Southampton, United Kingdom Wirral, United Kingdom Less <<
NCT00597038 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03430297 Metastatic Melanoma ... More >> Unresectable Melanoma Less << Phase 3 Recruiting December 2019 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Guo, Phd; Md       guoj307@126.com    Principal Investigator: Jun Guo, PhD; MD          China, Hubei Wuhan Union Hospital Not yet recruiting Wuhan, Hubei, China Contact: Li Fan    027-85873501    medbifish@126.com    Sub-Investigator: Li Fan, Phd,MD          Principal Investigator: Jing Chen, Phd,MD          China, Yunnan Yunnan Cancer Hospital Not yet recruiting Kunming, Yunnan, China Contact: Ying Wang, Phd,MD    0871-68179173    snwy1026@163.com    Principal Investigator: Xin Song, Phd,MD          Sub-Investigator: Ying Wang, Phd,MD Less <<
NCT03761095 Leiomyosarcoma Phase 1 Not yet recruiting July 23, 2020 United States, New York ... More >> Columbia University Medical Center Not yet recruiting New York, New York, United States, 10032 Less <<
NCT00597038 - Completed - -
NCT01133977 - Completed - -
NCT01480479 Glioblastoma ... More >>Small Cell Glioblastoma Giant Cell Glioblastoma Gliosarcoma Glioblastoma With Oligodendroglial Component Less << Phase 3 Completed - -
NCT00977431 Glioblastoma Phase 1 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN The Christie Hospital Manchester, United Kingdom, M20 4BX The Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Less <<
NCT01015534 Brain Neoplasms Phase 2 Completed - Mexico ... More >> Instituto Nacional de Cancerología de México México, D.F, Mexico, 14080 Less <<
NCT00978458 Brain and Central Nervous Syst... More >>em Tumors Neurotoxicity Less << Phase 3 Active, not recruiting December 31, 2026 -
NCT01043536 Glioblastoma Phase 1 Completed - France ... More >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Less <<
NCT01067066 Melanoma Phase 1 Terminated(Phase I/II study ha... More >>lted as Phase I, Low Response Rate) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01120639 Glioblastoma ... More >>Cancer of Brain and Nervous System Glioblastoma Multiforme Less << Phase 1 Phase 2 Active, not recruiting November 2020 United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01119599 Acoustic Schwannoma ... More >> Adult Anaplastic (Malignant) Meningioma Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma Adult Brain Stem Glioma Adult Choroid Plexus Neoplasm Adult Craniopharyngioma Adult Diffuse Astrocytoma Adult Ependymoblastoma Adult Ependymoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Grade I Meningioma Adult Grade II Meningioma Adult Medulloblastoma Adult Mixed Glioma Adult Myxopapillary Ependymoma Adult Oligodendroglioma Adult Papillary Meningioma Adult Pilocytic Astrocytoma Adult Pineal Gland Astrocytoma Adult Pineoblastoma Adult Pineocytoma Adult Primary Melanocytic Lesion of Meninges Adult Subependymal Giant Cell Astrocytoma Adult Subependymoma Adult Supratentorial Primitive Neuroectodermal Tumor Malignant Adult Intracranial Hemangiopericytoma Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT01220271 Glioma Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Jolla, California, United States, 92093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States, 94143 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durham, North Carolina, United States, 27710 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69120 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Less <<
NCT01015534 - Completed - -
NCT01180816 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 1 Active, not recruiting December 2018 United States, New York ... More >> Lenox Hill Brain Tumor Center New York, New York, United States, 10065 Less <<
NCT01127594 Melanoma Phase 1 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01242566 Primary Brain Tumor ... More >> Glioblastoma Less << Phase 2 Completed - France ... More >> Pitie salpetriere hospital Paris, France, 75013 Less <<
NCT01235793 B-Cell Lymphoma Originating in... More >> the CNS Less << Phase 2 Terminated(The clinical trial ... More >>was terminated due to poor enrollment) Less << - United States, California ... More >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 Less <<
NCT01260103 Optic Nerve Glioma Phase 3 Withdrawn(Withdrawn study halt... More >>ed prematurely, prior to enrollment of first participant) Less << December 2018 -
NCT01328535 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Active, not recruiting December 15, 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01235793 - Terminated(The clinical trial ... More >>was terminated due to poor enrollment) Less << - -
NCT01285414 Glioblastoma Multiforme Phase 2 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Texas University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01345370 - Completed - France ... More >> CHRU Hautepierre Strasbourg, Alsace, France, 67 CHU de Bordeaux Bordeaux, Aquitaine, France, 33000 CHU Cote de Nacre Caen, Basse Normandie, France, 14000 Center Eugene Marquis Rennes, Brittany, France, 35000 CHU La Salpetriere Paris, Ile de France, France, 75000 CHRU de Lille Lille, Nord Pas-de-Calais, France, 59000 CHU La Timone Marseille, Paca, France, 13000 CHU de Poitiers Poitiers, Poitou-Charentes, France, 86000 CHU de Grenoble Grenoble, Rhone-Alpes, France, 38000 CHU de Lyon Lyon, Rhone-Alpes, France, 69000 Less <<
NCT01402063 Glioblastoma Multiforme Phase 2 Completed - United States, California ... More >> UCSD Cancer Center La Jolla, California, United States, 92093 United States, Maine Maine Medical Center Scarborough, Maine, United States, 04074 United States, Massachusetts UMASS Medical Center Cancer Center Worcester, Massachusetts, United States, 01605 United States, New York SUNY Medical Center Syracuse, New York, United States, 13210 United States, Pennsylvania PSU Hershey, Pennsylvania, United States, 17033 Thomas Jefferson University Cancer Center Philadelphia, Pennsylvania, United States, 19107 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02906 United States, Texas UT Southwestern Cancer Center Dallas, Texas, United States, 75235 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT01328535 - Active, not recruiting - -
NCT01402063 - Completed - -
NCT03746080 Glioblastoma ... More >>Glioblastoma With Primitive Neuronal Component Gliosarcoma Malignant Glioma Oligodendroglial Component Present Less << Phase 2 Recruiting January 11, 2027 United States, California ... More >> Stanford Cancer Institute Palo Alto Recruiting Palo Alto, California, United States, 94304 Contact: Lawrence Recht    650-725-8630    lrecht@stanford.edu    Principal Investigator: Lawrence Recht Less <<
NCT03749187 Glioblastoma ... More >>IDH1 Gene Mutation IDH2 Gene Mutation Low Grade Glioma Malignant Glioma Recurrent Glioblastoma Recurrent WHO Grade II Glioma Recurrent WHO Grade III Glioma WHO Grade II Glioma WHO Grade III Glioma Less << Phase 1 Not yet recruiting July 2027 -
NCT00004106 Lymphoma Phase 2 Terminated(Per Data Monitoring... More >> Committee given the poor/inadequate accrual.) Less << - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00005597 Gastrointestinal Stromal Tumor Phase 2 Completed - -
NCT01364064 Glioblastoma Phase 3 Completed - -
NCT00005812 Brain Tumors ... More >>Central Nervous System Tumors Leptomeningeal Metastases Less << Phase 2 Terminated(No objective respon... More >>se documented, protocol terminated after 12 patients.) Less << - United States, New Hampshire ... More >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756-0002 Less <<
NCT00005955 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Less <<
NCT00022711 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Kimball Medical Center Lakewood, New Jersey, United States, 08701 South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 Community Medical Center Toms River, New Jersey, United States, 08755 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania Bon Secours-Holy Family Health System Altoona, Pennsylvania, United States, 16602 Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026-1186 Pinnacle Health Hospitals Harrisburg, Pennsylvania, United States, 17105-8700 Conemaugh Memorial Hospital Johnstown, Pennsylvania, United States, 15905 Saint Mary Regional Center Langhorne, Pennsylvania, United States, 19047 Central Montgomery Medical Center Lansdale, Pennsylvania, United States, 19446-1200 Paoli Memorial Hospital Paoli, Pennsylvania, United States, 19301-1792 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Pottstown Memorial Regional Cancer Center Pottstown, Pennsylvania, United States, 19464 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT00033280 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00034697 Metastases, Neoplasm ... More >> Carcinoma, Non-Small-Cell Lung Brain Neoplasms Less << Phase 2 Terminated(Slow Enrollment) - -
NCT00068666 Melanoma (Skin) ... More >> Metastatic Cancer Less << Phase 2 Terminated - -
NCT00006353 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 British Columbia Cancer Agency - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Doctor Leon Richard Oncology Centre Moncton, New Brunswick, Canada, E1C 8X3 Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Quebec Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 Less <<
NCT00076856 Carcinoma, Non-Small-Cell Lung... More >> Neoplasm Metastasis Brain Neoplasms Less << Phase 2 Completed - -
NCT00004204 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Florida Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Cancer Center of Albany Medical Center Albany, New York, United States, 12208 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Nalitt Institute for Cancer And Blood Related Diseases Staten Island, New York, United States, 10305 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Neurological Clinic Portland, Oregon, United States, 97210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Wisconsin Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00012116 Metastatic Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT03741244 Glioma Phase 1 Phase 2 Not yet recruiting November 2020 -
NCT00003062 Lung Cancer Phase 2 Completed - Italy ... More >> Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Poland Medical University of Gdansk Gdansk, Poland, 80-211 South Africa Medical Oncology Centre of Rosebank Johannesburg, South Africa, 2193 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00005037 Lung Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Waukesha Memorial Hospital Waukesha, Wisconsin, United States, 53188 Less <<
NCT00080938 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Completed - -
NCT00083070 Leukemia Phase 1 Completed - United States, California ... More >> Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Minnesota Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-9786 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Baylor University Medical Center - Houston Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT00020839 Melanoma (Skin) ... More >> Metastatic Cancer Less << Phase 3 Terminated(low accrual) - -
NCT00003718 Endometrial Cancer ... More >> Ovarian Cancer Sarcoma Less << Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00003731 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre Hospitalier Regional de Lille Lille, France, 59037 CHU de la Timone Marseille, France, 13385 CHU de Nancy - Hopital Neurologique Nancy, France, 54035 Hopital Pasteur Nice, France, 06002 Centre Antoine Lacassagne Nice, France, 06189 Institut Gustave Roussy Villejuif, France, F-94805 Germany Nervenklinik Bamberg Bamberg, Germany, D-96049 Universitaetsklinikum Benjamin Franklin Berlin, Germany, D-12200 Klinikum der Universitat Regensburg Regensburg, Germany, DOH-9-3053 Italy Azienda Ospedaliera di Padova Padova (Padua), Italy, 35128 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Netherlands University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA Portugal Instituto Portugues de Oncologia de Francisco Gentil Lisbon, Portugal, 1093 Slovakia Postgraduate Medical Institute Bratislava, Slovakia, 833 03 Switzerland Kantonspital Aarau Aarau, Switzerland, 5001 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Less <<
NCT00006877 Lung Cancer Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00085254 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00004113 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00089427 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Oligoastrocytoma Less << Phase 1 Completed - United States, California ... More >> University of California San Francisco - Dept. of Neurological Surgery San Francisco, California, United States, 94143 United States, North Carolina Carolina Neurosurgery & Spine Assoc. Charlotte, North Carolina, United States, 28204 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Department of Neurological Surgery Cleveland, Ohio, United States, 44195 United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health Systems - Department of Neurological Surgery Charlottesville, Virginia, United States, 22908 Less <<
NCT00003304 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00114140 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting - -
NCT00080938 - Completed - -
NCT00114140 - Active, not recruiting - -
NCT00098436 Leukemia Phase 1 Completed - United States, Indiana ... More >> American Health Network - North Illinois Street Indianapolis, Indiana, United States, 46202 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00182819 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00194766 Breast Cancer ... More >> Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Washington ... More >> University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00085254 - Completed - -
NCT00267592 Glioblastoma Multiforme Phase 2 Completed - -
NCT00266812 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(Patient target coul... More >>d not be reached within the planned timeframe.) Less << - -
NCT00266812 - Terminated(Patient target coul... More >>d not be reached within the planned timeframe.) Less << - -
NCT00276679 Neuroblastoma Phase 2 Completed - France ... More >> Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Ireland Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00304031 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - -
NCT00313729 CNS Tumor, Adult Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00338130 Melanoma Phase 2 Completed - -
NCT00165360 Glioma Astroc... More >>ytoma Oligodendroglioma Less << Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00362570 Oligoastrocytoma, Mixed ... More >> Anaplastic Oligodendroglioma Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00376103 Glioblastoma Multiforme Phase 1 Phase 2 Terminated(Loss of funding fro... More >>m sponsor) Less << - United States, Tennessee ... More >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Less <<
NCT00365222 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Terminated(IRB Study Closure) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00392171 Glioma Astroc... More >>ytoma Oligodendroglioma Glioblastoma Less << Phase 2 Completed - -
NCT00272415 Melanoma Phase 1 Terminated - -
NCT00392171 - Completed - -
NCT00400816 Central Nervous System Tumors ... More >> Brain Tumor Less << Phase 2 Completed - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00394628 Glioblastoma Multiforme Phase 1 Phase 2 Unknown - United States, California ... More >> University of California, Los Angeles Recruiting Los Angeles, California, United States Contact: Emese Filka    310-794-3521       Principal Investigator: Tim Clughsey, MD          United States, Illinois Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Lilia Gallot    312-695-1363       Principal Investigator: Jeffrey Raizer, MD          United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Ruth Ann Beasse    313-916-3731    rbeasse1@hfhs.org    Principal Investigator: Tom Mikkelsen, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Velmeca McCrea    919-684-5632    velmeca.mccrea@duke.edu    Principal Investigator: David Reardon, MD          United States, Texas Baylor Research Institute Recruiting Dallas, Texas, United States Contact: Stephanie Peschka, RN    214-820-8685       Principal Investigator: Karen Fink, MD Less <<
NCT00423150 Colorectal Neoplasm ... More >> Head and Neck Neoplasm Carcinoma, Non-Small-Cell Lung Esophageal Neoplasm Less << Phase 2 Terminated - -
NCT00441142 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 1 Phase 2 Active, not recruiting January 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber / Brigham and Women's Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232-1305 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908-4324 Less <<
NCT00423150 - Terminated - -
NCT00471653 - Terminated(low accrual) - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00424554 - Completed - -
NCT00482677 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Centre hospitalier regional de Trois-Rivieres Trois-Rivieres, Quebec, Canada, G8Z 3R9 Germany Klinikum Der J.W. Goethe Universitaet Frankfurt, Germany, 60590 Universitaetsklinikum Freiburg Freiburg, Germany, 79106 Universitaetsklinikum Leipzig Leipzig, Germany, 04103 Universitaetsklinikum Tuebingen Tuebingen, Germany, 72076 Japan Hiroshima University Hospital Hiroshima, Japan, 734-8551 Netherlands Maastro - Maastricht Radiation Oncology Maastricht, Netherlands, 6201 Less <<
NCT00304031 - Completed - -
NCT00498927 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00482677 - Completed - -
NCT00458601 Malignant Glioma Phase 2 Completed - -
NCT00508456 Glioblastoma Multiforme Phase 1 Terminated(Low Accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00498927 - Completed - -
NCT00516282 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Terminated(The pharmaceutical ... More >>collaborator filed for bankruptcy and as a result, the study was unable to move into the phase II portion.) Less << - United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00424554 Glioma Phase 2 Completed - -
NCT00516607 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - United Kingdom ... More >> Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Less <<
NCT00547131 Brain and Central Nervous Syst... More >>em Tumors Metastatic Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00575887 - Completed - -
NCT00582075 - Completed - -
NCT00582075 Cancer Brain ... More >>Metastases Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT00441142 - Active, not recruiting - -
NCT00591370 Melanoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00575887 Glioblastoma ... More >>Astrocytoma Oligodendroglioma Brain Tumor, Recurrent Less << Phase 2 Completed - Turkey ... More >> Marmara University Hospital Istanbul, Turkey, 34660 Less <<
NCT00601289 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Withdrawn(funding term ended) - -
NCT00601614 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Withdrawn(no enrollment) - -
NCT00611247 Leukemia, Myeloid Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00609011 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> The Angeles Clinic Los Angeles, California, United States, 90025 United States, Florida Cancer Centers of Florida Ocoee, Florida, United States, 34761 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00591370 - Completed - -
NCT00588341 - Completed - -
NCT00588341 Melanoma Skin... More >> Cancer Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00611247 - Completed - -
NCT00619112 Recurrent Central Nervous Syst... More >>em Neoplasm Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00632203 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma Carcinoma, Large Cell Carcinoma, Squamous Cell Less << Phase 2 Terminated - -
NCT00626990 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Active, not recruiting January 2024 -
NCT00619112 - Completed - -
NCT00638963 - Terminated(Terminated due to p... More >>oor accrual) Less << - -
NCT00632203 - Terminated - -
NCT00643825 Glioblastoma Phase 2 Unknown January 2012 Belgium ... More >> Cliniques Universitaires Saint-Luc Recruiting Brussels, Europe, Belgium, 1200 Contact: Jean-Francois BAURAIN, MD, PhD    +32 2 764 54 71    jean-francois.baurain@@uclouvain.be Less <<
NCT00657267 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, North Carolina Wake Forest Univsersity Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania University Of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00629187 Central Nervous System Neoplas... More >>ms Neoplasm Metastasis Less << Phase 1 Terminated(The study was stopp... More >>ed due to lack of adequate enrollment.) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT00638963 Breast Neoplasm ... More >> Brain Neoplasm Second Neoplasm Less << Phase 2 Terminated(Terminated due to p... More >>oor accrual) Less << - -
NCT00684567 Glioblastoma Phase 2 Completed - -
NCT00657267 - Completed - -
NCT00660283 Glioma Phase 2 Unknown December 2010 United States, Kentucky ... More >> Kentuckiana Cancer Institute Louisville, Kentucky, United States, 40202 Less <<
NCT00686725 Glioblastoma Phase 4 Completed - -
NCT00684567 - Completed - -
NCT00686725 - Completed - -
NCT00689221 Glioblastoma Phase 3 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Less <<
NCT00687323 Leukemia, Acute Myeloid ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - -
NCT00687323 - Completed - -
NCT00704808 - Completed - -
NCT00705198 - Completed - -
NCT00717210 Anaplastic Astrocytoma ... More >> Oligodendroglioma Oligoastrocytoma Less << Phase 3 Completed - Germany ... More >> University of Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurology and Radiotherapy Tübingen, Baden-Württemberg, Germany, 72076 Klinikum Aschaffenburg Aschaffenburg, Germany Nervenklinik Bamberg, Germany Charite Berlin, Germany Neurosurgery Düsseldorf, Germany Radiotherapy Erlangen, Germany Neurology Essen, Germany Neurosurgery Frankfurt, Germany Neurosurgery Kiel, Germany Neurosurgery Mainz, Germany County District Hospital Regensburg, Germany Less <<
NCT00704080 Mixed Gliomas ... More >> Malignant Gliomas Glioblastoma Multiforme Less << Phase 1 Completed - United States, Alabama ... More >> Investigational Site Number Birmingham, Alabama, United States, 35205 United States, California Investigational Site Number Los Angeles, California, United States, 90024 United States, Massachusetts Investigational Site Number Boston, Massachusetts, United States, 02115 United States, New York Investigational Site Number New York, New York, United States, 10021 Investigational Site Number Rochester, New York, United States, 14642 United States, Ohio Investigational Site Number Cleveland, Ohio, United States, 44195 Less <<
NCT00704808 - Completed - -
NCT00723827 - Completed - -
NCT00717275 Brain Metastases Phase 2 Terminated(Slow accrual.) - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 Less <<
NCT00723827 - Completed - -
NCT00689221 - Completed - -
NCT00724841 Metastatic Melanoma Phase 1 Phase 2 Terminated(Study terminated pr... More >>ematurely due to financial contraints.) Less << - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00740636 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT00725010 - Completed - -
NCT00725010 - Completed - -
NCT00768911 Glioblastoma Multiforme Phase 1 Unknown June 2011 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Kentucky University of Kentucky Hospital Lexington, Kentucky, United States, 40536 United States, Missouri Washington University Cancer Center St. Louis, Missouri, United States, 63110 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00792012 Glioblastoma Multiforme Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT00807027 Glioblastoma Phase 3 Completed - Korea, Republic of ... More >> Hanyang University Guri Hospital Guri, Gyeonggi-Do, Korea, Republic of Gyunghee University Medical Center Seoul, Korea, Republic of Konkuk University Seoul, Korea, Republic of Korea University Anam Hospital Seoul, Korea, Republic of Samsung Seoul Medical Center Seoul, Korea, Republic of Seoul Asan Medical Center Seoul, Korea, Republic of Yeonsei University Medical Center Seoul, Korea, Republic of Less <<
NCT00783393 Astrocytoma Phase 2 Completed - -
NCT00831545 Metastases of Central Nervous ... More >>System Melanoma Breast Neoplasm Carcinoma, Non-Small-Cell Lung Less << Phase 2 Completed - -
NCT00813943 Glioblastoma Phase 2 Completed - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please Contact the Merck KGaA Communication Center Located in Darmstadt, Germany Less <<
NCT00841555 - Completed - -
NCT00717275 - Terminated(Slow accrual.) - -
NCT00875355 Breast Cancer ... More >> Metastatic Cancer Less << Phase 2 Unknown - France ... More >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Youlia Kirova    33-44-32-4000 Less <<
NCT00740636 - Completed - -
NCT00813943 - Completed - -
NCT00892385 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00881595 Soft Tissue Sarcomas Phase 2 Withdrawn(No patients accrued ... More >>since study opened) Less << - -
NCT00916409 Glioblastoma Multiforme Phase 3 Completed - -
NCT00841555 Glioblastoma Multiforme/Anapla... More >>stic Astrocytoma Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00941460 Glioblastoma Phase 2 Completed - Austria ... More >> Landesnervenklinik Wagner-Jauregg Linz, Austria, 4020 Medical University Vienna, Department of Internal Medicine I Wien, Austria, 1090 Germany Charite, Department of Neurosurgery Berlin, Germany, 13353 Knappschaftskrankenhaus, Department of Neurology Bochum, Germany, 44892 University Hospital Bonn, Department of Neurology Bonn, Germany, 53105 University Hospital Düsseldorf Düsseldorf, Germany, 40001 Klinikum der Johann-Wolfgang von Goethe-Universität, Dr. Senckenbergisches Institut für Neuroonkologie, Zentrum für Neurologie und Neurochirurgie Frankfurt, Germany, 60528 University Hospital Freiburg Freiburg, Germany, 79106 University Hospital Heidelberg, Department of Neurooncology Heidelberg, Germany, 69120 Saarland University, Department of Neurosurgery Homburg/ Saar, Germany, 66421 Klinik für Allgemeine Neurochirurgie Köln, Germany, 50937 Klinik und Poliklinik für Neurochirurgie Leipzig, Germany, 04103 Ludwig Maximilians University of Munich , Grosshadern Hospital, Department of Neurosurgery Munich, Germany, 81377 University of Regensburg, Department of Neurology Regensburg, Germany, 93053 Switzerland University Hospital Zurich, Department of Neurology Zurich, CH, Switzerland, 8091 Centre Hospitalier Universitaire Vaudois and University of Lausanne Lausanne, Switzerland Less <<
NCT00920595 Solid Tumor Phase 1 Completed - France ... More >> Cephalon Investigational Site Nantes, France, 44805 United Kingdom Cephalon Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT00960492 Glioblastoma ... More >>Giant Cell Glioblastoma Gliosarcoma Less << Phase 1 Completed - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Beth Israel Medical Center New York, New York, United States, 10003 United States, North Carolina Duke University Medical Center; The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health System/Division of Neuro-Oncology Charlottesville, Virginia, United States, 22908 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00943462 - Withdrawn(No eligible patients... More >> could be recruited.) Less << June 2011 -
NCT01466686 High Grade Glioma Phase 2 Recruiting September 2022 United States, District of Col... More >>umbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016 Contact: Curtiland Deville, MD    202-537-4788    cdeville@jhmi.edu    United States, Maryland The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Principal Investigator: Kristin Redmond, M.D.          Sub-Investigator: Stuart Grossman, M.D.          Sub-Investigator: Matthias Holdhoff, M.D.          Sub-Investigator: John Lattera, M.D.          Sub-Investigator: Jaishri Blakeley, M.D.          Sub-Investigator: Lawrence Kleinberg, MD          Suburban Hospital Recruiting Bethesda, Maryland, United States, 20814 Contact: John Wallmark, MD    301-424-6231    jwallma1@jhmi.edu Less <<
NCT01452854 - Terminated(Low recruitment, sp... More >>onsor withdrew funding.) Less << - -
NCT01452854 - Terminated(Low recruitment, sp... More >>onsor withdrew funding.) Less << - United States, California ... More >> UCSF Center for Reproductive Health San Francisco, California, United States, 94115 Less <<
NCT01478854 Glioblastoma Multiforme Not Applicable Active, not recruiting July 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT01534845 Anaplastic Glioma of Brain ... More >> Loss of Chromosomes 1p/19q Less << Phase 2 Unknown February 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01473901 Glioblastoma Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Highlands Oncology Fayetteville, Arkansas, United States, 72703 United States, Massachusetts Dana Farber Cancer Institute SC (1) Boston, Massachusetts, United States, 02215 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson DeGrout Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3000 Canada, Ontario Novartis Investigative Site Hamilton, Ontario, Canada, L8V 5C2 Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28040 Less <<
NCT01649830 Astrocytoma O... More >>ligodendroglioma Oligodendroastrocytoma Less << Phase 3 Recruiting August 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Principal Investigator: Zhong-ping CHEN, MD, PhD Less <<
NCT01465659 Pancreatic Alpha Cell Carcinom... More >>a Pancreatic Beta Islet Cell Carcinoma Pancreatic Delta Cell Carcinoma Pancreatic G-cell Carcinoma Recurrent Islet Cell Carcinoma Less << Phase 1 Phase 2 Recruiting August 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Halla null. Nimeiri    312-695-4381    h-nimeiri@northwestern.edu    Principal Investigator: Halla null. Nimeiri          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Mark M. Zalupski    734-615-3969    zalupski@med.umich.edu    Principal Investigator: Mark M. Zalupski          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Steven J. Cohen    215-728-2570    Steven.Cohen@fccc.edu    Principal Investigator: Steven J. Cohen          United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jordan D. Berlin    615-936-8422    jordan.berlin@Vanderbilt.edu    Principal Investigator: Jordan D. Berlin          United States, Washington University of Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Gabriela Chiorean, MD    855-557-0555 Less <<
NCT01517776 Gliomas Phase 2 Terminated(due to an altered b... More >>enefit/risk assessment.) Less << - Germany ... More >> University Children´s Hospital Halle, Saxonia-Anhalt, Germany, 06120 Less <<
NCT01790503 Patients With Newly Diagnosed ... More >>Glioblastoma Less << Phase 1 Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio James Cancer Hospital/Ohio State University Columbia, Ohio, United States, 43210 United States, Utah Huntsman Cancer Institute University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01812603 Cancer Phase 1 Phase 2 Completed - United Kingdom ... More >> The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Guy's and St Thomas NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT01800695 Glioblastoma Multiforme Phase 1 Completed - -
NCT01702610 Glioblastoma Mutliforme Not Applicable Completed - Canada, Quebec ... More >> McGill University Health Center Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT01601184 Histologically Confirmed Medul... More >>loblastoma Activation of the Sonic Hedgehog (SHH) Pathway Less << Phase 1 Phase 2 Terminated(The number of succe... More >>sses is not reached at the end of first stage of the phase II. The study is stopped.) Less << - France ... More >> CHU La Timone Marseille, Bouches Du Rhône, France, 13385 Institut Claudius Régaud (iuct-oncopole) Toulouse, Haute-Garonne, France, 31059 Hopital de La Pitié Salpétrière Paris, Ile De France, France, 75013 Institut de Cancérologie de l'Ouest - René Gauducheau St Herblain, Loire Atlantique, France, 44805 Hopital Central de Nancy Nancy, Meurthe Et Moselle, France, 54035 CHBS Hôpital du Scorff Lorient, Morbihan, France, 56322 CHRU de Lille Lille, Nord, France, 59037 Centre Léon Bérard Lyon, Rhone, France, 69373 Institut de Cancérologie de l'Ouest - Paul Papin Angers, France, 49933 Institut Bergonié Bordeaux, France, 33076 Italy BELLARIA Ospedale Bologna, Italy, 40139 University of Turin Torino, Italy, 10126 Switzerland Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, CH-8091 University Hospital Zurich Zurich, Switzerland, CH-8091 United Kingdom University College London Hospital - Mount Vernon Cancer Centre - Mount Vernon hospital London, United Kingdom, London-NW1-2PG Less <<
NCT01857752 Retinoblastoma Phase 2 Terminated(accrual) - Guatemala ... More >> Unidad Nacional de Oncologia Pediatrica Guatemala, Guatemala Less <<
NCT01847235 Anaplastic Oligodendroglioma ... More >> Anaplastic Oligoastrocytoma Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01812616 Cancer Phase 1 Phase 2 Completed - Germany ... More >> Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Universitätsklinikum Aachen RWTH Aachen, Germany, 52074 Neurologie des Klinikums Altenburger Land Altenburg, Germany, 04600 Zentrum für Neuroonkologie der Universität Duesseldorf Duesseldorf, Germany, 40225 Strahlenklinik der Universität Erlangen Erlangen, Germany, 91054 United Kingdom The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom, CH63 4JY St James's Institute of Oncology, St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Queen's Centre for Haematology & Oncology, Castle Hill Hospital Cottingham, United Kingdom, HU16 5JQ West of Scotland Beatson Cancer Centre Glasgow, United Kingdom, G12 0YN Guy's & St Thomas' NHS Foundation Trust, of St Thomas' Hospital London, United Kingdom, SE1 7EH The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00613093 Glioblastoma Multiforme ... More >> Anaplastic Glioma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00614978 Metastatic Breast Cancer ... More >> Brain Metastases HER2 Positive Less << Phase 1 Completed - Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 Less <<
NCT01830101 Recurrent Glioblastoma Phase 3 Withdrawn(This study will not ... More >>be proceeding due to lack of funding from anticipated sources) Less << November 2017 Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00629343 Soft Tissue Sarcoma ... More >> Mesothelioma Less << Phase 1 Unknown August 2014 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01670890 Malignant Gliomas Phase 2 Unknown - China, Beijing ... More >> Beijing Tiantan Hospital Affiliated to Capital Medial University Recruiting Beijing, Beijing, China, 100050 Contact: Jiang tao, MD    86-010-67021832    jiangtao369@sohu.com    Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: wang ren zhi, MD    86-010-69156071    wangrz@126.com    Principal Investigator: Ma wen bin, MD          Sub-Investigator: wang yu, MD          China, Tianjin Tianjin medical university general university Recruiting Tianjin, Tianjin, China, 300052 Contact: Yang xue jun, MD       ydenny@yahoo.com Less <<
NCT01849146 Adult Glioblastoma ... More >> Recurrent Glioblastoma Less << Phase 1 Recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Suspended Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Suspended Los Angeles, California, United States, 90095 UCSF Medical Center-Parnassus Suspended San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Suspended Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact    877-726-5130       Principal Investigator: Eudocia Q. Lee          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact    877-442-3324       Principal Investigator: Eudocia Q. Lee          United States, Michigan Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202 Contact: Site Public Contact    313-916-1784       Principal Investigator: Tobias Walbert          United States, New York Memorial Sloan Kettering Cancer Center Suspended New York, New York, United States, 10065 United States, North Carolina Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Site Public Contact    336-713-6771       Principal Investigator: Glenn J. Lesser          United States, Ohio Cleveland Clinic Foundation Suspended Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Suspended Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute (UPCI) Suspended Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00650923 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Recurrent Adult Brain Tumor Less << Phase 1 Completed - United States, California ... More >> University of California at Los Angeles (UCLA ) Los Angeles, California, United States, 90095 UCSF-Mount Zion San Francisco, California, United States, 94115 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Charlestown, Massachusetts, United States, 02129 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00714181 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01781403 Rectal Cancer Phase 1 Active, not recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Less <<
NCT00720564 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00731731 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Cognitive Side Effects of Cancer Therapy Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00770471 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, California UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00731731 - Active, not recruiting - -
NCT01824875 Gastrinoma Gl... More >>ucagonoma Insulinoma Islet Cell Carcinoma Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Somatostatinoma Less << Phase 2 Active, not recruiting July 2023 -
NCT00804908 Melanoma Meta... More >>static Melanoma Skin Cancer Less << Phase 2 Completed - -
NCT01781403 - Active, not recruiting - -
NCT00826241 Brain Tumors ... More >>Spinal Cord Tumors Less << Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Medical Center - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States, 53792 Less <<
NCT00869401 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01939574 Glioblastoma Not Applicable Unknown September 2016 China, Shandong ... More >> Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT00804908 - Completed - -
NCT00895960 Glioblastoma ... More >>CNS Disease Brain Diseases Less << Phase 1 Terminated(Sponsor withdrew su... More >>pport; Study did not progress to Phase II.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00900757 Malignant Glioma Phase 2 Completed - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT00915694 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00900757 - Completed - -
NCT01987830 Recurrent Glioblastoma Not Applicable Recruiting September 2020 United States, Massachusetts ... More >> Massachuesett General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Tracy Batchelor, MD    617-724-8770    tbatchelor@partners.org    Principal Investigator: Tracy Batchelor, MD Less <<
NCT00869401 - Active, not recruiting - -
NCT00918320 Neuroblastoma ... More >> Brain Tumors Solid Tumors Less << Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02029573 Glioblastoma Multiforme Phase 2 Completed - Saudi Arabia ... More >> King Fahad Medical City Riyadh, Saudi Arabia, 11525 Less <<
NCT00974987 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Japan ... More >> Osaka Medical College Takatsuki, Osaka, Japan, 569-8686 Less <<
NCT02113007 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Terminated(Closed early due to... More >> slow accrual.) Less << - United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 United States, Florida Memorial Cancer Institute Hollywood, Florida, United States, 33021 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 Less <<
NCT02113007 - Terminated(Closed early due to... More >> slow accrual.) Less << - -
NCT01957956 Giant Cell Glioblastoma ... More >> Glioblastoma Gliosarcoma Less << Early Phase 1 Active, not recruiting November 15, 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01026493 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Hawaii Leeward Radiation Oncology 'Ewa Beach, Hawaii, United States, 96706 Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 Queen's Cancer Institute at Queen's Medical Center Honolulu, Hawaii, United States, 96813 Hawaii Medical Center - East Honolulu, Hawaii, United States, 96817 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Kansas CCOP - Kansas City Prairie Village, Kansas, United States, 66208 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503-9985 Louisville Oncology at Norton Cancer Institute - Louisville Louisville, Kentucky, United States, 40202 United States, Mississippi Regional Cancer Center at Singing River Hospital Pascagoula, Mississippi, United States, 39581 United States, Nevada Renown Institute for Cancer at Renown Regional Medical Center Reno, Nevada, United States, 89502 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Legacy Good Samaritan Hospital & Comprehensive Cancer Center Portland, Oregon, United States, 97210 Less <<
NCT01009788 Breast Cancer ... More >> Metastatic Breast Cancer BRCA1 Gene Mutation brca2 Gene Mutation Less << Phase 2 Active, not recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01005472 Metastatic Melanoma Phase 1 Completed - United States, California ... More >> University of California Los Angeles (UCLA) Los Angeles, California, United States, 90095 Less <<
NCT01107522 Solid Tumors, Glioblastoma, Re... More >>current Malignant Gliomas Less << Phase 1 Active, not recruiting - United States, New York ... More >> New York University New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10017 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 Oregon Health and Sciences University Portland, Oregon, United States, 97239 Less <<
NCT01076530 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Extra-adrenal Paraganglioma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Illinois ... More >> Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States, 55455 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT01044966 Glioblastoma Multiforme ... More >> Glioma Astrocytoma Brain Tumor Less << Phase 1 Phase 2 Terminated(The study was termi... More >>nated due to lack of adequate patient enrollment into trial.) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01119508 Metastatic Melanoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02263105 High-grade Gliomas Phase 2 Completed - China, Shanghai ... More >> Huashan Hospital Shanghai, Shanghai, China, 200040 Less <<
NCT01124734 Malignant Melanoma Phase 2 Unknown August 2017 United States, Pennsylvania ... More >> Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT01149109 Glioblastoma Phase 3 Completed - Germany ... More >> Depatment of Neurosurgery, Charité, University Hospital Berlin Berlin, Germany, 13353 Department of Neurology, University Hospital Bochum Bochum, Germany, 44892 Department of Neurology, University Hospital Bonn Bonn, Germany, 53105 Department of Neurosurgery, University Hospital Cologne Cologne, Germany, 50937 Department of Neurosurgery, University Hospital Dresden Dresden, Germany, 01307 Department of Neurosurgery, University Hospital Duesseldorf Duesseldorf, Germany, 40225 Department of Neurosurgery, University Hospital Frankfurt Frankfurt, Germany, 60528 Department of Radiooncology, University Hospital Leipzig Leipzig, Germany, 04103 Department of Neurosurgery, University of Heidelberg, Medical Faculty of Mannheim Mannheim, Germany, 68167 Department of Neurosurgery, University Hospital Muenster Muenster, Germany, 48149 Department of Neurosurgery, University Hospital Munich (LMU) Munich, Germany, 81377 Department of Neurology, University Hospital Regensburg Regensburg, Germany, 93053 Less <<
NCT01026493 - Completed - -
NCT02358356 Midgut Neuroendocrine Tumours ... More >> Pancreatic Neuroendocrine Tumours Less << Phase 2 Recruiting December 2020 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Kathryn Jenkins       Kathryn.Jenkins@health.nsw.gov.au    Principal Investigator: Nick Pavlakis          Australia, Queensland Royal Brisbane and Women's Hospital Recruiting Herston, Queensland, Australia, 4029 Contact: Jenny Campbell       Jenny.Campbell@health.qld.gov.au    Australia, Victoria Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 8006 Contact: Elizabeth Drummond       Elizabeth.Drummond@petermac.org    Australia, Western Australia Fiona Stanley Hospital Recruiting Murdoch, Western Australia, Australia, 6150 Contact: Kanako Ohara       kanako.ohara@health.wa.gov.au    Principal Investigator: David Ransom Less <<
NCT01205828 Hepatocellular Carcinoma Phase 2 Terminated(Lack of efficacy) - United States, District of Col... More >>umbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT01124240 Newly Diagnosed Non Methylated... More >> Glioblastoma Multiforme Grade 4 Less << Phase 2 Unknown January 2014 Australia, New South Wales ... More >> Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia, 2065 Contact: Sally McCowatt, Rn    61299265049    smccowat@nsccahs.health.nsw.gov.au    Contact: Helen Wheeler, MBBS    61299267111    hrwheeler@optusnet.com.au    Principal Investigator: Helen Wheeler, MBBS Less <<
NCT01139970 Accelerated Phase of Disease ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With PML-RARA Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult T Acute Lymphoblastic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Blastic Phase Chronic Myelomonocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Disease Secondary Acute Myeloid Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT01205828 - Terminated(Lack of efficacy) - -
NCT02343549 Cancer of Brain and Nervous Sy... More >>stem Less << Phase 2 Recruiting June 2021 United States, North Carolina ... More >> Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Sylvia Rushing Less <<
NCT01294735 Recurrence of Solid Tumor ... More >> Glioblastoma Multiforme Melanoma Less << Phase 1 Completed - -
NCT01193140 Solid Tumor Cancers Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 43022 Encinitas, California, United States, 92024 Site Reference ID/Investigator# 42662 Santa Monica, California, United States, 90404 Less <<
NCT02530502 Adult Glioblastoma Phase 1 Phase 2 Active, not recruiting November 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01342757 - Completed - -
NCT02416999 Recurrent High-grade Glioma Not Applicable Unknown May 2018 China, Beijing ... More >> Beijing Tiantan Hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Nan Ji, MD    +86 13910713896    neurochina@gmail.com    Principal Investigator: Jisheng Wang, MD          Principal Investigator: Nan Ji, MD          China, Hebei Hebei Yanda Hospital Not yet recruiting Sanhe, Hebei, China, 065200 Contact: Nan Ji, MD    +86 13910713896    neurochina@gmail.com    Principal Investigator: Jisheng Wang, MD          Principal Investigator: Nan Ji, MD Less <<
NCT01342757 Adult Glioblastoma ... More >> Depression Recurrent Adult Brain Tumor Less << Not Applicable Completed - United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01390571 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United Kingdom ... More >> Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 0QQ Christie Hospital Manchester, England, United Kingdom Royal Marsden Hospital Sutton, England, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH Western General Hospital Edinburgh, United Kingdom, EH4 2XU Less <<
NCT01213407 Glioblastoma Multiforme Phase 2 Completed - Austria ... More >> Landesnervenklinik Wagner-Jauregg Linz, Oberösterreich, Austria, 4020 Landeskrankenhaus Feldkirch Feldkirch, Austria, 6807 Department of Neurosurgery, Medical University Graz Graz, Austria, 8036 Clinical Department of Neurology, Medical University Innsbruck Innsbruck, Austria, 6020 Department of Neurosurgery, Christian Doppler Klinik, Paracelsus Medizinische Privatuniversität Salzburg, Austria, 5020 Neuroonkologisches Tumorboard KFJ-KA; Rudolfsstiftung Vienna, Austria, 1030 Department of Paediatrics, Medical University Vienna Vienna, Austria, 1090 Medical Department of Oncology, Donauspital, SMZ-Ost Vienna, Austria, 1220 Less <<
NCT02689336 Glioma Rhabdo... More >>myosarcoma Osteosarcoma Medulloblastoma Neuroectodermal Tumor Ependymoma Ewing's Sarcoma Wilms Tumor Less << Phase 2 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Alok Kothari, M.D.    314-454-6018    alok@wustl.edu    Principal Investigator: Alok Kothari, M.D. Less <<
NCT02780024 Glioblastoma Multiforme Phase 2 Recruiting December 2021 Canada, Quebec ... More >> Montreal Neurological Institute - McGill University Health Centre Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Marianna Perna, CCRP,CCRC    514-934-1934 ext 43191    marianna.perna@muhc.mcgill.ca    Contact: Tatiana Carvalho, CCRP    514-934-1934 ext 43698    tatiana.carvalho@muhc.mcgill.ca    Sub-Investigator: Bassam Abdulkarim, M.D.          Sub-Investigator: Marie-Christine Guiot, M.D.          Sub-Investigator: Scott Owen, M.D.          Sub-Investigator: Kevin Petrecca, M.D.          Sub-Investigator: Valerie Panet-Raymond, M.D.          Sub-Investigator: Luis Souhami, M.D. Less <<
NCT02649582 Glioblastoma Multiforme of Bra... More >>in Less << Phase 1 Phase 2 Recruiting December 2022 Belgium ... More >> Antwerp University Hospital Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Zwi N Berneman, MD, PhD       zwi.berneman@uza.be    Contact: Pol Specenier, MD, PhD    038214014 ext 0032    pol.specenier@uza.be Less <<
NCT01550224 - Completed - -
NCT01499251 Glioblastoma Phase 1 Terminated(Results did not cle... More >>arly support continuing development in recurrent GBM) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01587144 Glioblastoma Multiforme Phase 2 Terminated(Sponsor's decision) - United States, California ... More >> UCSD Moores Cancer Center La Jolla, California, United States, 92093 UCI Medical Center Orange, California, United States, 92868 United States, New York Dent Neurologic Institute Amherst, New York, United States, 14226 United States, Ohio Fairview Hospital Moll Cancer Center/Cleveland Clinic Cleveland, Ohio, United States, 44111 Cleveland Clinic Cleveland, Ohio, United States, 44195 Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic Mayfield, Ohio, United States, 44124 India Gujarat Cancer Research Institute Ahmedabad, Gujarat, India, 380016 Jaslok Hospital & Research Centre Mumbai, Maharashtra, India, 400062 Bhagwan Mahaveer Cancer Hospital & Reseach Centre Jaipur, Rajasthan, India, 302017 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Less <<
NCT02898012 Glioblastoma Multiforme ... More >> Primary Brain Tumor Less << Phase 2 Completed - France ... More >> Groupe Hospitalier Pitié-Salpêtrière Paris, France, 75013 Less <<
NCT02761070 Glioblastoma ... More >>Recurrence Progression Less << Phase 3 Recruiting July 2023 Japan ... More >> Hirosaki University School of Medicine Recruiting Hirosaki, Aomori, Japan, 036-8563 Contact: Kenichiro Asano, M.D.    +81-172-39-5111    asanoken@hirosaki-u.ac.jp    Ehime University Graduate School of Medicine Recruiting Shizukawa, Ehime, Japan, 791-0295 Contact: Shohei Kouno, M.D.    +81-89-960-5338    kouno1220@gmail.com    Iwate Medical University Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Takaaki Beppu, M.D.    +81-19-651-5111    tbeppu@iwate-med.ac.jp    Tohoku University Graduate School of Medicine Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Masayuki Kanamori, M.D.    +81-22-717-7000    mkanamori@med.tohoku.ac.jp    Kansai Medical University Recruiting Hirakata, Osaka, Japan, 573-1191 Contact: Akio Asai, M.D.    +81-72-804-0101    aasaikun@hirakata.kmu.ac.jp    Contact: Masahiro Nonaka, M.D.    +81-72-804-0101    nonakamasa65@gmail.com    Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0871 Contact: Naoki Kagawa, M.D.    +81-6-6879-3652    nkagawa@nsurg.med.osaka-u.ac.jp    Saitama Medical University International Medical Center Recruiting Hidaka, Saitama, Japan, 350-1298 Contact: Ryo Nishikawa, M.D., Ph.D.    +81-42-984-4111    rnishika@saitama-med.ac.jp    Contact: Kazuhiko Misima, M.D., Ph.D.    +81-42-984-4111    kmishima@saitama-med.ac.jp    Kusyu University Graduate School of Medical Sciences Recruiting Fukuoka, Japan, 812-8582 Contact: Koji Yoshimoto, M.D., Ph.D.    +81-92-642-5524    kyoshimo@ns.med.kyushu-u.ac.jp    Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Kazuhiko Sugiyama, M.D.    +81-82-257-5227    sugiyama-hma@umin.ac.jp    Kagoshima University Graduate School of Medical and Dental Sciences Recruiting Kagoshima, Japan, 890-8520 Contact: Hirofumi Hirano, M.D.    +81-99-275-5111    hirahira@m2.kufm.kagoshima-u.ac.jp    Kitasato University School of Medicine Recruiting Kanagawa, Japan, 252-0374 Contact: Toshihiro Kumabe, M.D., Ph.D.    +81-3-3972-8111    kuma@kitasato-u.ac.jp    Kyoto University Graduate School of Medicine Recruiting Kyoto, Japan, 606-8507 Contact: Yoshiki Arakawa, M.D.    +81-75-366-7776    yarakawa@kuhp.kyoto-u.ac.jp    Osaka International Cancer Institute Recruiting Osaka, Japan, 541-8567 Contact: Manabu Kinoshita, M.D.    +81-6-6945-1181    mail@manabukinoshita.com    Nakamura Memorial Hospital Recruiting Sapporo, Japan, 060-8570 Contact: Kenichi Sato, M.D.    +81-11-231-8555    satoken@med.nmh.or.jp    Hokkaido University Graduate School of Medicine Recruiting Sapporo, Japan, 060-8648 Contact: Hiroyuki Kobayashi, M.D.    +81-11-716-1161    hiro-ko@med.hokudai.ac.jp    Shizuoka Canser Center Hospital Recruiting Shizuoka, Japan, 411-8777 Contact: Yoko Nakasu, M.D.    +81-55-989-5222    y.nakasu@scchr.jp    Contact: Kouichi Mitsuya, M.D.    +81-55-989-5222    k.mitsuya@scchr.jp    National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Yoshitaka Narita, M.D., Ph.D.    +81-3-542-2511    yonarita@ncc.go.jp    The University of Tokyo Hospital Recruiting Tokyo, Japan, 113-8655 Contact: Shota Tanaka, M.D.    +81-3-5800-8853    tanakas-tky@umin.ac.jp    Keio University Hospital Recruiting Tokyo, Japan, 160-8582 Contact: Hikaru Sasaki, M.D.    +81-3-3353-1211    hsasaki@a5.keio.jp    Nihon University School of Medicine Itabashi Hospital Recruiting Tokyo, Japan, 173-0032 Contact: Atsuo Yoshino, M.D.    +81-3-3972-8111    yoshino.atsuo@nihon-u.ac.jp    Contact: Shun Yamamuro, M.D.    +81-3-3972-8111    yamamuro.shun@nihon-u.ac.jp    Kyorin University Faculty of Medicine, Department of Neurosurgery Recruiting Tokyo, Japan, 181-8611 Contact: Keiichi Kobayashi, M.D., Ph.D.    +81-422-47-5511    kekobayashi@kki.biglobe.ne.jp    Contact: Motoo Nagane, M.D., Ph.D.    +81-422-47-5511    mnagane@ks.kyorin-u.ac.jp Less <<
NCT03018288 Glioblastoma Phase 2 Recruiting January 9, 2024 United States, Arizona ... More >> Barrow Neurological Institute Recruiting Phoenix, Arizona, United States, 85013 Contact: Kathryn Gilbert    602-406-6274       United States, Florida UF Health Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Helen Tran    321-841-3812    helen.tran@orlandohealth.com    United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke    312-695-4772    anne.mendelke@nm.org    Northshore University Health System Recruiting Glenview, Illinois, United States, 60026 Contact: Patricia Lada    847-570-2025    plada@northshore.org    Advocate Health Care Recruiting Park Ridge, Illinois, United States, 60068 Contact: Sheri Velez    847-723-5579    sherri.velez@advocate.com    United States, Maryland National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937       United States, Michigan Henry Ford Health Systems Recruiting Detroit, Michigan, United States, 48202 Contact: Francesca Picotte, M.D.    313-916-3181    fpicott1@hfhs.org    United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Michael Roxas    919-962-8834    michael_roxas@med.unc.edu    United States, South Carolina MUSC Hollings Cancer Center Recruiting Charleston, South Carolina, United States, 29425 Contact: Michele DeCandio    843-792-9016    decandio@musc.edu    United States, Texas Texas Oncology-Austin Brain Tumor Center Recruiting Austin, Texas, United States, 78705 Contact: Michele Harris    972-490-2963    michelle.harris2@usoncology.com    Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Amy Solis    214-820-8685    amy.solis@BSW.edu    United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Lisa Angelos    801-587-4702    Lisa.Angelos@hci.uah.edu    United States, Washington University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Valeria Martin    206-221-1538    avmartin@uw.edu    United States, Wisconsin Aurora Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Gary Dennison    414-385-7129    gary.dennison@aurora.org Less <<
NCT01591577 Newly Diagnosed Glioblastoma M... More >>ultiforme Less << Phase 2 Recruiting December 7, 2019 United States, California ... More >> UCLA Recruiting Los Angeles, California, United States, 90095 Principal Investigator: Pioanh Nghiemphu, MD Less <<
NCT01638546 - Completed - -
NCT01550224 Acute Myeloid Leukemia With 11... More >>q23-abnormality in Relapse Less << Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT02934204 Primary CNS Lymphoma Phase 2 Recruiting February 2019 China, Guangdong ... More >> Guangdong general hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Sichu Liu, MD PhD    +86 20 81884713 ext 80411    sisi.lau@foxmail.com Less <<
NCT03156036 Advanced Rectal Cancer Phase 2 Recruiting February 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa, Korea, Republic of, 05505 Contact: Yong Sang Hong, M.D., Ph.D.    +82-2-3010-3227    yshong@amc.seoul.kr    Contact: Tae Won Kim, M.D., Ph.D.    +82-2-3010-3910    twkimmd@amc.seoul.kr Less <<
NCT01736800 Central Nervous System (CNS) M... More >>etastases Brain Metastases Less << Phase 2 Withdrawn(No enrollment and PI... More >> requested study termination per IRB system.) Less << - United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Methodist Neurological Institute - Department of Neurosurgery Houston, Texas, United States, 77030 Less <<
NCT03213002 Glioblastoma Multiforme (GBM) ... More >> Glioblastoma Glioma of Brain Glioblastoma, Adult Brain Tumor Brain Tumor, Primary Brain Tumor Adult Cancer Brain Cancer Less << Phase 1 Phase 2 Recruiting June 2021 United States, New York ... More >> Lenox Hill Brain Tumor Center Recruiting New York, New York, United States, 10075 Contact: Tamika Wong, MPH    212-434-4836    twong4@northwell.edu    Principal Investigator: John Boockvar, MD          Sub-Investigator: David Langer, MD          Sub-Investigator: Anuj Goenka, MD          Sub-Investigator: Christopher Filippi, MD          Sub-Investigator: Lalitha Anand, MD          Sub-Investigator: Sherese Fralin, NP          Sub-Investigator: Ashley Ray, NP          Sub-Investigator: Tamika Wong, MPH Less <<
NCT01638546 Recurrent Small Cell Lung Carc... More >>inoma Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT03243851 Glioblastoma Phase 2 Recruiting December 31, 2018 Korea, Republic of ... More >> National Cancer Center Korea Recruiting Ilsan, Gyeonggi-Do, Korea, Republic of, 10408 Contact: Heon Yoo, MD., PhD.    +82-31-920-1249    heonyoo@ncc.re.kr    Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-Do, Korea, Republic of, 13620 Contact: Yu Jung Kim, MD., PhD.    +82-31-787-8210    cong1005@gmail.com    Ajou University Hospital Recruiting Suwon-si, Gyeonggi-Do, Korea, Republic of, 16499 Contact: Se Hyuk Kim, MD., PhD.    +82-31-219-3559    nsksh@ajou.ac.kr    Chonnam National University Hwasun Hospital Recruiting Hwasun, Jeollanam-Do, Korea, Republic of, 58128 Contact: Shin Jung, MD., PhD.    +82-2-379-8954    sjung@chonnam.ac.kr    Incheon St. Mary's Hospital Recruiting Incheon, Korea, Republic of, 21431 Contact: Dong Sup Chung, MD., PhD.    +82-32-280-5876    dschung@catholic.ac.kr    Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Tae Min Kim, MD., PhD.    +82-2-2072-1672    gabriel9@snu.ac.kr    Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jong Hee Chang, MD., PhD.    +82-2-2228-2162    changjh@yuhs.ac    Konkuk University Hospital Recruiting Seoul, Korea, Republic of, 05030 Contact: Young Cho Koh, MD., PhD.    +82-2-2030-7622    kohyc@kuh.ac.kr    Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Jeong Hoon Kim, MD., PhD.    +82-2-3010-3559    jhkim1@amc.seoul.kr    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Do Hyun Nam, MD., PhD.    +82-2-3410-3497    nsnam@skku.edu    Seoul St Mary's Hospital Recruiting Seoul, Korea, Republic of, 06591 Contact: Yong-Kil Hong, MD., PhD.    +82-2-2258-2101    hongyk@catholic.ac.kr    Saint Vincent's Hospital, Korea Recruiting Suwon-si, Korea, Republic of, 16247 Contact: Seung Ho Yang, MD., PhD.    +82-31-249-8304    72ysh@catholic.ac.kr Less <<
NCT01868906 Malignant Glioma Phase 2 Terminated(Isotope (FMISO) pro... More >>duction is no longer available in our country.) Less << - Spain ... More >> Dr. Negrin University Hospital Las Palmas, Spain, 35010 Instituto Tecnologico Servicios Sanitarios, in MD Anderson Cancer Center, Madrid Madrid, Spain, 28.033 Less <<
NCT03542097 - Recruiting June 30, 2019 Italy ... More >> Fondazione IRCCS - Istituto Nazionale dei Tumori Completed Milan, Mi, Italy, 20133 Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS Completed Candiolo, Turin, Italy, 10060 Orthopedic Rizzoli Institute Recruiting Bologna, Italy, 40136 Contact: Emanuela Palmerini, MD    00390516366 ext 199    emanuela.palmerini@ior.it    Principal Investigator: Emanuela Palmerini, MD          Ospedale infantile Regina Margherita Completed Turin, Italy, 10126 United Kingdom The Royal Marsden NHS Foundation Trust Not yet recruiting London, United Kingdom, SW3 6JJ Contact: Robin Jones, MD    00442078082200 ext 2590    robin.jones4@nhs.net    Principal Investigator: Robin Jones, MD Less <<
NCT03519412 Colorectal Neoplasms ... More >> Microsatellite Instability Less << Phase 2 Not yet recruiting June 2022 Italy ... More >> Grande Ospedale Metropolitano Niguarda Not yet recruiting Milano, Italy Contact: Andrea Sartore Bianchi, MD          Istituto Nazionale Tumori di Milano Not yet recruiting Milano, Italy Contact: Filippo Pietrantonio, MD          Istituto oncologico Veneto Not yet recruiting Padova, Italy Contact: Sara Lonardi, MD Less <<
NCT01977677 Adult Ependymoblastoma ... More >> Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Medulloblastoma Adult Mixed Glioma Adult Oligodendroglial Tumors Adult Pineoblastoma Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) Less << Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University, School of Medicine Stanford, California, United States, 94305 Less <<
NCT03405792 Glioblastoma ... More >>Glioblastoma, WHO Grade IV Less << Phase 2 Recruiting February 2023 United States, Florida ... More >> University of Florida Health Recruiting Gainesville, Florida, United States, 32610 Less <<
NCT01985451 Central Nervous System Tumors Phase 2 Unknown March 2015 -
NCT03623347 - Completed - -
NCT01991977 Malignant Glioma Phase 2 Suspended(per study design) July 1, 2019 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03079440 Neuroendocrine Tumors ... More >> Neuroendocrine Carcinoma Temozolomide Capecitabine Less << Phase 2 Recruiting October 2020 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD    +82-2-3010-1727    yooc@amc.seoul.kr Less <<
NCT03643549 Glioblastoma Phase 1 Phase 2 Recruiting August 31, 2023 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Dorota Goplen, MD, PhD    +4755974019    dgop@helse-bergen.no    Contact: Jorunn Brekke, MD    +4755970986    joub@helse-bergen.no Less <<
NCT02137759 Glioblastoma Multiforme of Bra... More >>in Less << Phase 2 Recruiting June 2022 United States, Georgia ... More >> Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Rikesh Patel    404-778-2981    rikesh.b.patel@emory.edu    Contact: Lily Masoumy    404-778-1960    lily.masoumy@emory.edu    United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Matthias Holdhoff, MD, PhD    410-955-8837    mholdho1@jhmi.edu Less <<
NCT02085304 Glioblastoma Phase 1 Phase 2 Unknown December 2017 United States, Arizona ... More >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Recruiting Phoenix, Arizona, United States, 85013 Contact: Norissa Honea, PhD, RN    602-406-6267    Norissa.Honea@dignityhealth.org    Contact: Charlotte Myers, MS, ANP-C    602-406-5157    Charlotte.Myers@bnaneuro.net    Principal Investigator: Kris A Smith, MD Less <<
NCT03688178 Glioblastoma Phase 2 Not yet recruiting March 1, 2025 United States, North Carolina ... More >> Duke University Medical Center Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Stevie Threatt    919-684-5301    dukebrain1@dm.duke.edu    Contact: Susan Boulton, RN, BSN    919-684-5301    dukebrain1@dm.duke.edu Less <<
NCT02152982 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Phase 3 Active, not recruiting - -
NCT02168270 Anaplastic Astrocytoma ... More >> Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Glioblastoma Gliosarcoma Less << Phase 1 Terminated - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT02168270 - Terminated - -
NCT02337426 Adult Brain Glioblastoma ... More >> Adult Giant Cell Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT02343406 Glioblastoma Multiforme Phase 2 Recruiting December 13, 2020 -
NCT02344355 Glioblastoma Multiforme Phase 2 Recruiting December 2023 United States, Iowa ... More >> Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Sandy Vollstedt, RN, BSN    319-353-7143    sandy-vollstedt@uiowa.edu    Contact: Heather Brown, RN, BAN    319-384-7912    heather-brown@uiowa.edu    Sub-Investigator: John M. Buatti, MD          Sub-Investigator: Joseph J. Cullen, MD          Sub-Investigator: Daniel Berg, MD          Sub-Investigator: Matthew Howard, MD          Sub-Investigator: Jeremy Greenlee, MD          Sub-Investigator: David Hasan, MD          Sub-Investigator: Patrick Hitchon, MD          Sub-Investigator: Varun Monga, MD          Sub-Investigator: Mark C. Smith, MD          Sub-Investigator: Carryn M. Anderson, MD          Sub-Investigator: Wenqing Sun, MD, PhD          Sub-Investigator: Douglas Spitz, PhD          Sub-Investigator: Mohammed Milhem, MBBA          Sub-Investigator: Garry R. Buettner, PhD Less <<
NCT01977677 - Completed - -
NCT02389738 Blood Brain Barrier Defect Early Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT02389738 - Completed - -
NCT02490930 Glioblastoma ... More >>Anaplastic Astrocytoma Less << Early Phase 1 Completed - United States, Maryland ... More >> The Johns Hopkins University Baltimore, Maryland, United States, 21287 Less <<
NCT02573324 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 3 Recruiting February 13, 2021 -
NCT02272270 Newly Diagnosed High Grade Gli... More >>oma Less << Phase 1 Active, not recruiting October 2019 United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT02836028 Ovarian Cancer Phase 2 Withdrawn - -
NCT02655601 High Grade Glioma, Glioblastom... More >>a Less << Phase 2 Recruiting September 2022 United States, North Carolina ... More >> Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring    919-684-5301    sarah.woodring@dm.duke.edu    Contact: Susan Boulton, RN    919-684-5301    susan.boulton@duke.edu Less <<
NCT02972320 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Unknown December 2018 China, Liaoning ... More >> The First Affiliated Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: mingfang zhao, professor    13644055129 Less <<
NCT02928575 Glioblastoma Multiforme Phase 2 Unknown June 2017 Canada, Alberta ... More >> Tom Baker Cancer Center and University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Jacob Easaw, MD PhD FRCPC    403-521-3446    Jay.Easaw@albertahealthservices.ca    Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Bassam Abdulkarim, MD PhD FRCPC    514-934-1934 ext 43915    bassam.abdulkarim@mcgill.ca Less <<
NCT03011671 Malignant Glioma of Brain Phase 1 Not yet recruiting March 2020 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Bakhtiar Yamini, MD       byamini@surgery.bsd.uchicago.edu Less <<
NCT03150810 Locally Advanced or Metastatic... More >> Solid Tumors Less << Phase 1 Phase 2 Recruiting August 1, 2020 United States, Michigan ... More >> START Midwest Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Kathy Estkowski, BS, CCRP          Contact: Yvette C. Cole, RN, BSN, OCN          Principal Investigator: Nehal Lakhani, MD, PhD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Melissa Meredith, MD          Principal Investigator: Haesong Park, MD          United States, New York Mount Sinai - PRIME Recruiting New York, New York, United States, 10029 Principal Investigator: Matthew Galsky, MD          Montefiore Medical Center PRIME Recruiting New York, New York, United States, 10461 Principal Investigator: Sanjay Goel, MD          United States, Tennessee Sarah Cannon Research Institute (Tennessee Oncology) Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Melissa Johnson, MD          United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 Contact: Angela Streck          Contact: Jessica Bondurant          Principal Investigator: John Nemunaitis, MD Less <<
NCT03393000 Glioblastoma Phase 3 Recruiting June 23, 2022 United States, California ... More >> University of California Recruiting Irvine, California, United States, 92868 Contact: Ricardo Avalos    714-509-2495    ravalos2@uci.edu    Contact: Mohamad Alsharif    714-509-2371    alsharim@uci.edu    Principal Investigator: Daniela Bota, MD, PhD          Scott Peak, M.D. Recruiting Redwood City, California, United States, 94063 Contact: Nancy Mendelssohn    650-299-4165    nancy.d.mendelssohn@kp.org    John Wayne Cancer Institute @ Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Naj Boucher    310 582 7460    Najee.Boucher@Providence.Org    Principal Investigator: Santosh Kesari, MD, PhD, FANA, FAAN          United States, Georgia Piedmont Cancer Recruiting Atlanta, Georgia, United States, 30318 Contact: Jane R Myrie    404-425-7927    jacene.myrie@piedmont.org    Principal Investigator: Erin Dunbar, MD          John B. Amos Cancer Center Recruiting Columbus, Georgia, United States, 31904 Contact: Felicia Irvin    706-478-7968    firvin@iacthealth.com    Contact: Katrina Quidley    706-321-0495       Principal Investigator: Douglas Ciuba, M.D.          United States, Minnesota Abbott Northwestern Hospital Recruiting Minneapolis, Minnesota, United States, 55407 Contact: Amy Ellenberger, CCRC    612-863-6562       Contact: Emily Shoemaker, MPH    612-863-0324       Principal Investigator: John Trusheim, M.D.          United States, New Jersey John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello, RN, BSN, CCRP    551-996-5098    lori.cappello@hackensackmeridian.org    Principal Investigator: Samuel A Goldlust, MD          United States, New Mexico UNM Comprehensive Cancer Center Recruiting Albuquerque, New Mexico, United States, 87102 Contact: Melissa Gibson    505-272-5237    mngibson@salud.unm.edu    Contact: Sariat Ibrahim    505-272-7412    SIbrahim@salud.unm.edu    Principal Investigator: Ben Liem, MD          United States, New York North Shore University Hospital Recruiting Manhasset, New York, United States, 11030 Contact: Louise A Purcell, NP    516-941-1260    LPurcell@Northwell.edu    Principal Investigator: Michael Schulder, MD          Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Angela Stangarone    212-241-9843    Angela.stangarone@mssm.edu    Principal Investigator: Adilia Hormingo, MD, PhD          United States, Oregon Providence Portland Medical Center Recruiting Portland, Oregon, United States, 97213 Contact: Larisa Lindgren    503-215-2614       Principal Investigator: Herschel D Wallen, M.D.          United States, South Carolina Scott Lindhorst, M.D. Recruiting Charleston, South Carolina, United States, 29425 Contact: John "Bo" Keller    843-792-2209    kellej@musc.edu    Contact: Michele DeCandio    843-792-9016    decandio@musc.edu    United States, Texas Neuro Oncology Associates Recruiting Dallas, Texas, United States, 75246 Contact: Oghenevovwero Sido    214-820-6168    Oghenevovwero.sido@BSWhealth.org    Contact: Carolyn Nwankwo    214-865-4978    carolyn.nwankwo@BSWhealth.org    Principal Investigator: Karen Fink, MD, PhD Less <<
NCT02227901 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, California ... More >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 Less <<
NCT03212742 Malignant Gliomas ... More >> Radiotherapy PARP Inhibitor Less << Phase 1 Phase 2 Recruiting June 30, 2022 France ... More >> CHU Not yet recruiting Bordeaux, France Contact: Aymeri HUCHET, MD          Principal Investigator: Aymeri HUCHET, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Dinu STEFAN, MD    33 2 31 45 50 50    d.stefan@baclesse.unicancer.fr    Contact: Jean-Michel GRELLARD          Principal Investigator: Dinu STEFAN, MD          Sub-Investigator: Julien GEFFRELOT, MD          Sub-Investigator: Ioana HRAB, MD          Centre léon Bérard Not yet recruiting Lyon, France Contact: Marie-Pierre SUNYACH, MD          Principal Investigator: Marie-Pierre SUNYACH, MD          Hôpitaux universitaires La Pitié Salpétrière - Charles Foix Not yet recruiting Paris, France Contact: Loic FEUVRET, MD          Principal Investigator: Loic FEUVRET, MD          Sub-Investigator: Florence LAIGLE-DONADEY, MD          Sub-Investigator: Khe HOANG-XUAN, MD          Sub-Investigator: Ahmed IBDAIH, Pr          Institut Curie Not yet recruiting Paris, France Contact: Hamid MAMMAR, MD          Principal Investigator: Hamid MAMMAR, MD          Sub-Investigator: Laurence BOZEC LE MOAL, MD          Sub-Investigator: Coraline DUBOT, MD          Sub-Investigator: Patricia TRESCA, MD          Sub-Investigator: Patricia MOISSON, MD          Institut Claudius Regaud Not yet recruiting Toulouse, France Contact: Elisabeth MOYAL COHEN-JONATHAN, Pr          Principal Investigator: Elisabeth MOYAL COHEN-JONATHAN, Pr          Sub-Investigator: Ioana CARPUC, MD          Sub-Investigator: Jean-Pierre DELORD, MD          Sub-Investigator: Cécile GANDY, MD          Sub-Investigator: Carlos Alberto GOMEZ-ROCA, MD          Sub-Investigator: Anouchka MODESTO, MD          Sub-Investigator: Thibaud VALENTIN, MD Less <<
NCT03548571 Glioblastoma Phase 2 Phase 3 Recruiting May 1, 2023 Norway ... More >> Oslo University Hospital Recruiting Oslo, Norway Contact: Einar O Vik-Mo, MD, PhD    +47 23074340    uxvieb@ous-hf.no    Contact: Solveig Bringsli       solbri@ous-hf.no Less <<
NCT03554473 Carcinoma, Small Cell ... More >> Lung Cancer Small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting January 15, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02446704 Small Cell Lung Cancer Phase 1 Phase 2 Recruiting August 2022 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Anna Farago, MD, PhD    617-724-4000    afarago@mgh.harvard.edu    Principal Investigator: Anna Farago, MD, PhD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: David Barbie, MD    617-632-6049    dbarbie@partners.org    Principal Investigator: David Barbie, MD          Beth Israel Deaconess Medical Center Active, not recruiting Boston, Massachusetts, United States, 02215 Less <<
NCT03581292 Anaplastic Astrocytoma ... More >> Glioblastoma Malignant Glioma Less << Phase 2 Recruiting October 29, 2024 -
NCT03463733 Glioma Gliobl... More >>astoma Less << Phase 1 Recruiting June 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD    +31 (0)20 4444321    h.verheul@vumc.nl Less <<
NCT01956734 Glioblastoma Multiforme ... More >> Recurrent Tumor Less << Phase 1 Completed - Spain ... More >> Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT02039778 Glioblastoma ... More >>Malignant Glioma Brain Tumors Anaplastic Astrocytoma Less << Not Applicable Terminated(Poor Accural) - United States, New York ... More >> Roosevelt Hospital New York, New York, United States, 10019 Less <<
NCT01985087 Glioblastoma Phase 1 Phase 2 Recruiting May 2019 United States, Kentucky ... More >> James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 Contact: Clinical Trials Office    502-562-3429    ctobcc@louisville.edu    Principal Investigator: Eric Burton, MD          Sub-Investigator: Shiao Woo, MD Less <<
NCT02046187 Glioblastoma (GBM) Phase 1 Phase 2 Terminated(excessive protocol ... More >>deviations due to strict nature of diet requirements) Less << - United States, Arizona ... More >> Barrow Neurological Institute at St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 Less <<
NCT03672773 Recurrent Extensive Stage Smal... More >>l Cell Lung Carcinoma Refractory Extensive Stage Small Cell Lung Carcinoma Less << Phase 2 Not yet recruiting November 1, 2020 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90095 Contact: Jonathan W. Goldman    310-633-8400    jwgoldman@mednet.ucla.edu    Principal Investigator: Jonathan W. Goldman Less <<
NCT02092038 Glioblastoma Phase 1 Completed - United States, Florida ... More >> Tampa General Hospital Tampa, Florida, United States, 33606 Less <<
NCT02039778 - Terminated(Poor Accural) - -
NCT01900951 Carcinoma, Small Cell Phase 2 Unknown June 2016 China, Beijing ... More >> PLA general hospital BeiJing, Beijing, China, 100853 Less <<
NCT03139916 Glioblastoma Phase 2 Active, not recruiting July 31, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts general Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02177578 Glioblastoma Multiforme Phase 2 Recruiting November 2020 United States, District of Col... More >>umbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States Principal Investigator: Curtiland Deville, MD          United States, Maryland The SKCCC at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Sub-Investigator: Tracy Vannorsdall, Ph.D.          Sub-Investigator: Lawrence Kleinberg, M.D.          Sub-Investigator: Alfredo Quinones, M.D.          Sub-Investigator: Matthew Holdhoff, M.D.          Suburban Hospital Recruiting Bethesda, Maryland, United States Less <<
NCT02133677 Lung Cancer and Breast Cancer ... More >>Patients With Brain Metastases Less << Phase 2 Unknown May 2016 Taiwan ... More >> Far Eastern Memorial Hospital Not yet recruiting New Taipei City, Taiwan, 220 Contact: Pei-Wei Shueng, MD    886-2-8966-7000 ext 1022    shueng@mail.femh.org.tw    Principal Investigator: Pei-Wei Shueng, MD Less <<
NCT02179086 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 2 Recruiting May 2024 -
NCT02209948 Glioblastoma Phase 2 Recruiting January 2019 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Ana Márquez, Pharmacist    0034 934 33 44 12    ana.marquez@mfar.net    Principal Investigator: Carmen Balañá, MD          Institut Català D'Oncologia L'Hospitalet (Ico) Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Ana Márquez, Pharmacist    +34934344412    ana.marquez@mfar.net    Principal Investigator: Carles Mesia, MD          Hospital Universitario Fundación Alcorcón Active, not recruiting Alcorcón, Madrid, Spain, 28922 Hospital Son Espases Recruiting Palma de Mallorca, Mallorca, Spain, 07010 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Jose Fuster, MD          Hospital Universitario Sant Joan de Reus Recruiting Reus, Tarragona, Spain, 43204 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Sergio Peralta, MD          Consorcio Hospitalario Provincial de Castellón Active, not recruiting Castelló, Valencia, Spain, 12002 Hospital Del Mar Active, not recruiting Barcelona, Spain, 08003 Hospital de La Santa Creu I Sant Pau Active, not recruiting Barcelona, Spain, 08025 Hospital Clínic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Estela Pineda, MD          Hospital General de Ciudad Real Active, not recruiting Ciudad Real, Spain, 13005 Hospital Dr. Josep Trueta de Girona Recruiting Girona, Spain, 17007 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Sonia del Barco, MD          Hospital Arnau de Vilanova Active, not recruiting Lleida, Spain, 25198 Hospital Universitario Lucus Augusti Recruiting Lugo, Spain, 27003 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Marta Covela, MD          Hospital Ramón Y Cajal Recruiting Madrid, Spain, 28034 Contact: Ana Márquez, Pharmacist    +34934344412    ana.marquez@mfar.net    Principal Investigator: M Angeles Vaz Salgado, MD          Hospital Clínico San Carlos Active, not recruiting Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Active, not recruiting Madrid, Spain, 28041 Hospital Clínico Universitario de Salamanca Recruiting Salamanca, Spain, 37007 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Luis Miguel Navarro, MD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Begoña Pérez, MD          Consorcio Hospital General Universitario de Valencia Recruiting Valencia, Spain, 46014 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Alfonso Berrocal, MD          Hospital Universitario Miguel Servet Recruiting Zaragoza, Spain, 50009 Contact: Ana Márquez, Pharmacist    +34 934344412    ana.marquez@mfar.net    Principal Investigator: Ana Herrero, MD Less <<
NCT02315534 Glioblastoma Phase 1 Phase 2 Active, not recruiting - United States, New York ... More >> Laura and Isaac Perlmutter Cancer Center New York, New York, United States, 10016 Canada, Alberta University of Calgary Calgary, Alberta, Canada Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada Less <<
NCT02330991 Glioblastoma Phase 2 Unknown December 2017 -
NCT02343081 Brain Neoplasms, Malignant, Pr... More >>imary Less << Phase 4 Completed - Argentina ... More >> FLENI Instituto Clínico-Quirúrgico de Diagnóstico y Tratamiento Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1428AQK FLENI Instituto de Rehabilitación y Educación Terapéutica Escobar, Buenos Aires, Argentina, B1625XAS Less <<
NCT02343081 - Completed - -
NCT00004010 Lymphoma Phase 2 Completed - -
NCT02340156 RECURRENT GLIOBLASTOMA Phase 2 Recruiting December 2019 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter    713-745-5769    kuhunter@mdanderson.org    Taiwan China Medical University Hospital Recruiting Taichung, Taiwan, 40447 Contact: Sophia Lin    886-937-722118    tinghsun3@gmail.com    Contact: Ya-Hui Lin    886-978-523673    yahuilin02@gmail.com    Principal Investigator: Der-Yang Cho, MD Less <<
NCT00041210 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Royal United Hospital Bath, England, United Kingdom, BA1 3NG Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT1 3NG Saint Richards Hospital Chichester, England, United Kingdom, P019 4SE Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Doncaster Royal Infirmary Doncaster, England, United Kingdom, DN2 5LT Russells Hall Hospital Dudley, England, United Kingdom, DY1 2HQ Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Hemel Hempstead General Hemel Hempstead, England, United Kingdom, HP2 4AD Hull Royal Infirmary Hull, England, United Kingdom, HU3 2KZ King George Hospital Ilford, Essex, England, United Kingdom, IG3 8YB Lincoln County Hospital Lincoln, England, United Kingdom, LN2 5QY Royal Liverpool University Hospital Liverpool, England, United Kingdom, L7 8XP Aintree University Hospital Liverpool, England, United Kingdom, L9 7AL Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE St. George's Hospital London, England, United Kingdom, SW17 ORE University College Hospital - London London, England, United Kingdom, WC1E 6AU James Paget Hospital Norfolk, England, United Kingdom, NR31 6LA Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Portsmouth Oncology Centre at Saint Mary's Hospital Portsmouth Hants, England, United Kingdom, PO3 6AD Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Staffordshire General Hospital Stafford, England, United Kingdom, ST16 3SA Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA City Hospital - Birmingham West Bromwich, England, United Kingdom, B71 4HJ New Cross Hospital Wolverhampton, England, United Kingdom, WV10 0QP Worthing Hospital Worthing, England, United Kingdom, BN11 2DH Cancer Care Centre at York Hospital York, England, United Kingdom, Y031 8HE Craigavon Area Hospital Craigavon, Northern Ireland, United Kingdom, BT63 5QQ Monklands General Hospital Airdrie, Scotland, United Kingdom, ML6 0JF Pinderfields General Hospital Wakefield, Scotland, United Kingdom, WF1 4DG Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL South West Wales Cancer Institute Swansea, Wales, United Kingdom, SA2 8QA Less <<
NCT00025064 Lymphoma Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00003421 Lymphoma Phase 3 Completed - United Kingdom ... More >> St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT00410631 Neuroblastoma Phase 3 Unknown - -
NCT00017225 Neuroblastoma Phase 2 Completed - -
NCT00526318 Neuroblastoma Not Applicable Unknown - -
NCT00002802 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Frechen, Germany, DOH-5-0226 Less <<
NCT02209428 Astrocytoma O... More >>ligodendroglioma Oligoastrocytoma Less << Phase 2 Unknown May 2016 China, Shanghai ... More >> Huashan Hospital Affiliated to Fudan University Recruiting Shanghai, Shanghai, China, 200040 Contact: Jinsong Wu, Professor    52887200    wjsongc@126.com    Principal Investigator: Jinsong Wu, Professor Less <<
NCT01132807 Lymphoma Phase 2 Completed - -
NCT00416377 Lymphoma Not Applicable Unknown - -
NCT00920153 Lymphoma Phase 3 Terminated(Other new drugs) - France ... More >> FILO French Innovative Leukemia Organization Tours Cedex, France, 37044 Less <<
NCT00002791 Sarcoma Phase 2 Completed - -
NCT00023738 Sarcoma Phase 1 Phase 2 Completed - -
NCT00006025 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00416832 Lymphoma Phase 2 Completed - -
NCT00039494 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 2 Completed - -
NCT00021307 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Withdrawn(Study not activated.... More >>) Less << - -
NCT00006043 Ovarian Cancer ... More >> Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02231762 Gastroenteropancreatic Neuroen... More >>docrine Tumors Less << Phase 2 Completed - Austria ... More >> Vienna General Hospital Vienna, Austria, 1090 Germany Zentralklinik Bad Berka Bad Berka, Germany, 99437 Charité University Hospital Berlin, Germany, 13353 University Hospital Essen Essen, Germany, 45122 ENDOC Hamburg Hamburg, Germany, 20357 Oncological Center Leer Leer, Germany, 26789 University Hospital Mainz Mainz, Germany, 55131 University Hospital Mannheim Mannheim, Germany, 68167 University Hospital Marburg Marburg, Germany, 35043 University Hospital Munich Munich, Germany, 81377 Less <<
NCT01700569 Grade IV Astrocytoma ... More >> Glioblastoma Less << Phase 1 Unknown March 2018 France ... More >> ICO site Gauducheau Recruiting Nantes, France, 44805 Contact: Mario Campone, MD, PhD    +33240679900    mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD, PhD          Sub-Investigator: Jean S FRESNEL, MD Less <<
NCT02698410 Neuroendocrine Tumours Phase 2 Active, not recruiting June 2019 Italy ... More >> Oncologia Medica - Istituto Oncologico del Mediterraneo - IOM Viagrande, Catania, Italy, 95029 Unità Operativa di Oncologia Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy, 25123 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l., IRCCS Meldola, Italy, 47014 Unità Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Istituto Europeo di Oncologia, IEO Milan, Italy, 20141 Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica , Università degli Studi Napoli, Italy, 80131 Dipartimento di Oncologia Università di Torino Ospedale San Luigi Gonzaga Orbassano, Italy, 10043 S.C di Oncologia Medica, Azienda Ospedaliera Universitaria di Perugia Perugia, Italy, 06123 U.O. Oncologia - Azienda Ospedaliero-Universitaria Pisana Ospedale S. Chiara Pisa, Italy, 56126 Oncologia Medica - Istituto Tumori Regina Elena San Gallicano Roma, Italy, 00144 OUC di Oncologia- Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma Verona, Italy, 37134 Less <<
NCT03243461 Glioblastoma WHO Grade IV ... More >> Diffuse Midline Glioma Histone 3 K27M WHO Grade IV Anaplastic Astrocytoma WHO Grade III Diffuse Intrinsic Pontine Glioma Gliomatosis Cerebri Less << Phase 3 Recruiting June 1, 2023 Germany ... More >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Michael Frühwald, Prof.          Evangelisches Krankenhaus Bielefeld Recruiting Bielefeld, Germany Contact: Norbert Jorch, Dr.          Universitätsklinikum Bonn Recruiting Bonn, Germany Contact: Carola Weber, Dr.          Klinikum Bremen-Mitte gGmbH Recruiting Bremen, Germany Contact: Arnulf Pekrun, Prof.          Klinikum Chemnitz gGmbH Recruiting Chemnitz, Germany Contact: André Hofmann, Dr.          Carl-Thiem-Klinikum Cottbus gGmbH Recruiting Cottbus, Germany Contact: Georg Schwabe, PD Dr.          Sana Kliniken Duisburg GmbH - Wedau Kliniken Recruiting Duisburg, Germany Contact: Tanja Höll, Dr.          Universitätsklinikum Erlangen Recruiting Erlangen, Germany Contact: Markus Metzler, Prof.          Universitätsklinikum Freiburg Recruiting Freiburg, Germany Contact: Charlotte Niemeyer, Prof.          Universitätsmedizin Greifswald Recruiting Greifswald, Germany Contact: Holger Lode, Prof.          Universitätsmedizin Göttingen Recruiting Göttingen, Germany Contact: Christof Kramm, Prof.          Universitätsklinikum Halle Recruiting Halle, Germany Contact: Toralf Bernig, Dr.          Universitätsklinikum des Saarlandes Recruiting Homburg, Germany Contact: Norbert Graf, Prof.          Gesundheit Nordhessen - Klinikum Kassel Recruiting Kassel, Germany Contact: Michaela Nathrath, Prof.          Universitätsklinikum Leipzig Recruiting Leipzig, Germany Contact: Holger Christiansen, Prof.          UMM Universitätsmedizin Mannheim Recruiting Mannheim, Germany Contact: Matthias Dürken, PD Dr.          Johannes Wesling Klinikum Minden Recruiting Minden, Germany Contact: Bernhard Erdlenbruch, Prof.          Universitätsklinikum Münster Recruiting Münster, Germany Contact: Ronald Sträter, PD Dr.          Klinikum Oldenburg gGmbH Recruiting Oldenburg, Germany Contact: Hermann Müller, Prof.          Universitätsklinikum Regensburg Recruiting Regensburg, Germany Contact: Marcus Jakob, Dr.          ASKLEPIOS Klinik St. Augustin Recruiting Sankt Augustin, Germany Contact: Harald Reinhard, PD Dr.          Klinikum Stuttgart - Olgahospital Recruiting Stuttgart, Germany Contact: Stefan Bielack, Prof.          Universitätsklinikum Tübingen Recruiting Tübingen, Germany Contact: Martin Ebinger, PD Dr. Less <<
NCT00685750 Lung Cancer, Non-Small Cell Not Applicable Terminated(Slow enrolment over... More >> the last 2 years with none in the past 1 year. No increase in the number of completed subjects for 1 year and no more ongoing study subjects) Less << - United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90025 United States, Illinois GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63110 United States, Utah GSK Investigational Site Murray, Utah, United States, 84107 France GSK Investigational Site Dijon, France, 21079 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Marseille, France, 13274 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris, France, 75012 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Mannheim, Baden-Wuerttemberg, Germany, 68167 GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Regensburg, Bayern, Germany, 93049 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Greifswald, Mecklenburg-Vorpommern, Germany, 17487 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Ostercappeln, Niedersachsen, Germany, 49179 GSK Investigational Site Hemer, Nordrhein-Westfalen, Germany, 58675 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 51109 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Berlin, Germany, 12200 GSK Investigational Site Hamburg, Germany, 20246 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Milano, Lombardia, Italy, 20141 GSK Investigational Site Siena, Toscana, Italy, 53100 GSK Investigational Site Padova, Veneto, Italy, 35128 Sweden GSK Investigational Site Göteborg, Sweden, SE-413 45 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-171 76 Less <<
NCT00004068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Tennessee ... More >> Saint Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT02943733 Neuroendocrine Tumors ... More >> Neoplasms Cancer Tumors Less << Phase 1 Recruiting August 2020 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu    Principal Investigator: Nataliya Uboha Less <<
NCT00099125 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - -
NCT00068250 - Completed - -
NCT00311584 Neuroblastoma Phase 2 Completed - -
NCT00311584 - Completed - -
NCT00387400 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00006263 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Withdrawn - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00077454 Previously Treated Childhood R... More >>habdomyosarcoma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma Less << Phase 1 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00404495 Glioma Medull... More >>oblastoma Less << Phase 2 Completed - Australia, New South Wales ... More >> Pfizer Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Pfizer Investigational Site Herston, Queensland, Australia, 4029 Australia, Victoria Pfizer Investigational Site Parkville, Victoria, Australia, 3052 Belgium Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus N, Denmark, 8200 Pfizer Investigational Site Koebenhavn OE, Denmark, 2100 France Pfizer Investigational Site Angers, France, 49000 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Lille, France, 59020 Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Paris, France, 75005 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Padova, Italy, 35100 Poland Pfizer Investigational Site Warszawa, Poland, 04-730 Spain Pfizer Investigational Site Esplugues de Llobregat, Barcelona, Spain, 08950 Pfizer Investigational Site El Palmar, Murcia, Spain, 30120 Pfizer Investigational Site Barcelona, Spain, 08035 Pfizer Investigational Site Madrid, Spain, 28009 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46026 United Kingdom Pfizer Investigational Site Soouthampton, Hampshire, United Kingdom, SO16 6YD Pfizer Investigational Site Birmingham, United Kingdom, B4 6NH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site Manchester, United Kingdom, M27 4HA Pfizer Investigational Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Pfizer Investigational Site Nottingham, United Kingdom, NG7 2UH Pfizer Investigational Site Sutton, United Kingdom, SM2 5PT Less <<
NCT00404495 - Completed - -
NCT00433459 Lymphoma Phase 3 Completed - Germany ... More >> Universitaetsklinikum Giessen-Marburg Giessen, Germany, D-35385 United Kingdom Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Less <<
NCT00068250 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville Beach, Florida, United States, 32250 Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207 Integrated Community Oncology Network at Southside Cancer Center Jacksonville, Florida, United States, 32207 Baptist Medical Center South Jacksonville, Florida, United States, 32258 Integrated Community Oncology Network - Orange Park Orange Park, Florida, United States, 32073 Florida Cancer Center - Palatka Palatka, Florida, United States, 32177 Flagler Cancer Center Saint Augustine, Florida, United States, 32086 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49001 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Bronson Methodist Hospital Kalamazoo, Michigan, United States, 49007 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Nevada CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey John F. Kennedy Medical Center Edison, New Jersey, United States, 08818 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oregon Providence Milwaukie Hospital Milwaukie, Oregon, United States, 97222 Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 Providence St. Vincent Medical Center Portland, Oregon, United States, 97225 United States, Pennsylvania Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Utah Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray, Utah, United States, 84157 Utah Valley Regional Medical Center - Provo Provo, Utah, United States, 84604 United States, Washington Southwest Washington Medical Center Cancer Center Vancouver, Washington, United States, 98668 United States, Wisconsin Community Memorial Hospital Cancer Care Center Menomonee Falls, Wisconsin, United States, 53051 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00027742 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00077207 Brain Tumor C... More >>entral Nervous System Tumor Less << Not Applicable Completed - United States, Pennsylvania ... More >> Childrens Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00521001 - Completed - -
NCT00527761 Metastatic Melanoma Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00077207 - Completed - -
NCT00521001 Melanoma (Skin) Phase 2 Completed - -
NCT00615186 Glioblastoma Multiforme Phase 3 Terminated(Due to delay in sit... More >>e initiation and funding considerations) Less << December 2013 -
NCT00553150 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00617539 Breast Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00553150 - Active, not recruiting - -
NCT00617539 - Completed - -
NCT00939991 Brain Tumor G... More >>lioblastoma Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00616005 Glioblastoma Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00939991 - Completed - -
NCT00086879 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 CHU Pitie-Salpetriere Paris, France, 75651 Institut Gustave Roussy Villejuif, France, F-94805 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Medisch Centrum Haaglanden 's-Gravenhage, Netherlands, 2501 CK University Medical Center Rotterdam at Erasmus Medical Center Rotterdam, Netherlands, 3000 CA United Kingdom Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT01022918 Naive Unresectable Glioblastom... More >>a Less << Phase 2 Completed - France ... More >> Centre Georges François Leclerc Dijon, Bourgogne, France, 21000 Less <<
NCT01110876 Brain Cancer ... More >>Glioblastoma Multiforme Less << Phase 1 Phase 2 Terminated(Unanticipated Toxic... More >>ities) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01182350 Diffuse Intrinsic Pontine Glio... More >>ma Less << Phase 2 Completed - -
NCT00026494 Metastatic Cancer Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00047294 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Virginia Cancer Center at the University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00512798 Brain and Central Nervous Syst... More >>em Tumors Melanoma Solid Tumor Less << Phase 1 Phase 2 Terminated(This study was term... More >>inated due to lack of efficacy) Less << - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT01062399 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00512798 - Terminated(This study was term... More >>inated due to lack of efficacy) Less << - -
NCT01062399 - Active, not recruiting - -
NCT00026494 - Completed - -
NCT00492687 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00544817 Glioblastoma Multiforme Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00525525 - Completed - -
NCT00525525 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Less <<
NCT00544817 - Completed - -
NCT00597493 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00068952 Glioblastoma Phase 3 Completed - -
NCT00602576 Melanoma (Skin) Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00639262 Brain Metastases ... More >> Primary Brain Tumors Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00072345 Intraocular Melanoma ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01435395 Glioblastoma Multiforme Phase 1 Completed - United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01543464 Malignant Melanoma Phase 2 Terminated(Diminished rectruit... More >>ment) Less << - Denmark ... More >> Trine Zeeberg Iversen Brønshøj, Copenhagen, Denmark, 2700 Less <<
NCT01505608 Neuroblastoma Phase 1 Phase 2 Terminated(Lack of Enrollment) - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States United States, California Rady Children's Hospital San Diego, California, United States, 92123 United States, Connecticut Connecticut Children's Hospital Hartford, Connecticut, United States, 06106 United States, Florida Arnold Palmer Hospital for Children- MD Anderson Orlando, Florida, United States, 32806 United States, Michigan Helen DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Missouri Children's Mercy Hospitals and Clinics Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Medical Center St. Louis, Missouri, United States, 63104 United States, North Carolina Levine Children's Hospital Charlotte, North Carolina, United States, 28204 Less <<
NCT01601535 Neuroblastoma Phase 1 Phase 2 Active, not recruiting December 2018 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 United States, Texas Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00734526 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00597493 - Completed - -
NCT01004874 Malignant Glioma ... More >> Glioblastoma Gliosarcoma Less << Phase 2 Active, not recruiting December 2018 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT01752491 Glioblastoma ... More >>GBM Glioblastoma Multiforme Less << Phase 1 Active, not recruiting December 31, 2021 United States, Iowa ... More >> Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT01505608 - Terminated(Lack of Enrollment) - -
NCT00200161 Glioblastoma ... More >>Gliomas Less << Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00200161 - Completed - -
NCT01004874 - Active, not recruiting - -
NCT01105702 - Terminated(Due to slow accrual... More >>) Less << - -
NCT01105702 Brain Cancer Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, New Jersey ... More >> Overlook Hospital Summit, New Jersey, United States, 07902 United States, New York New York University Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT01858168 Ewing Sarcoma Phase 1 Recruiting July 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Barbara Anderson, RN    617-724-4000    banderson@partners.org    Contact: Sienna Durbin, BS    617-724-4000       Principal Investigator: Edwin Choy, MD, PhD          Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Steven Dubois, MD    617-632-5460    Steven_Dubois@dfci.harvard.edu    Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN    617-582-7162    mhohos@partners.org    Contact: Mark Morley, RN    617-632-3989    mmorley@partners.org    Principal Investigator: George Demetri, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Melissa Hohos, RN    617-582-7162    mhohos@partners.org    Contact: Mark Morley, RN    617-632-3989    mmorley@partners.org    Principal Investigator: George Demetri, MD          United States, Tennessee St. Jude's Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sara Federico, MD    866-278-5833    sara.federico@stjude.org Less <<
NCT01186406 - Active, not recruiting - -
NCT01186406 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 2 Active, not recruiting January 2019 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States, 27710 Less <<
NCT00302159 High Grade Gliomas ... More >> Brain Tumors Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-6056 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23284 Less <<
NCT01196416 Recurrent Melanoma ... More >> Stage IV Skin Melanoma Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00302159 - Completed - -
NCT02248012 Neuroendocrine Carcinoma Phase 2 Unknown December 2018 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Halfdan Sorbye, Prof       halfdan.sorbye@helse-bergen.no    Principal Investigator: Halfdan Sorbye, MD Less <<
NCT00316849 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Florida ... More >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Iowa Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Capitol Des Moines, Iowa, United States, 50307 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Altru Cancer Center Grand Forks, North Dakota, United States, 58201 Less <<
NCT00383851 Melanoma Phase 2 Unknown September 2008 United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Pacific Oncology and Hematology Encinitas, California, United States, 92024 Hematology - Oncology Group of Orange, Inc. Orange, California, United States, 92868 UCI Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 The Angeles Clinic Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Health Science Center Denver, Colorado, United States, 80262 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Louisiana Hematology and Oncology Specialists, LLC Metairie, Louisiana, United States, 70006 United States, Maryland The Harry and Jeanette Weinberg Cancer Institute at Franklin Square Baltimore, Maryland, United States, 21237 Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Montana Billings Clinic Billings, Montana, United States, 59101 United States, New Jersey Mountainside Hospital Cancer Center - The Melanoma Center Montclair, New Jersey, United States, 07042 United States, Ohio Oncology Hematology Care Cincinati, Ohio, United States, 45242 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29605 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Less <<
NCT00437957 Brain Metastases Phase 1 Terminated(Lack of enrollment) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02287428 Glioblastoma ... More >>Gliosarcoma Glioblastoma With Oligodendroglial Features Giant Cell Glioblastoma Glioblastoma Multiforme MGMT-unmethylated Glioblastoma MGMT-methylated Glioblastoma GBM Less << Phase 1 Active, not recruiting August 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02113 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02455557 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Active, not recruiting May 30, 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00492141 Ewing's Sarcoma Phase 1 Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00576680 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00527657 Brain Neoplasms ... More >> Melanoma Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00588523 CNS Cancer CN... More >>S BRAIN Less << Phase 2 Active, not recruiting September 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center Commack, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00612651 Gliosarcoma G... More >>lioblastoma Anaplastic Astrocytoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT02831179 Functional Pancreatic Neuroend... More >>ocrine Tumor Malignant Somatostatinoma Merkel Cell Carcinoma Metastatic Adrenal Gland Pheochromocytoma Metastatic Carcinoid Tumor Multiple Endocrine Neoplasia Type 1 Multiple Endocrine Neoplasia Type 2A Multiple Endocrine Neoplasia Type 2B Neuroendocrine Neoplasm Non-Functional Pancreatic Neuroendocrine Tumor Pancreatic Glucagonoma Pancreatic Insulinoma Recurrent Adrenal Cortex Carcinoma Recurrent Adrenal Gland Pheochromocytoma Recurrent Merkel Cell Carcinoma Somatostatin-Producing Neuroendocrine Tumor Stage III Adrenal Cortex Carcinoma Stage III Thyroid Gland Medullary Carcinoma Stage IIIA Merkel Cell Carcinoma Stage IIIB Merkel Cell Carcinoma Stage IV Adrenal Cortex Carcinoma Stage IV Merkel Cell Carcinoma Stage IVA Thyroid Gland Medullary Carcinoma Stage IVB Thyroid Gland Medullary Carcinoma Stage IVC Thyroid Gland Medullary Carcinoma Thymic Carcinoid Tumor VIP-Producing Neuroendocrine Tumor Well Differentiated Adrenal Cortex Carcinoma Zollinger Ellison Syndrome Less << Phase 1 Withdrawn(Loss of funding supp... More >>ort) Less << February 2020 -
NCT00715793 Malignant Melanoma Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03119064 Glioblastoma Multiforme ... More >> Glioblastoma GBM Less << Phase 1 Phase 2 Recruiting July 2020 United States, Rhode Island ... More >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Heinrich Elinzano, MD Less <<
NCT01196416 - Completed - -
NCT00715793 - Completed - -
NCT03139331 Sarcoma Phase 1 Recruiting November 30, 2019 United States, California ... More >> UCSF Benioff Children's Hospital, Oakland Recruiting Oakland, California, United States, 94609 Contact: Jennifer Michlitsch, MD    510-428-3372    jmichlitsch@mail.cho.org    Principal Investigator: Jennifer Michlitsch, MD          UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94158 Contact: Kieuhoa Vo, MD, MAS    415-476-3831    kieuhoa.vo@ucsf.edu    Principal Investigator: Kieuhoa Vo, MD, MAS          United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD    617-632-5640    steve_dubois@dfci.harvard.edu    Principal Investigator: Steven DuBois, MD Less <<
NCT01765088 Anaplastic Oligoastrocytoma ... More >> Anaplastic Astrocytoma Glioblastoma Less << Phase 3 Recruiting December 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhong-ping Chen, MD,PhD    +86-20-87343310    chenzhp@sysucc.org.cn    Contact: Cheng-cheng Guo, MD,PhD    +86-20-87343656    guochch@sysucc.org.cn    Principal Investigator: Zhong-ping Chen, MD,PhD Less <<
NCT00887146 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Recruiting - -
NCT02023905 Low Grade Glioma ... More >> WHO Grade II Astrocytomas Oligodendrogliomas Mixed Oligoastrocytomas Less << Phase 2 Recruiting January 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143-0372 Contact: Jennifer Clarke, MD, MPH    415-353-2966    Jennifer.Clarke@ucsf.edu    Contact: Tiffany Jones    415-353-9641    Tiffany.Jones@ucsf.edu    Principal Investigator: Jennifer Clarke, MD Less <<
NCT01860638 Glioblastoma Phase 2 Completed - -
NCT00946335 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Tennessee ... More >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Less <<
NCT03189706 Neuroblastoma (NB) Early Phase 1 Recruiting June 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Shakeel Modak, MD    212-639-7623       Contact: Brian Kushner, MD    212-639-6793       Principal Investigator: Shakeel Modak Less <<
NCT02052648 Glioblastoma Multiforme ... More >> Glioma Gliosarcoma Malignant Brain Tumor Less << Phase 1 Phase 2 Active, not recruiting October 2018 United States, California ... More >> Eden Medical Center Castro Valley, California, United States, 94546 Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UC Irvine Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia University Cancer and Blood Center Athens, Georgia, United States, 30607 Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30342 Georgia Regents University Augusta, Georgia, United States, 30912 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky University of Kentucy Lexington, Kentucky, United States, 40536 United States, Minnesota John Nasseff Neuroscience Institute Minneapolis, Minnesota, United States, 55407 United States, New Mexico University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States, 87131 United States, North Carolina Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Texas Texas Oncology Austin, Texas, United States, 78705 United States, Utah Huntsman Cancer Center Salt Lake City, Utah, United States, 84112 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 Less <<
NCT03359005 Ewing Sarcoma Phase 2 Recruiting February 28, 2025 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu    86 15901040835    xujie_pkuph@sina.com    Principal Investigator: Wei Guo, M.D., Ph.D. Less <<
NCT01062425 Adult Glioblastoma ... More >> Adult Gliosarcoma Less << Phase 2 Active, not recruiting - -
NCT00994071 Medulloblastoma ... More >> Pontine Glioma Ependymoma Astrocytoma PNET Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02311920 Gliosarcoma S... More >>upratentorial Glioblastoma Less << Phase 1 Active, not recruiting - United States, California ... More >> UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Cancer Center/Fairview Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01062425 - Active, not recruiting - -
NCT02599090 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Withdrawn(Multi phase study di... More >>d not progress to Phase II. Phase I registered as NCT00734526.) Less << - -
NCT03709680 Solid Tumors ... More >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma Less << Phase 1 Not yet recruiting September 27, 2023 -
NCT01085422 Prostate Cancer Phase 1 Completed - -
NCT02617589 Brain Cancer Phase 3 Recruiting October 1, 2019 -
NCT01051596 Colorectal Cancer Phase 2 Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20008 Less <<
NCT02667587 Brain Neoplasms Phase 3 Recruiting August 1, 2023 -
NCT01514201 Anaplastic Astrocytoma ... More >> Brain Stem Glioma Childhood Mixed Glioma Fibrillary Astrocytoma Giant Cell Glioblastoma Glioblastoma Gliosarcoma Untreated Childhood Anaplastic Astrocytoma Untreated Childhood Brain Stem Glioma Untreated Childhood Fibrillary Astrocytoma Untreated Childhood Giant Cell Glioblastoma Untreated Childhood Glioblastoma Untreated Childhood Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01735747 Central Nervous System Tumors Phase 2 Unknown November 2013 China, Shandong ... More >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT01777919 Glioblastoma Multiforme Phase 2 Not yet recruiting January 2020 Greece ... More >> Olympion Medical Center Not yet recruiting Patras, Greece, 26443 Contact: Petros N Karamanakos, MD, PhD          Principal Investigator: Petros N Karamanakos, MD, PhD Less <<
NCT03425292 Newly Diagnosed Glioblastoma Phase 1 Recruiting February 1, 2020 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jaya Gill, RN    310-582-7437    jaya.gill@providence.org    Principal Investigator: Santosh Kesari, MD, PhD Less <<
NCT03128047 High Grade Glioma Phase 1 Recruiting February 2019 United States, New Jersey ... More >> Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh, APN    551-996-3457    jeanette.haugh@hackensackmeridian.org Less <<
NCT02116777 Adult Solid Neoplasm ... More >> Childhood Solid Neoplasm Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Central Nervous System Neoplasm Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Less << Phase 1 Phase 2 Active, not recruiting - -
NCT03728361 Grade I Neuroendocrine Carcino... More >>ma Grade II Neuroendocrine Carcinoma Grade III Neuroendocrine Carcinoma Metastatic Neuroendocrine Carcinoma Neuroendocrine Carcinoma Recurrent Small Cell Lung Carcinoma Refractory Small Cell Lung Carcinoma Lung Cancer Stage IV Large Cell Neuroendocrine Carcinoma Neuroendocrine Tumors Small Cell Lung Cancer Metastatic Small-cell Lung Cancer Less << Phase 2 Not yet recruiting December 31, 2021 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Dwight H. Owen, MD, MS    614-685-2039    Dwight.owen@osumc.edu    Principal Investigator: Dwight H. Owen, MD, MS Less <<
NCT02378532 Glioblastoma Multiforme Phase 1 Recruiting June 2019 Netherlands ... More >> Maastricht Radiation Oncology Recruiting Maastricht, Netherlands, 6202 AZ Less <<
NCT02715609 Glioblastoma Multiforme Phase 1 Phase 2 Suspended(Waiting to see if a ... More >>dose expansion phase will be added) Less << February 28, 2022 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03204019 Pancreatic Neuroendocrine Tumo... More >>r Less << Phase 2 Recruiting September 2018 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi       yihebalichi@yahoo.com.cn Less <<
NCT01590082 Melanoma Phase 1 Phase 2 Terminated(Accrual slow due to... More >> alternate trials and treatment options.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03174197 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Phase 2 Recruiting June 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Shiao-Pei S. Weathers    713-792-2883       Principal Investigator: Shiao-Pei S. Weathers Less <<
NCT03204032 Extrapancreatic Neuroendocrine... More >> Tumor Less << Phase 2 Recruiting September 2018 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Yihebali Chi, doctor       yihebalichi@yahoo.com.cn Less <<
NCT03363659 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 2 Recruiting January 21, 2027 United States, Wisconsin ... More >> Aurora Health Care, Aurora St. Luke's Medical Center Recruiting Milwaukee, Wisconsin, United States, 53215 Contact: Lynda Yanny    414-649-6685    lynda.yanny@aurora.org    Principal Investigator: George Bobustuc, MD          Sub-Investigator: Richard A Rovin, MD          Sub-Investigator: Asad Khan, MD          Sub-Investigator: Amin Kassam, MD          Sub-Investigator: Santhi Konduri, PhD Less <<
NCT03150862 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Recruiting October 31, 2021 -
NCT01907165 Glioblastoma Early Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00096265 Metastatic Malignant Neoplasm ... More >>in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Terminated - -
NCT00137774 Neuroendocrine Tumors Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00096265 - Terminated - -
NCT00003747 Melanoma (Skin) Phase 1 Unknown - United Kingdom ... More >> Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Less <<
NCT00187486 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 2 Completed - United States, California ... More >> UCSF Department of Neurological Surgery San Francisco, California, United States, 94143-0372 Less <<
NCT00049595 Lymphoma Phase 3 Active, not recruiting - -
NCT00147160 Glioma Phase 2 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 United Kingdom Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8BJ Less <<
NCT00187486 - Completed - -
NCT00268684 Carcinoma, Non-Small-Cell Lung... More >> Neoplasm Metastasis Less << Phase 3 Unknown - Israel ... More >> Tel Aviv Sourasky Medical Center Recruiting Tel Aviv, Israel, 63409 Contact: Felix Bokstein, M.D.    972-524266532    fbok@netvision.net.il    Contact: Debora Blumenthal, M.D.    972-524266403    dvorab@tasmc.gov.il Less <<
NCT00303940 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00165230 Neuroendocrine Tumor Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconness Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00274833 CNS Tumor, Adult Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00311857 Glioblastoma Multiforme Phase 1 Phase 2 Unknown - Germany ... More >> University of Heidelberg Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Daniela Schulz-Ertner, MD    +49-6221-56 ext 8201    Daniela.Ertner@med.uni-heidelberg.de    Contact: Stephanie E Combs, MD    +49-6221-56 ext 8201    Stephanie.Combs@med.uni-heidelberg.de    Principal Investigator: Daniela Schulz-Ertner, MD          Sub-Investigator: Stephanie E Combs, MD Less <<
NCT00360945 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Middlesex Hospital London, England, United Kingdom, W1T 3AA Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00385398 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Withdrawn(lack of funding and ... More >>drug supply) Less << - -
NCT00362817 Brain Tumor B... More >>rain Metastases Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00805961 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00970996 Melanoma Phase 1 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00505635 Melanoma Phase 2 Terminated(Slow accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00433381 - Completed - -
NCT00612638 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00362817 - Completed - -
NCT00505635 - Terminated(Slow accrual) - -
NCT01767194 Ganglioneuroblastoma ... More >> Recurrent Neuroblastoma Less << Phase 2 Completed - -
NCT01014767 Brain Cancer ... More >>Choroid Plexus Tumors Less << Phase 3 Suspended(PI departure from co... More >>ordinating institution) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT01217437 Recurrent Childhood Medullobla... More >>stoma Recurrent Childhood Pineoblastoma Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified Less << Phase 2 Active, not recruiting - -
NCT00433381 Adult Glioblastoma ... More >> Adult Gliosarcoma Recurrent Adult Brain Neoplasm Less << Phase 2 Completed - -
NCT00786669 Solid Tumor Phase 1 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01467986 Neuroblastoma Recurrent Phase 2 Recruiting December 2019 Germany ... More >> University Hospital Regensburg, Department of Pediatric Hematology and Oncology Recruiting Regensburg, Germany, 93053 Contact: Selim Corbacioglu, MD    +49(0)941 944-2101    selim.corbacioglu@ukr.de    Principal Investigator: Selim Corbacioglu, MD Less <<
NCT00749723 Recurrent Brain Tumors ... More >> Supratentorial PNETs Medulloblastomas Ependymomas Less << Phase 2 Phase 3 Completed - -
NCT02203526 Primary Central Nervious Syste... More >>m Lymphoma Less << Phase 1 Recruiting June 15, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00248534 - Terminated(slow accrual/lack o... More >>f resources/low priority due to combining 2 consortia) Less << - -
NCT02015728 Recurrent Childhood Brain Tumo... More >>r Less << Not Applicable Unknown December 2017 United States, Washington ... More >> Seattle Children's Seattle, Washington, United States, 98105 Less <<
NCT01236560 Brain Stem Glioma ... More >> Cerebral Astrocytoma Childhood Cerebellar Anaplastic Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Spinal Cord Neoplasm Untreated Childhood Brain Stem Glioma Untreated Childhood Cerebral Astrocytoma Less << Phase 2 Phase 3 Completed - -
NCT00884741 Glioblastoma ... More >>Gliosarcoma Supratentorial Glioblastoma Less << Phase 3 Completed - -
NCT00248534 Lymphoma Phase 2 Terminated(slow accrual/lack o... More >>f resources/low priority due to combining 2 consortia) Less << - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT02595424 Gastric Neuroendocrine Carcino... More >>ma Intestinal Neuroendocrine Carcinoma Pancreatic Neuroendocrine Carcinoma Less << Phase 2 Recruiting January 1, 2029 -
NCT00884741 - Completed - -
NCT03607643 Cancer of Pancreas ... More >> Cancer of Liver Cancer of Rectum Cancer of Colon Cancer, Gall Bladder Myeloma Multiple Glioblastoma Multiforme Less << Phase 1 Phase 2 Not yet recruiting December 15, 2020 United States, Florida ... More >> Southwest Cancer Center Not yet recruiting Orlando, Florida, United States, 32806 Contact: Sarah Katta, DO    407-426-8660    sarahfk1978@yahoo.com    Contact: Philip Arlen, PhD    407-443-0656    parlen@leafvertical.com Less <<
NCT01055314 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Metastatic Childhood Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT01837862 Pilomyxoid Astrocytoma ... More >> Pilocytic Astrocytoma Glioma, Astrocytic Optic Nerve Glioma Pleomorphic Xanthoastrocytoma Glioblastoma Multiforme Anaplastic Astrocytoma Gliosarcoma Diffuse Intrinsic Pontine Glioma DIPG Low-grade Glioma Brainstem Glioma Less << Phase 1 Phase 2 Recruiting April 2020 United States, New York ... More >> Cohen Children's Medical Center of New York Recruiting New Hyde Park, New York, United States, 11040 Contact: Mark P Atlas, MD    718-470-3460    matlas@nshs.edu    Contact: Derek R Hanson, MD    551-996-5437    DHanson@hackensackumc.org    Principal Investigator: Mark P Atlas, MD          Sub-Investigator: Derek R Hanson, MD          Sub-Investigator: Arlene Redner, MD          Sub-Investigator: Mohamad Badawi, MD          Sub-Investigator: Avery Wright, DO Less <<
NCT03495960 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Not yet recruiting October 31, 2023 Italy ... More >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD          Principal Investigator: Benjamin Kasenda          IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland Less <<
NCT01525082 Gastrinoma Gl... More >>ucagonoma Insulinoma Pancreatic Polypeptide Tumor Recurrent Islet Cell Carcinoma Recurrent Pancreatic Cancer Somatostatinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Active, not recruiting July 2019 United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Florida Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01313884 Bone Cancer E... More >>wing's Sarcoma Less << Phase 2 Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01055314 - Completed - -
NCT01864109 Newly Diagnosed Ewing Sarcoma Phase 2 Recruiting May 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Paul Meyers, MD    212-639-5952       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul Meyers, MD    212-639-5952       Contact: Emily Slotkin, MD    212-639-8856       Principal Investigator: Paul Meyers, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Paul Meyers, MD    212-639-5952 Less <<
NCT02770378 Glioblastoma Phase 1 Active, not recruiting March 2020 Germany ... More >> University of Ulm School of Medicine Ulm, Baden-Württemberg, Germany, 89081 Less <<
NCT01313884 - Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - -
NCT00626405 - Completed - -
NCT00613028 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00626405 Melanoma (Skin) Phase 2 Completed - -
NCT00613028 - Completed - -
NCT01284335 Advanced Solid Tumors Phase 1 Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35233 United States, Arkansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States, 72703 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States, 32806 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Park Ridge, Illinois, United States, 60068 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89169 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albany, New York, United States, 12206 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45429 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75246 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spokane, Washington, United States, 99218 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, Washington, United States, 98684 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Less <<
NCT01506609 Metastatic Breast Cancer Phase 2 Active, not recruiting May 30, 2019 -
NCT01284335 - Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - -
NCT00504660 Anaplastic Glioma of Brain ... More >> Glioblastoma Multiforme Brain Cancer Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00504660 - Completed - -
NCT01189643 Sarcoma Desmo... More >>plastic Small Round Cell Tumor (DSRCT) Less << Early Phase 1 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00503594 Lymphoma Phase 2 Unknown July 2012 France ... More >> Groupe hospitalier la Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Antonio OMURO, MD,PhD    + 33(0) 1 42 16 41 60    antonio.omuro@psl.aphp.fr Less <<
NCT01891747 Malignant Glioma Phase 1 Active, not recruiting March 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00528437 Brain Tumors Phase 2 Active, not recruiting July 2019 United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Hawaii Hawaii Pacific Health Lihue, Hawaii, United States, 96766 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Minnesota Children's Hospital and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Steven and Alexandra Cohen Children's Medical Center of New York- North Shore LIJ New Hyde Park, New York, United States, 11040 NYU Hassenfeld Center New York, New York, United States, 10016 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical Univ. of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt Univ. Nashville, Tennessee, United States, 37240 United States, Texas Children's Medical Center of Dallas Dallas, Texas, United States, 75235 MD Anderson Cancer Center (MDACC) Houston, Texas, United States, 77030 United States, Virginia Virginia Commonwealth Univ. Richmond, Virginia, United States, 23284 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00993044 - Completed - -
NCT01141244 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT01528046 Solid Tumors ... More >>Primary Brain Tumors Less << Phase 1 Recruiting December 2020 United States, Connecticut ... More >> Connecticut Children's Medical Center Recruiting Hartford, Connecticut, United States, 06106 Contact: Robin Arens    860-545-9637    Rarens@ccmckids.org    Principal Investigator: Michael Isakoff, M.D.          Sub-Investigator: Donna Boruchov, M.D.          Sub-Investigator: Kerry Moss, M.D.          Sub-Investigator: Andrea Orsey, M.D.          Sub-Investigator: Nehal Parikh, M.D.          Sub-Investigator: Arnold Altman, M.D.          United States, Delaware Nemours/Alfred I. duPont Hospital for Children, Delaware Recruiting Wilmington, Delaware, United States, 19803 Contact: Debra J. Bertz    302-651-5757    debra.bertz@nemours.org    Principal Investigator: Edward A. Kolb, M.D.          Sub-Investigator: Andrew Walter, M.D.          Sub-Investigator: Jonathan Powell, M.D.          Sub-Investigator: Emi Caywood, M.D.          Sub-Investigator: Robin Miller, M.D.          Sub-Investigator: Gregory Griffin, M.D.          United States, Florida University of Florida Terminated Gainesville, Florida, United States, 32611 Nemours Children's Clinic Recruiting Jacksonville, Florida, United States, 32207 Contact: Ingrid Ingram    904-697-3985    iingram@nemours.org    Principal Investigator: Scott Bradfield, M.D.          Sub-Investigator: Eric Sandler, M.D.          Sub-Investigator: Michael Joyce, M.D.          Sub-Investigator: Cynthia Gauger, M.D.          Sub-Investigator: Manisha Bansal, M.D.          Sub-Investigator: Paul Pitel, M.D.          Holtz Children's Hospital at the University of Miami Recruiting Miami, Florida, United States, 33124 Contact: Myriam Zayas    305-243-7846    MZayas2@med.miami.edu    Principal Investigator: John Goldberg, M.D.          Sub-Investigator: Cristina Fernandes, M.D.          Sub-Investigator: Joanna Davis, M.D.          Sub-Investigator: Antonello Podda, M.D.          Sub-Investigator: Martin Andreansky, M.D.          Sub-Investigator: Julio Barredo, M.D.          Sub-Investigator: Ofelia Alvarez, M.D.          Johns Hopkins All Children's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Ashley Repp, RN    727-767-4784    Ashley.Repp@allkids.org    Contact: Frances Hamblin    727-767-2423    frances.hamblin@allkids.org    Principal Investigator: Damon Reed, M.D.          Sub-Investigator: Irmel Ayala, M.D.          Sub-Investigator: Gregory Hale, M.D.          Sub-Investigator: Nanette Grana, M.D.          Sub-Investigator: Stacie Stapleton, M.D.          Sub-Investigator: Kelly Sawczyn, M.D.          Sub-Investigator: Jennifer Mayer, M.D.          Sub-Investigator: Jody Kerr, M.D.          Tampa General Hospital Recruiting Tampa, Florida, United States, 33606 Contact: Denise Fife    813-844-7829    dafife@tgh.org    Principal Investigator: Cameron Tebbi, M.D.          H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Tiffany Smith    813-745-6250    tiffany.smith@moffitt.org    Principal Investigator: Damon Reed, M.D.          United States, Kentucky University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Tammy Taylor    859-323-6975    tammy.taylor@uky.edu    Principal Investigator: Lars Wagner, M.D.          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: David Loeb, M.D.    410-502-7247    loebda@jhmi.edu    Principal Investigator: David Loeb, M.D.          United States, New York The Children's Hospital at Montefiore Recruiting Bronx, New York, United States, 10467 Contact: Noam Zeffren    718-741-2356    nzeffren@montefiore.org    Principal Investigator: Jonathan Gill, M.D.          United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Sharon Guerry    919-966-1178       Contact: Patrick Thompson, M.D    919-966-1178    patom@email.unc.edu    Principal Investigator: Patrick Thompson, M.D.          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Amy Yekisa    614-722-6570    Amy.Yekisa@nationwidechildrens.org    Principal Investigator: Bhuvana Setty, M.D.          United States, Utah Primary Children's Medical Center/Utah Recruiting Salt Lake City, Utah, United States, 84113 Contact: Melissa Bolton    801-213-3909    melissa.bolton@hsc.utah.edu    Principal Investigator: Holly Spraker-Perlman, M.D.          Sub-Investigator: Richard Lemons, M.D., Ph.D.          Sub-Investigator: Jennifer Wright, M.D. Less <<
NCT02044120 Ewing Sarcoma Phase 1 Active, not recruiting April 2021 United States, California ... More >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48106 United States, Washington Seattle's Children Cancer Center Seattle, Washington, United States, 98101 United Kingdom University College London Hospital London, United Kingdom, W1T 7HA Less <<
NCT02308527 Neuroblastoma Phase 2 Recruiting January 2022 Austria ... More >> St Anna Children's Hospital and CCRI/Studies and Statistics Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43 1 40470 4750    ruth.ladenstein@ccri.at    Principal Investigator: Ruth Ladenstein, MD          Denmark University Hospital Rigshospitalet Recruiting Copenhagen, Denmark, DK-2100 Contact: Karsten Nysom, MD    45 35 45 08 09    Karsten.Nysom@regionh.dk    Principal Investigator: Karsten Nysom, MD          France Hopital des Enfants Recruiting Toulouse, France, 31059 Contact: Herve Rubie, MD    33 534 55 86 11    rubie.h@chu-toulouse.fr    Principal Investigator: Herve Rubie, MD          Ireland Our Ladys Children's Hospital Dublin Recruiting Dublin, Ireland, Dublin 12 Contact: Cormac Owens, MD    35 31 409 6659    cormac.owens@olchc.ie    Principal Investigator: Cormac Owens, MD          Italy Ospedale Pediatrico Bambino Gseu Recruiting Rome, Italy, 00165 Contact: Aurora Castellano, MD       aurora.castellano@opbg.net    Principal Investigator: Aurora Castellano, MD          Spain Instituto de Investigacion Sanitaria Recruiting Valencia, Spain, 46026 Contact: Victoria Castel, MD    34 963 862 758    castel_vic@gva.es    Principal Investigator: Victoria Castel, MD          Switzerland Swiss Paediatric Oncology Group Recruiting Bern, Switzerland, 3008 Contact: Nicolas Gerber    +41 (0)31 508 42 38    'nicolas.gerber@kispi.uzh.ch'    Contact: TuMy DiepLai    +41 (0)31 508 42 38    Tu-My.Diep@spog.ch    Principal Investigator: Nicolas Gerber`          United Kingdom The Royal Marsden NHS Foundation Trust and Institute of Cancer Research Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Andrew DJ Pearson, MD          Contact: Lucas Moreno, MD          Principal Investigator: Andrew DJ Pearson, MD Less <<
NCT02049593 Metastatic Cancer ... More >> Unspecified Adult Solid Tumor Less << Phase 1 Active, not recruiting June 30, 2019 United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT00993044 Refractory Solid Tumors in Chi... More >>ldren Less << Phase 1 Completed - United States, California ... More >> Childrens Hospital los Angeles Los angeles, California, United States, 90027 Less <<
NCT02392793 Childhood Solid Tumors Phase 1 Recruiting March 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sara M. Federico, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Sara M. Federico, MD Less <<
NCT02975882 Childhood Solid Neoplasm ... More >> Recurrent Central Nervous System Neoplasm Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Malignant Solid Neoplasm Less << Phase 1 Recruiting June 3, 2020 -
NCT02740920 Metastatic Melanoma Phase 2 Recruiting December 2019 Canada, Ontario ... More >> Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Tara Baetz    613 544-2630       London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Donald Scott Ernst    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Michael Ong    613 737-7700 ext 75051       Odette Cancer Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Teresa M. Petrella    416 480-4662       Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Mussawar Iqbal    306 766-2691 Less <<
NCT03149575 Glioblastoma Multiforme ... More >> Glioblastoma Glioma GBM Brain Cancer Less << Phase 3 Active, not recruiting August 2019 United States, California ... More >> Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 University of California, San Francisco - Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Atlantic Neuroscience Institute - Brain Tumor Center of NJ Summit, New Jersey, United States, 07901 United States, New York Dent Neurosciences Research Center Amherst, New York, United States, 14226 Less <<
NCT00249964 Lung Diseases ... More >> Cancer Less << Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Less <<
NCT00138216 Brain and Central Nervous Syst... More >>em Tumors Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Oregon Health and Science University Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Lehigh Valley Hospital - Muhlenberg Bethlehem, Pennsylvania, United States, 18107 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-9786 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT00409383 Melanoma Phase 1 Unknown June 2013 United States, New York ... More >> New York University Cancer Center New York, New York, United States, 10016 Less <<
NCT01149850 Giant Cell Glioblastoma ... More >> Glioblastoma Gliosarcoma Less << Phase 2 Active, not recruiting January 1, 2019 United States, California ... More >> Kaiser Foundation Hospital Los Angeles, California, United States, 90027 University of California, Los Angeles Los Angeles, California, United States, 90095 Kaiser Permanente at San Diego San Diego, California, United States, 92120 Less <<
NCT03495921 Ewing Sarcoma ... More >> Ewing Family of Tumors Ewing's Tumor Metastatic Ewing's Sarcoma Metastatic Less << Phase 3 Recruiting July 1, 2022 United States, Arkansas ... More >> Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Catherine Redinger, RN    501-364-4290    RedingerCatherineL@uams.edu    United States, Florida Mayo Clinic Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO    904-953-7292    Attia.Steven@mayo.edu    Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Coraly Diaz-Gamboa, BS    786-624-2853    coraly.diaz@NicklausHealth.org    United States, Massachusetts Dana-Farber/Boston Children's Cancer and Blood Disorders Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD    617-632-5460    Steven_Dubois@dfci.harvard.edu    United States, Missouri Washington University Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Michele Landeau    314-747-9488    landeaum@wustl.edu    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Dara Herman       schwamd@mskcc.org    Contact: Leonard H. Wexler, MD    212-639-7990       Principal Investigator: Leonard H. Wexler, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact    513-636-2799    cancer@cchmc.org    Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Peter Anderson, MD    216-445-4044    andersp@ccf.org    Contact: Stacey Zahler, MD    216-445-3588    zahlers@ccf.org    United States, Pennsylvania Fox Chase Cancer Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Sujana Movva, MD    215-728-4300    Sujana.Movva@fccc.edu    United States, Texas Texas Oncology - Pediatrics Recruiting Dallas, Texas, United States, 75230 Contact: Maurizio Ghisoli, MD    972-566-6647    Maurizio.Ghisoli@usoncology.com Less <<
NCT00093353 Diarrhea Drug... More >>/Agent Toxicity by Tissue/Organ Neuroblastoma Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0718 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT02502708 Glioblastoma Multiforme ... More >> Glioma Gliosarcoma Malignant Brain Tumor Ependymoma Medulloblastoma Diffuse Intrinsic Pontine Glioma Primary CNS Tumor Less << Phase 1 Recruiting December 2019 United States, Georgia ... More >> Children's Heathcare of Atlanta Recruiting Atlanta, Georgia, United States, 30342 Contact: Amy Autry-Bush    404-785-6011    amy.autry-bush@choa.org    Principal Investigator: Tobey MacDonald, MD          Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Robin Dobbins    706-721-2154    RDOBBINS@augusta.edu    Principal Investigator: Theodore Johnson, MD Less <<
NCT00568451 - Terminated(Slow accrual.) - -
NCT00597402 Glioblastoma ... More >>Gliosarcoma Brain Tumor Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00597402 - Completed - -
NCT00805961 - Completed - -
NCT00876993 Central Nervous System Tumors Phase 1 Completed - United States, Florida ... More >> Johns Hopkins All Children's Hospital Saint Petersburg, Florida, United States, 33701 Less <<
NCT00568451 Melanoma (Skin) Phase 2 Terminated(Slow accrual.) - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00979017 Glioblastoma Multiforme ... More >> Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00979017 - Completed - -
NCT00890786 Newly Diagnosed High-Grade Gli... More >>omas Diffuse Intrinsic Pontine Glioma Less << Early Phase 1 Completed - United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60614 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00014261 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New Hampshire ... More >> Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756-0002 Less <<
NCT01009515 - Terminated(Low accrual; target... More >> accrual not met) Less << - -
NCT01113957 Ovarian Cancer Phase 2 Completed - -
NCT01114555 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01355445 RHABDOMYOSARCOMA Phase 2 Active, not recruiting September 2023 France ... More >> Centre Hospitalier Universitaire Nord Amiens, France, 80000 Hôpital des Enfants, Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU Morvan Brest, France CHU Estaing Clermont ferrand, France, 63003 Centre Oscar Lambret Lille cedex, France, 59020 Centre Léon Bérard Lyon, France CHU, Hôpital d'Enfants de la Timone Marseille, France Hôpital Arnaud de Villeneuve - CHU Montpellier, France CHU, Hôpital Mère enfants Nantes, France Hôpital Armand Trousseau Paris, France Institut Curie Paris, France Hôpital Jean Bernard Poitiers, France CHU - Hôpital Américain Reims, France CHU Rennes - Hôpital Sud Rennes, France CHU St Etienne - Hôpital Nord Saint-Etienne, France Hôpital de Hautepierre Strasbourg, France Hôpital des enfants Toulouse, France CHRU Tours, France CHRU Hôpital d'Enfants Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France Less <<
NCT00052455 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00525031 Melanoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00817284 Glioblastoma Multiforme Phase 2 Completed - Denmark ... More >> Rigshospitalet Copenhagen, Denmark Odense Hospital Odense, Denmark Århus Hospital Århus, Denmark Less <<
NCT00525031 - Completed - -
NCT00112502 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Florida University of Texas MD Anderson Cancer Center at Orlando Orlando, Florida, United States, 32806-2134 United States, Georgia CCOP - Atlanta Regional Atlanta, Georgia, United States, 30342-1701 United States, Illinois CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Grand Rapids Grand Rapids, Michigan, United States, 49503 CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, South Carolina CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02065466 Metastatic Melanoma ... More >> Brain Metastases Less << Phase 1 Phase 2 Withdrawn(lack of accrual) - United States, Arizona ... More >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 University of Arizona Cancer Center Tucson, Arizona, United States, 85742 Less <<
NCT00003567 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(slow accrual) - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00262730 - Completed - -
NCT00390403 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01430351 Brain Cancer Phase 1 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00555399 Glioblastoma Multiforme ... More >> Anaplastic Glioma Less << Phase 1 Phase 2 Active, not recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01478321 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Ependymoma Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Less << Phase 2 Active, not recruiting November 2020 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 Northwestern Lake Forest Hospital Lake Forest, Illinois, United States, 60045 Edward Cancer Center Naperville, Illinois, United States, 60540 Central Dupage Hospital Warrenville, Illinois, United States, 60555 Less <<
NCT00925132 Metastatic Melanoma Phase 1 Phase 2 Terminated(Change in the numbe... More >>r of approved drugs for metastatic melanoma) Less << - United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT00262730 Glioblastoma Multiforme Phase 2 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT03323034 Recurrent Central Nervous Syst... More >>em Neoplasm Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Refractory Central Nervous System Neoplasm Refractory Lymphoma Refractory Malignant Solid Neoplasm Less << Phase 1 Recruiting December 1, 2021 -
NCT01019434 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Belgium ... More >> UZ Leuven Leuven, Belgium France Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Nantes-Saint Herblain, France, 44805 CHU Pitie-Salpetriere AP-HP Paris, France, FR 75651 Germany Universitaetsklinikum Freiburg Freiburg, Germany, DE 79106 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Italy Ospedale Bellaria Bologna, Italy, I-40139 Netherlands Medisch Centrum Haaglanden - Westeinde Den Haag, Netherlands, NL 2501 Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands, NL 3008 Spain ICO Badalona - Hospital Germans Trias i Pujol Badalona, Spain, ES 08916 Switzerland Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 United Kingdom Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom Western General Hospital Edinburgh, United Kingdom Less <<
NCT01009515 Melanoma Phase 2 Terminated(Low accrual; target... More >> accrual not met) Less << - United States, New Mexico ... More >> Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 The Cancer Center at Presbyterian Albuquerque, New Mexico, United States, 87110 Less <<
NCT03387592 Neuroendocrine Carcinoma Phase 2 Recruiting January 2021 Italy ... More >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Recruiting Meldola, FC, Italy, 47014 Contact: Toni Ibrahim, MD    0543739100    toni.ibrahim@irst.emr.it    Principal Investigator: Toni Ibrahim, MD          Sub-Investigator: Albero Bongiovanni, MD          Istituto Nazionale Tumori Milano Recruiting Milano, MI, Italy Contact: Sara Pusceddu          Azienda Ospedaliera-Universitaria di Modena Recruiting Modena, MO, Italy Contact: Gabriele Luppi, MD          Ospedale Civile degli Infermi Recruiting Faenza, RA, Italy Contact: Stefano Tamberi          Ospedale di Bolzano Recruiting Bolzano, Italy Contact: Giovanni Di Meglio, MD          IRCCS "Saverio De Bellis" Recruiting Castellana Grotte, Italy Contact: Ivan Lolli          Ospedale "Vito Fazzi" Recruiting Lecce, Italy Contact: Silvana Leo          Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Francesca Bergamo, MD          Azienda Ospedaliera-Universitaria di Parma Recruiting Parma, Italy Contact: Francesca Pucci, MD          Ospedale S.Chiara - AOU Pisana Recruiting Pisa, Italy Contact: Sergio Ricci, MD Less <<
NCT00925132 - Terminated(Change in the numbe... More >>r of approved drugs for metastatic melanoma) Less << - -
NCT01450826 Nausea Vomiti... More >>ng Glioma Less << Phase 2 Completed - United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT02414165 Glioblastoma Multiforme ... More >> Anaplastic Astrocytoma Less << Phase 2 Phase 3 Active, not recruiting March 2023 -
NCT00662506 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01480050 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00038493 Glioblastoma Multiforme Phase 2 Completed - United States, Texas ... More >> UTMD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01450826 - Completed - -
NCT00501891 Glioblastoma Multiforme Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center (Brain Tumor Center) Durham, North Carolina, United States, 27710 Less <<
NCT00401180 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT03426891 Glioblastoma ... More >>Brain Tumor GBM Less << Phase 1 Recruiting April 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Melissa Wicklund    813-745-3620    melissa.wicklund@moffitt.org    Contact: Solmaz Sahebjam, M.D.    813-745-6101    solmaz.sahebjam@moffitt.org Less <<
NCT00050986 Glioblastoma Multiforme Phase 1 Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00501891 - Completed - -
NCT00020150 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00027625 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75390-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-6220 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00050986 - Completed - -
NCT00049361 Brain and Central Nervous Syst... More >>em Tumors Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Illinois ... More >> CCOP - Central Illinois Decatur, Illinois, United States, 62526 United States, North Carolina CCOP - Southeast Cancer Control Consortium Goldsboro, North Carolina, United States, 27534-9479 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1030 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 Less <<
NCT00033709 Sarcoma Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT00006024 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 1 Completed - -
NCT00568048 Melanoma (Skin) Phase 2 Completed - Switzerland ... More >> Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Less <<
NCT00544284 Brain and Central Nervous Syst... More >>em Tumors Lymphoma Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT00612339 Glioblastoma ... More >>Gliosarcoma Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT00052780 Childhood Central Nervous Syst... More >>em Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Tennessee ... More >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 Less <<
NCT00590681 Glioblastoma Multiforme Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 NorthShore University health system Evanston, Illinois, United States, 60201 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48103 United States, Wisconsin Medical college of Wisconsin Milwaukee, Wisconsin, United States, 53226 Waukesha health care Waukesha, Wisconsin, United States, 53188 Less <<
NCT00072163 Recurrent Melanoma ... More >> Stage IV Melanoma Tumors Metastatic to Brain Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00049387 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Completed - United States, Maryland ... More >> Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Less <<
NCT00673361 Melanoma Phase 2 Terminated - -
NCT00660621 Glioma Phase 2 Unknown December 2010 United States, Kentucky ... More >> Kentuckiana Cancer Institute Recruiting Louisville, Kentucky, United States, 40202 Contact: Roxann R. Smalley, JD    502-561-8200 ext 285    rsmalley@kci.us    Principal Investigator: Renato V. LaRocca, MD Less <<
NCT00673361 - Terminated - -
NCT00003176 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00083096 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Unknown - France ... More >> Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT00004200 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Agouron Pharmaceuticals, Inc. La Jolla, California, United States, 92037 Less <<
NCT00782756 - Completed - -
NCT00006358 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Maryland Neuro-Oncology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00883298 Recurrent Glioblastoma Multifo... More >>rme Recurrent Gliosarcoma Less << Phase 2 Completed - United States, Arizona ... More >> Center for Neurosciences Tucson, Arizona, United States, 85718 Less <<
NCT00869050 Neuroendocrine Tumors Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00904852 Glioblastoma Multiforme Phase 1 Withdrawn June 2010 -
NCT00782756 Brain Cancer ... More >>Malignant Glioma Less << Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00811759 Melanoma (Skin) Phase 1 Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00905060 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> UCSF Department of Neurosurgery San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, New Jersey The Valley Hospital Paramus, New Jersey, United States, 07652 United States, New York Northern Westchester Hospital Mount Kisco, New York, United States, 10549 Columbia University New York, New York, United States, 10032 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00098865 Central Nervous System Tumor, ... More >>Pediatric Neuroblastoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00869050 - Completed - -
NCT00612339 - Completed - -
NCT00102648 Malignant Supratentorial Neopl... More >>asm Recurrent Glioblastoma Recurrent Gliosarcoma Less << Phase 1 Active, not recruiting December 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00098865 - Completed - -
NCT00100802 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Unknown - -
NCT00943826 - Completed - -
NCT00104988 Melanoma (Skin) Phase 2 Completed - -
NCT00998010 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting June 30, 2019 United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 Less <<
NCT00100802 - Unknown - -
NCT00109798 Central Nervous System Tumors ... More >> Lymphoma Less << Not Applicable Withdrawn(Sub-Investigator rel... More >>oacted to another institution) Less << - -
NCT00943826 Glioblastoma Phase 3 Completed - -
NCT01013285 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown January 2017 United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT01048554 Melanoma Phase 2 Completed - United States, California ... More >> Saint Mary's Medical Center, 6th Floor San Francisco, California, United States, 94117 The Angeles Clinic and Research Institute Santa Monica, California, United States, 90404 United States, Florida Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT00990652 - Completed - -
NCT00238277 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Terminated(Terminated - due to... More >> low accrual) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00128700 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Germany Klinikum der Universitaet Regensburg Regensburg, Germany, D-93053 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3075 EA Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT00238251 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Completed - Switzerland ... More >> Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT01115491 Glioblastoma Multiforme Phase 2 Completed - Spain ... More >> Barcelona, Spain, 08025 Barcelona, Spain, 08907 Barcelona, Spain, 08916 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Valencia, Spain, 41014 Valencia, Spain, 46026 Less <<
NCT01102595 Glioblastomas Phase 2 Completed - Spain ... More >> Grupo Español de Investigacion en Neurooncologia Madrid, Spain, 28001 Less <<
NCT00275002 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00990652 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00275002 - Completed - -
NCT01115491 - Completed - -
NCT00283543 Newly Diagnosed Supratentorial... More >> Malignant Glioma Less << Phase 2 Unknown April 2008 United States, Kentucky ... More >> Kentuckiana Cancer Institute Louisville, Kentucky, United States, 40202 Less <<
NCT00275067 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Active, not recruiting May 2020 United States, Illinois ... More >> Hematology-Oncology Associates of Illinois Chicago, Illinois, United States, 60611-2998 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Edward Cancer Center Naperville, Illinois, United States, 60540 Less <<
NCT01164189 Central Nervous System Tumors Phase 2 Unknown - -
NCT00268385 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Recurrent Adult Brain Neoplasm Less << Phase 1 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00305864 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Less << Phase 1 Phase 2 Completed - -
NCT01209442 Glioblastoma Multiforme Phase 2 Completed - United States, Colorado ... More >> University of Colorado Denver, University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT00305864 - Completed - -
NCT00304200 Metastatic Malignant Melanoma Phase 1 Phase 2 Terminated(Funding was inadequ... More >>ate to continue; Companies requested closure.) Less << - United States, California ... More >> Northern California Melanoma Center San Francisco, California, United States, 94109 Less <<
NCT00301067 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting May 2020 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00354068 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT01217398 Intraocular Melanoma Phase 2 Unknown - France ... More >> Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Contact Person    33-1-4432-4068    sophie.piperno-neumann@curie.net Less <<
NCT00385853 Glioblastoma Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00389090 Glioma Astroc... More >>ytoma Oligodendroglioma Oligoastrocytoma Less << Phase 2 Terminated(AOI Pharma terminat... More >>ed the license agreement. IND Transferred to NCI) Less << - United States, California ... More >> AOI Pharmaceuticals Investigative Site Los Angeles, California, United States, 90033 United States, Florida AOI Pharmaceuticals Investigative Site Orlando, Florida, United States, 32804 United States, Illinois AOI Pharmaceuticals Investigative Site Chicago, Illinois, United States, 60611 AOI Pharmaceuticals Investigative Site Evanston, Illinois, United States, 60201 United States, Kentucky AOI Pharmaceuticals Investigative Site Lexington, Kentucky, United States, 40536 AOI Pharmaceuticals Investigative Site Louisville, Kentucky, United States, 40202 United States, Minnesota AOI Pharmaceuticals Investigative Site Minneapolis, Minnesota, United States, 54407 United States, North Carolina AOI Pharmaceuticals Investigative Site Durham, North Carolina, United States, 27710 United States, South Carolina AOI Pharmaceuticals Investigative Site Greenville, South Carolina, United States, 29605 United States, Texas AOI Pharmaceuticals Investigative Site Dallas, Texas, United States, 75246 AOI Pharmaceuticals Investigative Site Houston, Texas, United States, 77024 United States, Utah AOI Pharmaceuticals Investigative Site Salt Lake City, Utah, United States, 84132 Less <<
NCT00436436 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Terminated(Study closed to acc... More >>rual after the company chose to stop development of the drug.) Less << - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Neuro-Oncology Branch Bethesda, Maryland, United States, 20892-8200 Less <<
NCT00436436 - Terminated(Study closed to acc... More >>rual after the company chose to stop development of the drug.) Less << - -
NCT00481455 Recurrent Glioblastoma Multifo... More >>rme Less << Phase 2 Completed - United States, North Carolina ... More >> The Brain Tumor Center, Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00514397 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Contact Person    44-353-1-409-6659       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B4 6NH Contact: Martin W. English, MD    44-121-333-8412    martin.english@bch.nhs.uk    Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: Contact Person    44-117-342-0205       Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Amos Burke, MD    44-1223-348-151       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Adam Glaser, MD    44-113-206-4984    adam.glaser@leedsth.nhs.uk    Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Contact Person    44-151-252-5294       University College Hospital Recruiting London, England, United Kingdom, NW1 2BU Contact: Contact Person    44-20-7380-9950       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person    44-20-7829-7924       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Contact Person    44-113-206-4985       Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Contact Person    44-115-823-0620       Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Contact Person    44-1865-234-205       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Contact Person    44-114-271-7366       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-2380-794-101       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-20-8661-3455       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Veronica Neefjes    44-1224-550-217       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Heidi Traunecker, MD, PhD    44-29-2074-2285    heidi.traunecker@cardiffandvale.wales.nhs.uk Less <<
NCT00515788 Neoplastic Meningitis Phase 1 Terminated(Study terminated du... More >>e to slow accrual with no expansion to additional phase.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00486603 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Unknown - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00521482 Glioblastoma Phase 2 Unknown January 2009 Switzerland ... More >> University Zurich, Departement of Neurosurgery Not yet recruiting Zurich, Switzerland, 8091 Principal Investigator: Miroslava Bjeljac, MD Less <<
NCT00526617 Non-hematologic Malignancies ... More >> Metastatic Melanoma Breast Cancer Ovarian Cancer Primary Peritoneal Cancer Fallopian Tube Cancer Hepatocellular Carcinoma Less << Phase 1 Completed - -
NCT00548938 Glioblastoma Multiforme ... More >> High-Grade Glioma Less << Phase 2 Terminated(Principal Investiga... More >>tor has left the institution) Less << October 2010 United States, Tennessee ... More >> Methodist University Hospital Memphis, Tennessee, United States, 38104 Less <<
NCT00612989 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT03517137 Advanced Hodgkin Lymphoma Phase 2 Not yet recruiting September 1, 2023 -
NCT00412503 Refractory Tumors ... More >> Malignant Tumors Less << Phase 1 Completed - France ... More >> Institut Gustave Roussy Villejuif, Ille de France, France, 94805 Less <<
NCT02394665 Glioblastoma Phase 2 Terminated(Lack of Accrual/Enr... More >>ollment) Less << - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 Less <<
NCT02477813 Small Cell Lung Cancer Recurre... More >>nt Less << Phase 2 Terminated(Lack of eligible pa... More >>tient recruitment) Less << - Italy ... More >> Ircc Irst Meldola, FC, Italy, 47014 Oncologia Medica, Azienda ospedaliera universitaria di Ferrara Ferrara, FE, Italy, 44124 Oncologia Medica AOU Policlinico di Modena Modena, MO, Italy, 41100 U.O. Oncologia Medica Faenza, RA, Italy, 48018 U.O Oncologia medica Lugo, RA, Italy, 48022 UO Oncologia Medica, Ospedale S.Maria delle Croci Ravenna, RA, Italy, 48121 U.O Oncologia medica Rimini, RN, Italy, 47923 Oncologia Medica Ospedale Guglielmo da Saliceto Piacenza, Italy, 29121 Less <<
NCT02394665 - Terminated(Lack of Accrual/Enr... More >>ollment) Less << - -
NCT02494804 Cytokine-Induced Killer Cells ... More >> Milignant Gliomas Less << Phase 1 Phase 2 Not yet recruiting July 2030 -
NCT02385136 NSCLC Phase 1 Phase 2 Unknown December 2018 -
NCT02395692 Adult Brain Glioblastoma Phase 2 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Maryland Adult Brain Tumor Consortium Baltimore, Maryland, United States, 21231-1000 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Michigan Henry Ford Cancer Institute¿Downriver Brownstown, Michigan, United States, 48183 Henry Ford Hospital Detroit, Michigan, United States, 48202 Henry Ford West Bloomfield Hospital West Bloomfield, Michigan, United States, 48322 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02507232 Glioma Phase 2 Recruiting April 2022 United States, California ... More >> John Wayne Cancer Institute Recruiting Santa Monica, California, United States, 90404 Less <<
NCT02496988 Cytokine-Induced Killer Cells ... More >> Advanced Milignant Gliomas Less << Phase 4 Not yet recruiting July 2030 -
NCT02590263 Malignant Glioma ... More >> Glioblastoma Multiforme Less << Phase 1 Phase 2 Recruiting December 31, 2020 Japan ... More >> Nagoya University Hospital /ID# 138559 Completed Nagoya-shi, Aichi, Japan, 466-8560 Iwate Medical University Hospital /ID# 149145 Recruiting Morioka-shi, Iwate, Japan, 020-8505 Kitasato University Hospital /ID# 148493 Recruiting Sagamihara-shi, Kanagawa, Japan, 252-0375 Kyoto Prefect Univ Med /ID# 149093 Recruiting Kyoto-shi, Kyoto, Japan, 602-8566 Tohoku University Hospital /ID# 138464 Recruiting Sendai-shi, Miyagi, Japan, 980-8574 Okayama University Hospital /ID# 148674 Recruiting Okayama-shi, Okayama, Japan, 700-8558 Osaka University Hospital /ID# 140438 Recruiting Suita-shi, Osaka, Japan, 565-0871 Shizuoka Cancer Center /ID# 148673 Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 National Cancer Center Hospital /ID# 140435 Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Kyorin University Hospital /ID# 140360 Recruiting Mitaka-shi, Tokyo, Japan, 181-8611 Tokyo Women's Medical University Hospital /ID# 140436 Recruiting Shinjuku-ku, Tokyo, Japan, 162-8666 Chiba Cancer Center /ID# 164375 Recruiting Chiba, Japan, 260-0801 Saitama Med Univ Int Med Ctr /ID# 140361 Recruiting Hidaka, Japan, 350-1241 Hiroshima University Hospital /ID# 139399 Recruiting Hiroshima, Japan, 734-8551 Kumamoto University Hospital /ID# 138558 Recruiting Kumamoto, Japan, 860-0862 NHO Kyoto Medical Center /ID# 140437 Recruiting Kyoto, Japan, 612-0861 Osaka Inter. Cancer Institute /ID# 148494 Recruiting Osaka, Japan, 541-8567 Kyoto University Hospital /ID# 163206 Recruiting Sakyo-ku, Japan, 606-8507 Hokkaido University Hospital /ID# 150589 Recruiting Sapporo, Japan, 060-8648 Dokkyo Medical University Hosp /ID# 150990 Recruiting Shimotsuga, Japan, 321-0293 Nihon University Itabashi Hosp /ID# 149385 Recruiting Tokyo, Japan, 173-0032 Tsukuba University Hospital /ID# 140433 Recruiting Tsukuba, Japan, 305-8576 Less <<
NCT00610571 Glioblastoma ... More >>Gliosarcoma Anaplastic Astrocytoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT02605811 Small Cell Lung Cancer ... More >> Metastatic Carcinoma Less << Phase 2 Enrolling by invitation April 2021 China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT02663440 Glioblastoma Multiforme Phase 2 Unknown - China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    86-571-88122098    cxzfyun@sina.com    Principal Investigator: Xiaozhong Chen, MD Less <<
NCT02654106 Brain Metastases Phase 2 Completed - China, Beijing ... More >> Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Less <<
NCT02661282 Glioblastoma ... More >>Gliosarcoma Less << Phase 1 Phase 2 Recruiting June 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02766270 Grade II/III Glioma Early Phase 1 Recruiting December 2018 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100050 Contact: Xiao-Guang Qiu, M.D.       ttyy6611@126.com    Principal Investigator: Tao Jiang, M.D. Less <<
NCT02685605 Glioblastoma Phase 3 Recruiting February 2021 United States, Arizona ... More >> Barrow Neurological Institute (SJHMC) Not yet recruiting Phoenix, Arizona, United States, 85013 Contact: Rima Woo       Rima.Woo@barrowbrainandspine.com    Principal Investigator: Peter Nakaji, MD          United States, Illinois Stritch School of Medicine Loyola University Recruiting Maywood, Illinois, United States, 60153 Contact: Beth A Chiappetta, RN, BSN, CCRP    708-216 ext 2568    BCHIAPPETTA@lumc.edu    Principal Investigator: William Small Jr, MD, FACRO, FACR, FASTRO          United States, New York Long Island Jewish Medical Center, North Shore University Hospital Recruiting Lake Success, New York, United States, 11042 Contact: Louise A Purcell, MS ANP-C CCRN-CMC    +1 516-941 ext 1263    LPurcell@northwell.edu    Sub-Investigator: Michael Schulder, MD          Lenox Hill Hospital, Hofstra Northwell School of Medicine Recruiting New York, New York, United States, 10028 Contact: Tamika A Wong, MPH    212-434-4836    twong4@northwell.edu    Principal Investigator: John A. Boockvar, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506-9260 Contact: Joseph Brunetti    304-293-7360       Principal Investigator: Christopher P Cifarelli, MD, PhD, FAANS, FACS          Canada, Quebec Montreal Neurological Institute and Hospital Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact: Anna Pietromonaco    +1-514-398- ext 2591    anna.pietromonaco@mcgill.ca    Contact: Gregory Ringkamp    +1-514-398- ext 2667    gregory.ringkamp@mcgill.ca    Principal Investigator: Kevin Petrecca, MD          Sub-Investigator: Luis Souhami, MD          Germany Klinikum Augsburg Recruiting Augsburg, Germany, 86156 Contact: Sabine Schill, PhD    +49 821 400 25 42    Sabine.Schill@klinikum-augsburg.de    Principal Investigator: Klaus H Kahl, MD          University Hospital Mannheim Recruiting Mannheim, Germany, 68167 Contact: Anke Keller, MSc    00496213834960    anke.keller@medma.uni-heidelberg.de    Principal Investigator: Frank A Giordano, MD          Sub-Investigator: Daniel Haenggi, MD          Sub-Investigator: Michael Platten, MD          Technical University of Munich (TUM), Department of Radiation Oncology Recruiting Munich, Germany, 81675 Contact: Carmen Kessel, PhD    +49 89 4140-4501    carmen.kessel@tum.de]    Principal Investigator: Stephanie E Combs, MD          Klinikum Stuttgart Recruiting Stuttgart, Germany, 70174 Contact: Ulrike Arzbach    +49 711/ 278-33700    u.arzbach@klinikum-stuttgart.de    Principal Investigator: Oliver Ganslandt, MD          Sub-Investigator: Marc Münter, MD          Spain Catalan Institute of Oncology (ICO) Recruiting Barcelona, Spain, 08908 Contact: Montserrat Ventura Bujalance    + 34 93 260 77 22    montseventura@iconcologia.net    Principal Investigator: Ferran Guedea, MD, PhD          United Kingdom The London Clinic Not yet recruiting London, United Kingdom, W1G 6BW Contact: Christine Topham    020 3219 3570 ext 8389    C.Topham@thelondonclinic.co.uk    Contact: Alistair Gifford-Moore    020 3219 3570 ext 8384    A.Gifford-Moore@thelondonclinic.co.uk    Principal Investigator: n.n. n.n. Less <<
NCT02681705 Medulloblastoma Phase 2 Unknown December 2016 China, Shanghai ... More >> The Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Chuanying zhu, MD    862125076994    sdnanhai123@163.com    Principal Investigator: Mawei Jiang, MD Less <<
NCT02772107 Extensive-stage Small Cell Lun... More >>g Cancer Less << Phase 2 Phase 3 Unknown January 2018 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: haitao tao, PhD    +861066937875    whatyouknow@126.com Less <<
NCT02672241 Childhood Brain Stem Neoplasm Phase 2 Recruiting August 2019 China, Shanghai ... More >> he Department of Radiation Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: chuanying zhu, MD    862125076994    sdnanhai123@163.com Less <<
NCT02799238 Glioblastoma Phase 2 Recruiting January 2022 Sweden ... More >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden Contact: Katja Werlenius, Dr. Med          Principal Investigator: Katja Werlenius          Sub-Investigator: Marie Sjögren          Ryhov hospital Recruiting Jönköping, Sweden, 55185 Contact: Mickael Stradeus, MD       mickael.stradeus@rjl.se    Skånes university hospital Recruiting Lund, Sweden, 221 85 Contact: Sara Kinhult, MD       sara.kinhult@skane.se    Karolinska University hospital Recruiting Stockholm, Sweden, 171 76 Contact: Giuseppe Stragliotto, MD       giuseppe.stragliotto@karolinska.se    Contact: Sofia Hylin, MD       sofia.hylin@karolinska.se Less <<
NCT02781792 Glioma Gliobl... More >>astoma Multiforme Less << Phase 1 Recruiting August 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jian Campian, M.D., Ph.D.    314-747-4241    campian.jian@wustl.edu    Principal Investigator: Jian Campian, M.D., Ph.D.          Sub-Investigator: Katherine Weilbaecher, M.D.          Sub-Investigator: Joshua Rubin, M.D., Ph.D. Less <<
NCT02805179 Glioma Phase 2 Recruiting June 2020 United States, Michigan ... More >> University of Michigan Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Jody Sharp    734-615-4909    sharpjd@umich.edu    Principal Investigator: Michelle Kim, M.D. Less <<
NCT02871843 Glioblastoma ... More >>Oligodendroglioma Anaplastic Oligodendroglioma Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California San Francisco (UCSF) Recruiting San Francisco, California, United States, 94143 Contact: Jane Rabbitt    415-353-2652    Jane.Rabbitt@ucsf.edu    Contact: Thelma Munoz    415-353-2523    Thelma.Munoz@ucsf.edu    Principal Investigator: Nicholas Butowski, MD          United States, New Jersey The Cancer Institute of New Jersey (Rutgers University) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Ling Zheng    732-235-8865    Zhengl1@cinj.rutgers.edu    Principal Investigator: Robert Aiken, MD          United States, New York Weill Cornell Brain Tumor Center Recruiting New York, New York, United States, 10021 Contact: Kate Carbonell    646-962-6137    kac2051@med.cornell.edu    Principal Investigator: Howard A Fine, MD Less <<
NCT02864368 Glioblastoma ... More >>Glioblastoma Multiforme Less << Phase 1 Recruiting October 2020 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Kristen Fisher    919-684-5301 Less <<
NCT02970448 High Grade Glioma Early Phase 1 Recruiting January 2020 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Jennifer Yu, MD, PhD    216-445-9799    yuj2@ccf.org Less <<
NCT02903069 Glioblastoma ... More >>Malignant Glioma Less << Phase 1 Recruiting May 31, 2020 United States, California ... More >> University of California, Irvine Medical Center Comprehensive Brain Tumor Program Recruiting Irvine, California, United States, 92697 Contact: Jinah Chung    714-456-8442    jinahec@uci.edu    Principal Investigator: Daniela Bota, MD, PhD          University of California, San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92037 Contact: Brian Churas    858-534-7996    bchuras@ucsd.edu    Principal Investigator: David Piccioni, MD, PhD          John Wayne Cancer Institute at the Providence Saint John's Health Center Recruiting Santa Monica, California, United States, 90404 Contact: Najee Boucher    310-582-7460    najee.boucher@providence.org    Principal Investigator: Santosh Kesari, MD, PhD          United States, Illinois Northwestern Brain Tumor Institute at Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Anne Mendelke       anne.mendelke@northwestern.edu    Contact: Roger Stupp, MD    (855) 695-6284       United States, North Carolina Duke University Medical Center, Preston Robert Tisch Brain Tumor Center Recruiting Durham, North Carolina, United States, 27710 Contact: Sarah Woodring    919-684-2527    sarah.woodring@duke.edu    Contact: Denise Jaggers    919-613-6803    denise.jaggers@dm.duke.edu    Principal Investigator: Annick Desjardins, MD          United States, Pennsylvania Penn State Health Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Scott Murphy    717-531-0003 ext 283114    smurphy6@pennstatehealth.psu.edu    Principal Investigator: Dawit G Aregawi, MD          Canada, Ontario Princess Margaret Hospital, Gerry and Nancy Pencer Brain Tumour Centre Recruiting Toronto, Ontario, Canada Contact: Mariya Bakalets    416-946-4603    mariya.bakalets@uhn.ca    Contact: Elena Chizhov    416-946-4624    elena.chizhov@uhn.ca    Principal Investigator: Warren Mason, MD          Switzerland University Hospital Zurich Brain Tumor Center Recruiting Zurich, Switzerland, 8091 Contact: Carola Keding    +41 44 255 55 00    carola.keding@usz.ch    Principal Investigator: Patrick Roth, MD Less <<
NCT02976441 Astrocytoma B... More >>rainstem Glioma Ependymoma Mixed Glioma Oligodendroglioma Optic Nerve Glioma Less << Early Phase 1 Withdrawn(Physician decided no... More >>t to go through with study) Less << February 2018 -
NCT02977780 Glioblastoma Phase 2 Recruiting May 2021 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: L. Burt Nabors, MD    205-934-1432    bnabors@uab.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Isabel Arrillaga-Romany, MD PhD    617-724-8770    iarrillaga@mgh.harvard.edu    Principal Investigator: Isabel Arrillaga-Romany, MD PhD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Brian Alexander, MD MPH    617-732-7560    Brian_Alexander@dfci.harvard.edu    Contact: Lisa Doherty, NP    617-632-2166    lisa_doherty@dfci.harvard.edu    Principal Investigator: Brian Alexander, MD MPH          United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Eva Galanis, MD    507-284-2511    galanis.evanthia@mayo.edu    United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Mary Welch, MD    212-342-0571    mw2517@cumc.columbia.edu    United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia,, MD    216-444-6145    ahluwam@ccf.org    United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Jan Drappatz, MD    412-864-7791    drappatzj@upmc.edu    United States, Texas UT MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: John DeGroot, MD    713-745-3072    jdegroot@mdanderson.org    United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Howard Colman, MD    801-587-4042    Howard.colman@hci.utah.edu    United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: David Schiff, MD    434-924-5610    Ds4jd@virginia.edu Less <<
NCT03008148 Glioblastoma Phase 2 Phase 3 Not yet recruiting October 2023 Taiwan ... More >> Taipei Veterans General Hospital Not yet recruiting Taipei City, Taiwan, 11217 Principal Investigator: Yu-Ming Liu          Tri-Service General Hospital Not yet recruiting Taipei City, Taiwan, 11490 Principal Investigator: Hsin-I Ma Less <<
NCT03082846 Glioma Radiot... More >>herapy, Intensity-Modulated Maximum Tolerated Dose Less << Not Applicable Completed - -
NCT03180502 1p/19q Co-deletion ... More >> Anaplastic Astrocytoma Diffuse Astrocytoma Glioma IDH1 Gene Mutation IDH2 Gene Mutation Oligoastrocytoma Oligodendroglioma WHO Grade III Glioma Less << Phase 2 Recruiting August 31, 2027 United States, Illinois ... More >> Northwestern Medicine Cancer Center Delnor Recruiting Geneva, Illinois, United States, 60134 Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org    Principal Investigator: Vinai Gondi          Northwestern Medicine Cancer Center Warrenville Recruiting Warrenville, Illinois, United States, 60555 Contact: Site Public Contact    630-315-1918    Claudine.Gamster@CadenceHealth.org    Principal Investigator: Vinai Gondi          United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact    877-726-5130       Principal Investigator: Helen A. Shih          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Site Public Contact    855-776-0015       Principal Investigator: Anita Mahajan          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Christina I. Tsien          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: David R. Grosshans          United States, Washington Seattle Cancer Care Alliance at Northwest Hospital Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact    206-606-5800       Principal Investigator: Yolanda D. Tseng          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact    800-804-8824       Principal Investigator: Yolanda D. Tseng Less <<
NCT03181477 Glioblastoma, Adult Not Applicable Recruiting August 4, 2020 France ... More >> CHU Besançon Not yet recruiting Besançon, France Principal Investigator: Patrick Dr Bontemps, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21850 Principal Investigator: Dr Gille TRUC, MD          Centre d'oncologie et de radiothérapie Not yet recruiting Mâcon, France Principal Investigator: Valérie Dr POUCHARD, MD          Institut de cancérologie de Lorraine Recruiting Nancy, France Principal Investigator: valérie Dr Bernier, MD          Paul Strauss Not yet recruiting Strasbourg, France, 67000 Principal Investigator: Delphine Dr Antoni, MD          Centre de Cancérologie Des Dentellières Not yet recruiting Valenciennes, France Principal Investigator: niolas Dr BLANCHARD, MD Less <<
NCT03232424 Glioblastoma, Adult Phase 1 Recruiting July 2027 United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Lori Cappello    551-996-5098    Lori.Cappello@HackensackMeridian.org    Principal Investigator: Samuel A Goldlust, MD          Sub-Investigator: Samuel Singer, MD          Sub-Investigator: Kangmin D Lee, MD          Sub-Investigator: Hooman Azmi Ghadimi, MD          Sub-Investigator: Anthony C Ingenito, MD          Sub-Investigator: Brett E Lewis, MD, PhD          Sub-Investigator: George J Kaptain, MD Less <<
NCT03310372 Glioblastoma Multiforme Phase 2 Completed - -
NCT03345095 Newly Diagnosed Glioblastoma Phase 3 Recruiting July 2023 Belgium ... More >> GasthuisZusters Antwerpen - Sint-Augustinus Recruiting Antwerpen, Belgium Principal Investigator: Paul Meijnders, Dr          Grand Hopital de Charleroi - Grand Hôpital de Charleroi - Site Notre Dame Recruiting Charleroi, Belgium Principal Investigator: Vincent Verschaeve, Dr          Canada, Ontario Windsor Regional Cancer Centre Recruiting Windsor, Ontario, Canada Principal Investigator: Kay Amin, Dr          Canada CHUM - Centre Hospitalier de l'Université de Montreal - Hopital Notre-Dame Recruiting Montréal, Canada Principal Investigator: Laura Masucci Giuseppina          CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Québec, Canada Principal Investigator: Andre Blaise          Allan Blair Cancer Centre Recruiting Regina, Canada Principal Investigator: Ibrahim Chalchal Haji          Odette Cancer Centre - Sunnybrook Health Sciences Centre Recruiting Toronto, Canada Principal Investigator: James Perry          University Health Network - Oci / Princess Margaret Hospital Recruiting Toronto, Canada Principal Investigator: Mason Warren          Centre hospitalier regional de Trois-Rivieres Recruiting Trois-Rivières, Canada Principal Investigator: Anouk Tremblay, Dr          France CHRU de Lille Recruiting Lille, France Principal Investigator: Emilie Le Rhun, Dr          Institut de Cancerologie de l'Ouest Recruiting Nantes, France Principal Investigator: Jean-Sebastien Frenel          Netherlands Spaarne Gasthuis - Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Netherlands Principal Investigator: Myra van Linde          Universitair Medisch Centrum - Academisch Ziekenhuis Recruiting Utrecht, Netherlands, 3584 Contact       f.devos@umcutrecht.nl    Principal Investigator: Filip De Vos          Norway Oslo University Hospital - Radiumhospitalet Recruiting Oslo, Norway Contact       petter.brandal@ous-hf.no    Principal Investigator: Petter Brandal          Spain Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) Recruiting Badalona, Spain Contact       cbalana@iconcologia.net    Principal Investigator: Carmen Balana          Clinica Universidad de Navarra - Clinica Universitaria De Navarra Recruiting Pamplona, Spain Principal Investigator: Gallego Jaime          Switzerland University Hospital of Geneva Recruiting Geneva, Switzerland Contact: Anna Patrikidou, MD          Principal Investigator: Anna Patrikidou          Centre Hospitalier Universitaire Vaudois Not yet recruiting Lausanne, Switzerland Contact: Andreas Hottinger, MD          Principal Investigator: Andreas Hottinger          Kantonsspital Not yet recruiting Saint Gallen, Switzerland Principal Investigator: Thomas Hundsberger          UniversitaetsSpital Recruiting Zürich, Switzerland Contact: Patrick Roth, MD          Principal Investigator: Patrick Roth Less <<
NCT03388372 Glioblastoma Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 China Guangdong Brain Hospital Guangdong, China The First Affiliated Hospital/School of Clinical Medicine of Guangdong Guangdong, China The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China Shenzhen People's Hospital Shenzhen, China Less <<
NCT02880410 Glioblastoma Phase 1 Active, not recruiting December 2020 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03451799 GBM Glioblast... More >>oma Less << Phase 1 Recruiting September 2020 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Laura Lockshon    424-315-2219    Laura.Lockshon@cshs.org    Principal Investigator: Jethro Hu, MD Less <<
NCT03466450 Glioblastoma Phase 1 Phase 2 Recruiting March 2021 Spain ... More >> Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Carmen Balañá, M.D.    +34 972 22 58 34    cbalana@iconcologia.net    Principal Investigator: Carmen Balañá, M.D.          Institut Catalá de Oncología Girona/Hospital Universitari Dr. Josep Trueta Recruiting Girona, Spain, 17007 Contact: Sonia del Barco, M.D.    +34 972 22 58 34 ext 7977    sdelbarco@iconcologia.net    Principal Investigator: Sonia del Barco, M.D.          Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain Contact: Mª Ángeles Vaz    91 336 80 00 ext 7977    mavaz4@gmail.com    Principal Investigator: Mª Ángeles Vaz, M.D.          Hospital Universitario y Politécnico La Fe Recruiting Valencia, Spain, 46009 Contact: José Muñoz Langa, M.D.    +34 934344412    munyoz_joslan@gva.es    Principal Investigator: José Muñoz Langa, M.D. Less <<
NCT03291990 Glioblastoma Multiforme Early Phase 1 Recruiting October 1, 2021 United States, District of Col... More >>umbia Sibley Hospital Not yet recruiting Washington, District of Columbia, United States, 20016 Contact: Victoria Croog, MD    202-537-4787    vcroog1@jhmi.edu    Principal Investigator: Victoria Croog, MD          Suburban Hospital Not yet recruiting Washington, District of Columbia, United States, 20818 Contact: Brandi Pge, MD    301-896-2012    bpage5@jhmi.edu    Principal Investigator: Brandi Page, MD          United States, Maryland SKCCC at Johns Hopkins (East Baltimore) Recruiting Baltimore, Maryland, United States, 21287 Contact: Lawrence Kleinberg, MD    410-614-2597    lkleinb1@jhmi.edu    Sub-Investigator: Chetan Bettegowda, MD          Sub-Investigator: Stuart Grossman, MD          Sub-Investigator: Matthias Holdhoff, MD          Sub-Investigator: Michael Lim, MD          Sub-Investigator: Kristin Redmond, MD Less <<
NCT03477110 Glioblastoma Early Phase 1 Recruiting March 2020 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Wenyin Shi, MD    215-955-6702    wenyin.shi@jefferson.edu Less <<
NCT03514069 Glioma Gliobl... More >>astoma Less << Phase 1 Recruiting December 2020 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet Ahluwalia, MD    866-223-8100    CancerCenterResearch@ccf.org    Principal Investigator: Manmeet Ahluwalia, MD Less <<
NCT02520635 Glioblastoma Phase 4 Unknown December 2017 China, Beijing ... More >> Beijing Tiantan Hospital Recruiting Beijing, Beijing, China, 100005 Less <<
NCT03491683 Glioblastoma Phase 1 Phase 2 Recruiting January 18, 2021 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Site Care Coordinator Nurse Fatemeh Bidmeshk, BSN    626-218-4062    fbidmeshki@coh.org    Principal Investigator: Dr. Jana Portnow          Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Study Coordinator Hari Priya Yerraballa    650-724-9363    yhpriya@stanford.edu    Principal Investigator: Seema Nagpal, MD          University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Study Coordinator Karishma Kumar    415-514-5529    karishma.kumar@ucsf.edu    Principal Investigator: Nancy Ann Oberheim Bush, MD          United States, Florida University of Miami - Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Study Coordinator Alain Fernandez    305-243-9553    axf1187@med.miami.edu    Principal Investigator: Antonio Omuro, MD          United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator John Gaggin, RN    313-916-3731    gaggin1@hfhs.org    Principal Investigator: Tobias Walbert, MD          United States, New Jersey Rutgers University - Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Study Coordinator Coordinator Sarah Nabeel, CCRP    732-235-8995    sn569@cinj.rutgers.edu    Principal Investigator: Robert Aiken, MD          United States, New York New York University Langone Medical Center; Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact: Study Coordinator Amie Patel, RN       Amie.Patel@nyumc.org    Principal Investigator: Andrew Chi, MD, PhD          Columbia University Medical Center The Neurological Institute of New York Recruiting New York, New York, United States, 10032 Contact: Clinical Research Manager Natalie Busby    212-305-8487    Nb2718@cumc.columbia.edu    Principal Investigator: Dr. Mary Welch          United States, Oklahoma Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Senior Oncology Research Nurse Team Lead Dena Suthers    405-271-8001 ext 2    Phase1ResearchNurses@ouhsc.edu    Principal Investigator: Dr. James Battiste          United States, Pennsylvania University of Pennsylvania Health System: Penn Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Department of Neurosurgery Penn Brain Tumor Center       NCRD-BTC@uphs.upenn.edu    Principal Investigator: Steven Brem, MD          UPMC Cancer Center Neuro-Oncology; UPMC Cancer Pavilion Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Supervisor, Clinical Research Services Melinda Vargas-Jaffe, BSN RN CCRC    412-235-1320    vargasjaffema@upmc.edu    Principal Investigator: Dr. Frank Lieberman          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Clinical Research Coordinator Matt Halverson    801-587-4756    Matt.Halverson@hci.utah.edu    Principal Investigator: Howard Colman, MD PhD Less <<
NCT03535350 Glioblastoma Phase 1 Recruiting April 1, 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Manmeet S. Ahluwalia, MD, FACP    216-444-6145    ahluwam@ccf.org Less <<
NCT03480867 Glioblastoma Multiforme, Adult Phase 1 Recruiting July 31, 2022 Canada, Québec, Canada ... More >> McGill University Health Centre-Cedars Cancer Centre Recruiting Montréal, Québec, Canada, Canada, H4A 3J1 Contact: Valerie Panet-Raymond, M.D.    514-934-4440    valerie.panet-raymond@mcgill.ca    Contact: Marianna Perna, CCRP    514-934-1934 ext 43191    marianna.perna@muhc.mcgill.ca    Sub-Investigator: Bassam Abdulkarim, M.D.          Sub-Investigator: Kevin Petrecca, M.D.          Sub-Investigator: Scott Owen, M.D.          Sub-Investigator: Donatella Tampieri, M.D.          Sub-Investigator: Marie-Christine Guiot, M.D. Less <<
NCT03529448 Glioblastoma Phase 1 Phase 2 Not yet recruiting June 2020 Spain ... More >> Institut Català d'Oncología L'Hospitalet Not yet recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Miguel Gil, M.D.       secretaria@geino.es    Principal Investigator: Miguel Gil, M.D.          Hospital Universitario Son Espases Palma de Mallorca, Mallorca, Spain Consorcio Hospitalario Provincial de Castellón Not yet recruiting Castelló, Valencia, Spain, 12002 Contact: Ramón de las Peñas, M.D.       secretaria@geino.es    Principal Investigator: Ramón de las Peñas, M.D.          Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Contact: Maria Martinez, M.D.       secretaria@geino.es    Principal Investigator: María Martínez, M.D.          Complejo Hospitalario Regional Virgen de las Nieves Not yet recruiting Granada, Spain, 18004 Contact: Raquel Luque, MD       secretaria@geino.es    Principal Investigator: Raquel Luque, M.D.          Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact: Juan Sepúlveda       secretaria@geino.es    Principal Investigator: Juan Sepúlveda, M.D.          Hospital Regional Universitario de Malaga Malaga, Spain Hospital Clínico Universitario de Salamanca Not yet recruiting Salamanca, Spain, 37007 Contact: Luis Miguel Navarro, M.D.       secretaria@geino.es    Principal Investigator: Luis Miguel Navarro, M.D. Less <<
NCT03422445 Advanced Melanoma Phase 2 Recruiting February 2019 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China Contact: Jun Guo Less <<
NCT03528642 Anaplastic Astrocytoma, IDH-Mu... More >>tant Diffuse Astrocytoma, IDH-Mutant IDH1 Gene Mutation IDH2 Gene Mutation Less << Phase 1 Not yet recruiting August 31, 2020 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.49mL

1.10mL

0.55mL

27.45mL

5.49mL

2.74mL

54.89mL

10.98mL

5.49mL

References

 

Historical Records

Categories